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Abstract 
The field of peptidomimetics has rapidly grown into an area of great interest for 
the design and synthesis of pharmaceutical drug targets.  The large array of natural 
peptides with biological function as well as the growing understanding of the roles of 
these peptides in biological events has led to a large interest in these compounds as 
drug candidates.  The majority of peptide and peptide-like molecules have not found 
widespread pharmaceutical utility; however, due to there lability in biological systems.  
This major drawback leads to the necessity for the development of peptide-like 
molecules with increased stability under biological conditions.  To this end there has 
been an increased interest in the development of unnatural amino acids for the 
synthetic modification of peptides and proteins.  
Presented in this dissertation is the synthesis of a series of unnatural amino 
acids designed for applications to [3+2] click cycloaddition reactions.  It also covers the 
introduction of these amino acids into the sequence of peptides for the purpose of 
labeling the peptide with aryl triazole chromophores in an attempt to analyze the 
electron transfer capabilities of aryl triazoles.  The information from the fluorescent 
studies of these peptides will provide a basis for the design of fluorophoric peptide 
probes that can be introduced into a peptide at any time under labile conditions.  This 
methodology provides a powerful tool for the analysis of peptide structure and the 
analysis of peptide-macromolecular interactions. 
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Part 1:  Clickable Unnatural Amino Acids and Their Application to the 
Modification of Peptides  
 2
Chapter 1:  Introduction 
 
Proteins are a key class of macromolecules that perform functional and structural 
tasks in virtually all physiological processes.  They are composed of linear sequences of 
amino acids that fold into specific three dimensional structures with exquisite control 
over reactive group placement.  Protein-macromolecule interactions implicated in 
disease have long been the highest goal of drug discovery; however, the complexities of 
protein structure, the conformational flexibility, and the poor pharmacology of peptide 
fragments have hindered this approach to therapeutic development.1   
Peptidomimetics is the term used to describe the design of modified peptides and 
peptide mimic compounds, and they address both the complexity and flexibility of 
protein structure by attempting to restrain peptide fragments in conformations similar to 
that of their intact protein’s structure.2  The reduced size and chemical diversity of 
peptidomimetics relative to natural peptides make them more pharmacologically 
desirable.  An enormous number of biological and physiological processes are 
controlled by peptides and short proteins.3, 4  Successful peptidomimetics offer the 
possibility of disrupting pathological protein-protein interfaces by competing with one of 
the interacting species.5-7  Traditionally peptidomimetics have been synthesized in non-
aqueous solvents; however, this often hinders attempts to isolate the biologically-
relevant conformations and can lead to peptidomimetics that are constrained in inactive 
states or that are largely disordered in solution.7  In many cases the final 
peptidomimetics constructed in this fashion are only mildly water soluble, which limits 
their utility as drug candidates.    
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To address this problem, synthetic transformations compatible with naturally 
occurring sidechain functional groups and aqueous solvents present the possibility of 
novel peptidomimetics with greater therapeutic potential.  Alkynes, nitriles and azides 
are energetic functional groups with narrow reactivity distributions under physiological 
conditions.8  When co-localized, alkynes and nitriles react rapidly, reliably, and 
irreversibly with azides in a [3+2] cycloaddition, click reaction, to form triazoles and 
tetrazoles respectively (Figure 1-1).  
Realizing the biological utility of [3+2] click cycloaddition reactions has led our 
group to the design and syntheses of amino acids bearing “clickable” functionalities 
(Figure 1-2).  Our major focus involves the development, characterization, and activity 
analysis of a variety of novel peptidomimetics, which incorporate a developed library of 
“clickable” amino acids.  It is well known that many biologically active peptides assume 
unique secondary structure upon interaction with their targets; however, the 
conformation is lost in the absence of the target which makes characterization of the 
active structure difficult.9, 10  The developed peptidomimetic libraries can then be used 
as functional probes for investigating the conformational requirements of active 
peptidomimetic compounds in systems where active species determination is not 
otherwise possible.   
The major peptidomimetic approach of this method involves spacing two 
“clickable” amino acids at well defined intervals within a peptide sequence.  The 
remaining residues may be modified according to a specific natural peptide sequence or 
may be used as sites of adding diversity elements through the use of standard split-pool  
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Figure 1-1.  General Reaction Schemes for Alkynes and Nitriles with Azides to Give 







Figure 1-2.  Unnatural “Clickable” Amino Acid Analogues for Peptidomimetic 
Applications 
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 synthesis.  These peptidomimetic compounds can then be equilibrated with specific 
macromolecular targets. Equilibrating our modified peptides with a biological target or 
with a structure inducing co-solvent can cause the peptide to assume its bioactive 
conformation.  This will bring the click functionalities into contact leading to the 
irreversible click reaction that will lock the peptide into its active conformation (Figure 1-
3). 
This method of peptidomimetic design allows for the enforcement of a multitude 
of variations in secondary structures such as α-helices and β-sheets, providing peptides 
with a broad range of applications including antimicrobials, and therapeutic treatments 
of neurodegenerative diseases.  This strategy can be applied to the construction of 
antimicrobial α-helical and β-sheet peptides.  Antimicrobial peptides with α-helical 
structures and positive net charges have been a focus of interest for the development of 
antibiotic agents against Gram-negative bacteria.10  The use of a short peptide 
sequence may provide greater selectivity for the bacteria cells, and usually decreases 
unwanted toxic side effects of the peptidomimetic compound.11  It has been found that 
bacteria are less likey to develop resistance to antimicrobial peptides compared to other 
antimicrobial treatments.12-14  For this reason, many peptidomimetics may also provide 
methods of overcoming drug resistant strains of bacteria.  Once constructed, the new α-
helical and β-sheet peptides can be characterized and then assayed against a panel of 
clinically relevant pathogens in order to assess their antibiotic profiles.   
One well accepted approach for the discovery of drugs for neurodegenerative 









are known to inhibit plaque formation of amyloid proteins, which is believed to be a major 
cause of some neurodegenerative diseases, show secondary sheet and turn sructures. 
15 Our peptidomimetic approach would allow for the rapid preparation of modified 
peptides that would lock into these conformations.  The sequences of these peptides 
would also be tunable to provide the solubility, and bioactivity necessary to make them 
effective therapeutic agents for neurodegenerative diseases.   
 This chemistry not only provides a means of constraining and influencing 
peptidomimetic structure, but placement of clickable amino acids in the sequences of 
peptides then allows for the possible attachment of fluorescent probes to the 
constructed peptidomimetics.  This methodology would provide a tool for the analysis of 
binding behaviors of constructed peptidomimetics, as well as, the active and inactive 
structures of the peptidomimetics.   Incorporation of fluorescent probes directly to a 
peptide via click chemistry provides a variety of possibilities for studying peptide folding 
both in solution and during interactions with their macromolecular targets.  This 
approach lends flexibility to the analysis of peptide binding interactions.  
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Chapter 2:  Synthesis of Unnatural Amino Acids Bearing High Energy 
Side Chain Functionalities for Applications to Click Chemistry 
 
Background and Significance  
 
The field of peptidomimetics has rapidly grown into an area of great interest for 
the design and synthesis of pharmaceutical drug targets.  The large array of natural 
peptides with biological function as well as the growing understanding of the roles of 
these peptides in biological events has led to a large interest in these compounds as 
drug candidates.  The majority of peptide and peptide-like molecules have not found 
widespread pharmaceutical utility, due to their limited stability in biological systems.16 
Small peptides, up to a few hundred Daltons,  usually have half-lifes of only a few 
seconds to a few minutes, and are rapidly metabolized, usually to their constituent 
amino acids.17  Larger peptides, a thousand Daltons or more, have been shown to have 
improved half-lifes, but neither large nor short peptides have lifetimes long enough to be 
effective if administered orally.  This major drawback leads to the necessity for the 
development of peptide-like molecules with increased stability under biological 
conditions.  To this end there has been an increased interest in the development of 
unnatural amino acids for the synthetic modification of peptides and proteins.  
 Realizing the biological utility of [3+2] cycloaddition “click” reactions has led our 
research group to the design and synthesis of amino acids bearing “clickable” 
functionalities.  Chapter 2 outlines the synthesis of a sizable library of unnatural chiral 
amino acids bearing highly energetic nitrile, azide, and alkyne functional groups.  These 
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unnatural amino acids will provide the base for a wide range of peptidomimetic 
applications involving click chemistry.   
Synthesis of Amino Acids Bearing Nitrile Side Chains 
 
 Nitrile substituted amino acids can function as click partners with azides for  [3+2] 
click cycloadditions.  These unnatural amino acids were originally envisioned as the 
primary coupling partners for click reactions with azides, however, they were found to 
react sluggishly and less cleanly than anticipated, and so they were substituted by 
alkynes until more beneficial reaction conditions could be found.  The most direct 
method for the synthesis of amino acids bearing nitrile side chains involves the 
conversion of the amide side chains of asparagine and glutamine into nitriles via 
isocyanate formation.  This has been accomplished most commonly with N,N’-
dicyclohexylcarbodiimide (DCC) in pyridine.18  We have found that the same conversion 
can be carried out just as easily with trichloroacetic anhydride or acetic anhydride in 
pyridine.19   
The synthetic route to the 9-fluorenylmethoxycarbonyloxy (Fmoc) protected 
amino acid nitriles can be carried out as shown in Figure 2-1.  The commercially 
available chiral amino acids asparagine 1 and glutamine 2 were easily protected with di-
tert-butyl dicarbonate (Boc Anhydride) under basic aqueous conditions to give the tert-
butyl carbamate (Boc) protected amino acids 3 and 4 Figure 2-1.  Reaction of the Boc 
amino acids with acetic anhydride in pyridine gives the corresponding Boc amino acid 
nitriles 5 and 6.  The amino acid nitriles can then be deprotected with trifluoroacetic acid 







Figure 2-1.  Scheme for the Synthesis of Unnatural Amino Acid Nitriles  
Fmoc-2-Amino-3-Cyanopentanoic Acid 7 and Fmoc-2-Amino-3-Cyanobutanoic Acid 8 
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acid can be 9-Fluorenylmethoxycarbonyloxy (Fmoc) protected by reaction with N-(9-
fluorenylmethoxycarbonyloxy) succinimide (FmocOSu) in aqueous potassium carbonate 
to give the desired Fmoc-2-amino-3-cyanopentanoic acid 7 and Fmoc-2-amino-4-
cyanobutanoic acid 8 (Figure 2-1).  The synthetic sequence is robust enough to allow all 
steps to be carried out with minimal purification requiring only one purification by column 
chromatography on the final Fmoc protected amino acids.  This synthetic strategy also 
allows for the synthesis of both L and D conformations of the amino acid nitriles 
because the enantiomeric purity of the starting materials can be carried through the 
entire synthesis.   
Synthesis of Amino Acids Bearing Azide Side Chains 
 
 Since azides are the required coupling partners for both nitriles and alkynes, the 
ability to introduce azides into a peptide sequence was crucial for any envisioned click 
applications for unnatural peptides.  For this reason the procedures and methods for the 
synthesis of these compounds needed to be both effective and straightforward.   
Amino acids bearing azide functionalized side chains linked to the backbone with 
either one or two carbons as spacers can be synthesized from the L or D forms of 
asparagine and glutamine respectively.  The commercially available chiral amino acids 
asparagine 1 and glutamine 2 can be Boc protected with Boc Anhydride under basic 
aqueous conditions to give the Boc amino acids 3 and 4 (Figure 2-2).  The protected 
amino acids can then be converted to the corresponding amines, 9 and 10, via the 







Figure 2-2. Synthetic Scheme for Fmoc -2-Amino-3-Azidopropanoic Acid 13 and  
Fmoc-2-Amino-4-Azidobutanoic Acid 14 
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ethyl acetate and acetonitrile at 0oC (Figure 2-2).20, 21  The amines are easily recovered 
as white solids by filtration from the reaction solution and can be used without any 
further purification.  The sidechain amine functionalities can then be converted to azides 
by diazo transfer to provide amino acids 11 and 12 (Figure 2-2).   
Initially this transformation was carried out using triflyl azide as the azo transfer 
reagent.22-24  The reaction was carried out in basic aqueous solution with copper sulfate 
as a catalyst.  However, the triflyl azide reagent suffered from several drawbacks.25  The 
reagent itself is very volatile so it could not be concentrated or left in the open, and 
reaction vessels needed to be sealed for long reaction times.  The reagent had to be 
made and stored as a solution in toluene, and the shelf-life of the azide reagent was not 
suitable for storage of large quantities.  This led to the reagent having to be made 
frequently in small batches.  For these reasons the triflyl azide reagent was later 
replaced with the more robust and economical imidazole-1-sulfonyl azide.26  This 
reagent can be isolated as a hydrochloride salt which allows for isolation and 
characterization.  The formation of the reagent as a salt also allows larger quantities to 
be made and stored with little to no degradation of the reagent.  It is used in a similar 
fashion to the triflic azide, except that the imidizole-1-sulfonyl azide diazo transfer can 
be run in methanol which provides better results and easier cleanup.  Also, it requires 
an extra equivalent of base to neutralize the HCl.  Both the triflyl and imidzole-1-sulfonyl 
azide reagents provided the corresponding azides 13 and 14 in good to excellent yield.  
From here the amino acid azides could be Boc deprotected in TFA/DCM to give the free 
amino acids.  The free amino acids were then Fmoc protected in basic aqueous solution 
with FmocOSu as the reagent.  Isolation of the amino acids by column chromatography 
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over silica gel provided pure products Fmoc-2-amino-3-azidopropanoic acid 13 and 
Fmoc-2-amino-4-azidobutanoic acid 14 as white to off-white solids (Figure 2-2).  
 Amino acid azides bearing three and four carbon side chains can be directly 
synthesized from the diprotected amino acids ornithine 15 and lysine 16 (Figure 2-3).  
The side chain Boc groups were removed with 25% TFA/DCM to give the free amines.  
The free amines were converted to the Fmoc amino acid azides via azo transfer.  The 
formation of these amino acid azides proceeds well; however, the reaction cannot be 
run in base for extended periods of time due to loss of the Fmoc protecting group.  The 
final amino acids were purified over silica gel to provide Fmoc-2-amino-5-
azidopentanoic acid 17 and Fmoc-2-amino-6-azidohexanoic acid 18 (Figure 2-3). 
 Since deprotection of the Fmoc protected amines occationally occured during the 
azo transfer, an alternate route for synthesis of the long chain azides was desirable.  
Copper has been used as a coordination metal with amino acids for many applications 
including side chain functionalization.27, 28  This approach was applied to the azide 
synthesis using commercially available L-lysine hydrochloride (Figure 2-4).  The lysine 
hydrochloride was coordinated to copper in aqueous base using copper sulfate 
pentahydrate as the copper source to produce the amino acid complex 19.  After two to 
three hours the azo transfer reaction was then set in the same pot by addition of an 
extra catalytic amount of copper sulfate pentahydrate and excess potassium carbonate.  
This was followed by the addition of imidazole-1-sulfonyl azide and the reaction was 
stirred at room temperature overnight (Figure 2-4).  The copper complexed lysine azide 
20 was recovered as a light blue solid by filtration from the reaction solution.  The solid 






Figure 2-3. Synthesis of Fmoc-2-Amino-5-Azidopentanoic Acid 17 and  








Figure 2-4.  Synthetic Scheme for the Synthesis of Fmoc-2-Amino-6-Azidohexanoic 
Acid Using Copper Complex 
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(EDTA) solution and the mixture was shaken vigorously for 1-2 hours.  During this time 
the solution turned a very deep blue color indicating the formation of the copper EDTA 
complex.  When this method is used for side chain protection the product amino acid is 
often filtered from the copper EDTA solution28; however, the lysine azide was 
completely soluble in the aqueous solution.  Rather than attempting a tedious 
purification of the amino acid azide from the solution of copper and base, the Fmoc 
protection was attempted on the resulting crude solution.  The solution was transferred 
to a larger flask and the pH was adjusted to approximately 8 using solid potassium 
carbonate.  A solution of FmocOSu in acetonitrile was then added at 0oC and then the 
reaction was stirred at room temperature for 4-6 hours.  The Fmoc protection proceeded 
efficiently on the crude solution and the protected amino acid 18 was removed from the 
solution by acidification of the reaction solution to a pH of 2 followed by extraction with 
ethyl acetate (Figure 2-4).  Occationally the products were sufficiently pure from 
extraction alone; however, when needed the products were purified by flash 
chromatography over silica gel. 
Synthesis of Amino Acids Bearing Alkyne Side Chains 
 
 The synthesis of chiral amino acid alkynes involved a more elaborate approach 
than that of the nitriles and azides.  Alkyene amino acids cannot be readily synthesized 
directly from chiral amino acid starting materials.  This means that the chirality must be 
installed during the synthesis, which can lead to mixtures of stereoisomers, as well as 
tedious isomeric separations.29, 30   Many effective methods have emerged for the 
asymmetric synthesis of α-amino acids.31    One of the most direct and general methods 
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involves the alkylation of a chiral auxiliary of glycine.31  There are examples of 
auxiliaries that have been employed for the synthesis of chiral amino acids; however, 
many of these also possess negative qualities as well.32, 33  The use of chiral auxiliaries 
almost always lengthens the synthesis, usually because the auxiliary itself must be 
synthesized.  The nickel benzylproline benzophenone glycine complex 21 was chosen 
as an appropriate auxiliary for several attractive reasons (Figure 2-5).  The complex 
itself can be synthesized from mostly low cost materials, including the chiral installation 
which consists of commercially available L or D proline, which is of moderate price. 34, 35 
The synthesized benzylproline benzophenone ligand is recoverable in high yields from 
the hydrolysis of the nickel complex, and is also reusable which cuts down on synthesis 
steps and cost after the initial synthesis.  The side chain functionality of the glycine 
residue is achieved by alkylation of the nickel complex with alkyl bromides under basic 
conditions.  The alkylation of the complex can be easily accomplished in high yield and 
with excellent selectivity.  
The synthesis of complex 21 can be accomplished in three synthetic steps and 
the intermediate steps can be sufficiently purified without the need for column 
chromatography (Figure 2-6).  The formation of the complex begins with the synthesis 
of S-benzyl proline from L-proline and benzyl chloride.  The reaction provides a 
moderate yield, but it is robust and resilient enough to allow for large multigram scale 
up.  The second step involves the reaction of benzyl proline with 2-amino 











Figure 2-6. Synthetic Scheme for the Synthesis of the Nickel (II) Benzylproline 
Benzophenone Glycine Complex 21 
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The ligand can be separated from the reaction by crystallization from methanol and can 
be used for the synthesis of the final complex without further purification.  Benzylproline 
benzophenone, glycine, and nickel nitrate hexahydrate are combined and stirred in 
refluxing methanol followed by potassium hydroxide (KOH) addition to produce the deep 
red complex 21 (Figure 2-6).  The reaction is quenched by the slow dropwise addition of 
acetic acid followed by water.  The product is extracted with DCM and concentrated to 
yield a fluffy, red foam that can be alkylated without purification.  If desired, the complex 
can be purified by flash chromatography over silica gel with a 3:1 DCM to acetone 
eluent system or it can be recrystalized from acetonitrile.  The complex can be made 
quickly and efficiently in large quantities and the various components are all stable 
enough to be synthesized in bulk and stored indefinitely at room temperature. 
 The alkylation of the complex can be easily accomplished in acetonitrile with an 
alkyl halide and using powdered KOH as a base.34, 36  The synthesis of the alkyne 
amino acid with a three carbon side chain was accomplished with the commercially 
available propargyl bromide.  The four and five carbon side chain amino acid alkynes 
required the synthesis of reactive alkyl halides.  Both the four and five carbon alkynes 
can be synthesized from butyne-1-ol and pentyne-1-ol respectively.  Tosylation of the 
alcohol followed by protection of the terminal alkynes with trimethylsilane (TMS) gives 
the protected tosylates.  These tosylates can be converted to the TMS protected 
bromides by reaction with lithium bromide in dry actone for 18-36 hours.  The protected 
bromides can then be used for the alkylation of the nickel glycine complex 21.  The 













Figure 2-7.  Scheme for the Synthesis of Alkyne Amino Acids Using the Nickel (II) 
Benzylproline Benzophenone Glycine Complex 
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given a breakdown product of the complex and little to no desired alkylation product 
under a variety of conditions.  More studies are required to determine the difficulties in 
producing this particular alkylated complex.  Instead, the commercially available 
propargyl bromide was used and yields the propargyl glycine complex directly; however 
the TMS protected alkyne bromide provides a mixture of TMS protected alkyne glycine 
complex 23 and deprotected alkyne glycine complex 24 (Figure 2-7).  Treatment of the 
mixture with tetrabutylammonium fluoride converts all of the protected complex to the 
deprotected complex.  All of the reactions produce a small amount of the undesired 
stereochemical product.  The undesired stereochemical product and side products are 
removed by column chromatography using 4:1 DCM to acetone as an eluent to provide 
pure alkylated complexes. 
 The alkyated complexes can then be hydrolyzed by stirring in 50:50 5M 
hydrochloric acid and methanol to produce the free amino acid and regenerating the 
BPB ligand.  The BPB ligand can be extracted out with DCM.  The free amino acid is 
then dried and the nickel is removed by purification over ion exchange resin to provide 
pure alkyne amino acid which can then be reacted with FmocOSu to provide the Fmoc 
amino acid alkyne (Figure 2-7). 
Experimental 
 
General Considerations.  Amino acid starting materials were purchased from 
Advanced Chem Tech.  Reagents were used as recieved without additional purification.  
Dry solvents were obtained from a Grubb’s solvent system and used immediately or 
stored over activated 4 Å molecular sieves.  Proton and carbon nuclear magnetic 
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resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker 400 MHz or a 
Varian 300 mHz spectrometer and referenced with respect to internal TMS standard or 
residual solvent.  Infrared spectra were obtained using a Bomen B100 FT-IR 
spectrometer.  IR samples were prepared as films on a sodium chloride plate by 
evaporating DCM solutions.  High resolution mass spectroscopy (HRMS) was 
performed at the Mass Spectrometry Center located in the Chemistry Department of the 
University of Tennessee on a JOEL JMS-T100CC ACCU-TOF instrument using either 
direct analysis in real time (DART) ionization or by matrix assisted laser deposition 
ionization (MALDI).  Thin layer chromatography (TLC) was carried out on E. Merck 
Silica Gel 60 F-254 TLC plates.  Ion exchange chromatography was performed using 
Dowex 50WX2-100 ion exchange resin.  Selected amino acid proton spectra are listed 
in the appendix of this section. 
Boc-L-2-amino-3-cyanopropanoic acid. (Figure 2-1, Entry 5) Boc-D-
asparagine-OH (3.40 g, 15.0 mmol, 1.00 equiv.) was weighed out into a roundbottom 
flask with a stirbar and dissolved in 50 mL of pyridine.  Once the acid was fully dissolved 
acetic anhydride (1.70 mL, 18.0 mmol, 1.20 equiv.) was added all at once at room 
temperature.  The reaction mixture was stirred at room temperature overnight.  
Depending on the purity of the commercially acquired amino acid a slight red hue was 
occasionally observed; however, no effect on the reaction was observed.  The reaction 
was concentrated in vacuo and taken up in ethyl acetate.  The ethyl acetate layer was 
rinsed three times with 30 mL portions of 2 M acetic acid, followed by rinses with water 
(2 x 20mL) and brine (2 x 20mL).  The ethyl acetate layer was collected, dried over 
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anhydrous sodium sulfate, and concentrated in vacuo to yield a crude viscous oil which 
was carried on without futher purification.  Crude Yield = 87% 
Fmoc-L-2-amino-3-cyanopropanoic acid.  (Figure 2-1, Entry 7) Boc-L-2-amino-
3-cyanopropanoic acid (2.79 g, 13.0 mmol, 1.00 Equiv.) was dissolved in 25% 
trifluoroacetic acid in DCM and stirred at room temperature for 30-45 minutes.  The 
reaction was concentrated in vacuo, redissolved in DCM and reconcentrated.  The 
residue was dissolved in 75 mL of 10% potassium carbonate solution and cooled to 0 
oC in an ice bath.  FmocOSu (4.71 g, 14.0 mmol, 1.10 Equiv.) was dissolved in a 
minimal amount of acetonitrile and the solution was added to the reaction dropwise at 0 
oC.  The reaction was stirred at 0 oC for 30 min. then it was stirred at room temperature 
for 3-3.5 hours.  The reaction was filtered through celite, and the aqueous filtrate was 
collected.  The aqueous layer was suspended with ethyl acetate in an Erlenmeyer flask.  
The aqueous layer was acidified to a pH of 2-3 using 2 M HCL.  The ethyl acetate was 
collected and the aqueous layer was extracted twice with ethyl acetate (40 mL).  The 
organic extracts were combined, dried over anhydrous sodium sulfate and concentrated 
in vacuo.  The product was purified by column chromatography over silica gel eluting 
with 2 hexane: 1 ethyl acetate: 0.1 acetic acid. The yield of purified amino acid was 3.4 
g (80% overall).  1H NMR ( 400 MHz, CD3OD):  δ 2.61 (ddd, 1H, J = 2.5, J = 7.5, J = 
17), 2.69 (ddd, 1H, J = 2.5 Hz, J = 5.1 Hz, J = 17 Hz), 4.09 (t, 1H, J = 7.1 Hz), 4.20 (m, 
3H), 7.17 (t, 2H, J = 7.3 Hz), 7.25 (t, 2H, J = 7.3 Hz), 7.54 (d, 2H, J = 7.0 Hz), 7.65 (d, 
2H, J = 7.7 Hz).  13C (100 MHz, CD3OD):  δ 23.7, 55.3, 69.2, 73.2, 81.4, 122.0, 127.4, 
129.2, 129.8, 143.6, 146.3, 159.4, 174.8.  HRMS-DART ([M]-): for C19H16N2O4 
Calculated 335.1038, Found 335.1041. 
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Boc-L-2-amino-4-cyanobutanoic acid.  (Figure 2-1, Entry 6) Boc-L-glutamine-
OH (2.00 g, 8.60 mmol, 1.00 equiv) was weighed out into a roundbottom flask with a 
stirbar and dissolved in 50 mL of pyridine.  Once the acid was fully dissolved, acetic 
anhydride (0.98 mL, 10.3 mmol, 1.20 equiv.) was added all at once at room 
temperature.  The reaction mixture was stirred at room temperature overnight.  
Depending on the purity of the commercially acquired amino acid a slight red hue was 
occasionally observed; however no effect on the reaction was observed.  The reaction 
was concentrated in vacuo and taken up in ethyl acetate.  The ethyl acetate layer was 
rinsed three times with 30 mL portions of 2M acetic acid, followed by rinses with water 
(2 x 20mL) and brine (2 x 20mL).  The ethyl acetate layer was collected, dried over 
anhydrous sodium sulfate, and concentrated in vacuo to yield a crude viscous oil which 
was carried on without further purification.  Crude Yield 83%. 
Fmoc-L-2-amino-4-cyanobutanoic acid. (Figure 2-1, Entry 8) Boc-L-2-amino-4-
cyanobutanoic acid (7.30 mmol, 1.00 equiv.) was dissolved in 25% TFA acid in DCM 
and stirred at room temperature for 30-45 minutes.  The reaction was concentrated in 
vacuo, redissolved in DCM and reconcentrated.  The residue was dissolved in 75 mL of 
10% potassium carbonate solution and cooled to 0 oC in an ice bath.  FmocOSu (7.26 
g, 18.3 mmol, 2.50 equiv.) was dissolved in a minimal amount of acetonitrile and the 
solution was added to the reaction dropwise at 0 oC.  The reaction was stirred at 0 oC 
for 30 min. then it was stirred at room temperature for 3-3.5 hours.  The reaction was 
filtered through celite, and the aqueous filtrate was collected.  The aqueous layer was 
suspended with ethyl acetate in an Erlenmeyer flask.  The aqueous layer was acidified 
to a pH of 2-3 using 2 M HCL.  The ethyl acetate was collected and the aqueous layer 
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was extracted twice with ethyl acetate (40 mL).  The organic extracts were combined, 
dried over anhydrous sodium sulfate and concentrated in vacuo.  The product was 
purified by column chromatography over silica gel eluting with 2 hexane: 1 ethyl acetate: 
0.1 acetic acid to provide 2.25 g (75.7% overall).  1H NMR (400MHz, CD3OD):  δ 2.44-
2.51 (q, 2H, J = 7.0 Hz), 2.59-2.65 (t, 2H, J = 6.9 Hz), 4.21-4.41 (m, 2H), 4.49-4.56 (d, 
2H, J = 6.8 Hz), 7.29-7.34 (t, 2H, J = 7.4 Hz), 7.36-7.43 (t, 2H, J = 7.4 Hz), 7.60-7.65 (d, 
2H, J = 7.6 Hz), 7.77-7.78 (d, 2H, J = 7.6 Hz).  13C NMR (100 MHz, CD3OD):  δ 28.8, 
29.5, 47.8, 66.9, 72.4, 121.0, 126.1, 128.3, 129.0, 142.6, 144.4, 158.0, 171.5.  HRMS-
DART ([M]-): for C20H18N2O4 Calculated 349.1188, Found 349.1184. 
Boc-L-2-amino-3-aminopropanoic acid. (Figure 2-2, Entry 9) Boc-L-asparagine 
(2.00 g, 8.60 mmol, 1.00 equiv.) was weighed out into a 100 mL roundbottom flask with 
a stirbar.  Ethyl acetate (20 mL), acetonitrile (20 mL), and 1-2 mL of water were added 
and the solution was stirred at room temperature until all of the amino acid was 
dissolved.  The solution was cooled to 0 oC in an ice water bath.  Once the solution 
reached 0 oC, phenyl iododiacetate (3.32 g, 10.3 mmol, 1.20 equiv.) was added to the 
reaction all at once.  The reaction was stirred at 0 oC for 30 min. and then warmed to 
room temperature.  The reaction was then stirred at room temperature for five to six 
hours.  During the reaction time some product occasionally precipitated from the 
reaction solution.  The ethyl acetate and acetonitrile were then removed in vacuo.  The 
concentrated solution was then cut with pure acetonitrile until precipitation was 
observed.  Once precipitation began another 5-8 mL of acetonitrile was added and the 
solution was cooled to 0 oC to ensure complete precipitation of the product.  The white 
solid was collected on a fritted filter funnel and dried on a vacuum line to afford 1.45 g of 
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the desired amine (82%).  HRMS-DART ([M]+): for C8H16N2O4 Calculated 205.1188, 
Found 205.1191. 
Boc-L-2-amino-3-azidopropanoic acid. (Figure 2-2, Entry 11) Boc-L-2-amino-
3-aminopropanoic acid (1.45 g, 7.10 mmol, 1.00 equiv.) was weighed into a 
roundbottom flask and suspended in methanol.  Potassium carbonate (2.65 g, 19.1 
mmol, 2.70 equiv.) and copper sulfate (0.0180 g, 0.0710 mmol, 0.0100 equiv.) were 
added to the solution.  The mixture was stirred until all of the materials had mostly 
dissolved.  Imidazole sulfonyl azide (2.08 g, 10.0 mmol, 1.40 equiv.) was then added to 
the reaction.  The reaction solution was stirred at room temperature for 6-8 hours until 
TLC showed the consumption of all starting material.  The organic layer was removed 
on a rotary evaporator and the residue was taken up in aqueous potassium carbonate, 
extracted with ethyl acetate.  The ethyl acetate was discarded and the aqueous layer 
was acidified to a pH of approximately 2.  The organic layer was extracted with ethyl 
acetate (3 x 30 mL).  The ethyl acetate extracts were combined, dried over sodium 
sulfate, and concentrated on a rotovap.  The crude material was carried on without 
further purification.  Crude Yield 91%. 
N-Fmoc-L-2-amino-3-azidopropanoic acid. (Figure 2-2, Entry 13) The residue 
of Boc-L-2-amino-3-azidopropanoic acid (6.40 mmol, 1.00 equiv.) was redissolved in 
25% TFA acid in DCM.  The solution was stirred for approximately 30 min.  The reaction 
was concentrated in vacuo, redissolved in DCM and reconcentrated.  The residue was 
dissolved in 10% potassium carbonate solution and cooled to 0 oC in an ice bath.  
Fmoc-OSu (2.39 g, 7.10 mmol, 1.10 equiv.) was dissolved in a minimal amount of 
acetonitrile, and the solution was added to the reaction dropwise at 0 oC.  The reaction 
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was stirred at 0 oC for 30 min; then stirred at room temperature for 4-5 hours.  The 
reaction was filtered through celite, and the aqueous filtrate was collected.  The 
aqueous layer was suspended with ethyl acetate in an Erlenmeyer flask.  The aqueous 
layer was acidified to a pH of 2-3 using 2 M HCL.  The ethyl acetate was collected and 
the aqueous layer was extracted twice with ethyl acetate (40 mL).  The organic extracts 
were combined, dried over anhydrous sodium sulfate and concentrated in vacuo.  The 
product was purified by column chromatography over silica gel eluting with 2 hexane: 1 
ethyl acetate: 0.1 acetic acid to provide approximately 1.83 g the desired product (88%).  
1H NMR (400MHz, CD3OD):  δ 3.70 (m, 2H), 4.25 (t, 1H, J = 6.8 Hz), 4.38 (d, 2H, J = 
6.8 Hz), 4.43 (t, 1H, J = 5.25 Hz), 7.32 (t, 2H, J = 7.5 Hz), 7.40 (t, 2H, J = 7.5 Hz), 7.69 
(m, 2H), 7.80 (d, 2H, J = 7.5 Hz).  13C NMR (100MHz, CD3OD):  δ 51.5, 54.1, 66.9, 
119.6, 124.9, 126.9, 127.5, 141.3, 143.9, 157.2, 171.3.  HRMS-DART ([M]-): for 
C18H16O4N4, Calculated 351.1093, Found 351.1089. 
 Boc-D-2-amino-3-aminopropanoic acid. (Figure 2-2, Entry 9) Boc-D-
asparagine (2.00 g, 8.60 mmol, 1.00 equiv.) was weighed out into a 100 mL 
roundbottom flask with a stirbar.  Ethyl acetate (20 mL), acetonitrile (20 mL), and 1-2 mL 
of water were added and the solution was stirred at room temperature until all of the 
amino acid was dissolved.  The solution was cooled to 0 oC in an ice water bath.  Once 
the solution reached 0 oC, phenyl iododiacetate (3.32 g, 10.0 mmoles, 1.20 equiv.) was 
added to the reaction all at once.  The reaction was stirred at 0 oC for 30 min. and then 
warmed to room temperature.  The reaction was then stirred at room temperature for 
five to six hours.  During the reaction time some product occasionally precipitated from 
the reaction solution.  The ethyl acetate and acetonitrile were then removed in vacuo.  
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The concentrated solution was then cut with pure acetonitrile until precipitation was 
observed.  Once precipitation began another 5-8 mL of acetonitrile was added and the 
solution was cooled to 0 oC to ensure complete precipitation of the product.  The white 
solid was collected on a fritted filter funnel and dried on a vacuum line to afford 
approximately 1.62 g of the desired amine (80%).  HRMS-DART ([M]+): for C8H16N2O4 
Calculated 205.1188, Found 205.1184. 
Boc-D-2-amino-3-azidopropanoic acid. (Figure 2-2, Entry 11) Boc-D-2-amino-
3-aminopropanoic acid (1.45 g, 6.70 mmol, 1.00 equiv.) was weighed into a round 
bottom flask and suspended in methanol.  Potassium carbonate (2.47 g, 18.0 mmol, 
2.70 equiv.) and copper sulfate (0.0170 g, 0.0600 mmol, 0.0100 equiv.) were added to 
the solution.  The mixture was stirred until all of the materials had mostly dissolved.  
Imidazole sulfonyl azide (1.67 g, 7.94 mmol, 1.20 Equiv.) was then added to the 
reaction.  The reaction solution was stirred at room temperature for 6-8 hours until TLC 
showed the consumption of all starting material.  The organic layer was removed on a 
rotovap and the residue was taken up in aqueous potassium carbonate, extracted with 
ethyl acetate.  The ethyl acetate was discarded and the aqueous layer was acidified to a 
pH of approximately 2.  The organic layer was extracted with ethyl acetate (3 x 30 mL).  
The ethyl acetate extracts were combined, dried over sodium sulfate, and concentrated 
on a rotovap.  Crude Yield 87%. 
N-Fmoc-D-2-amino-3-azidopropanoic acid. (Figure 2-2, Entry 13) The residue 
of Boc-D-2-amino-3-azidopropanoic acid (5.80 mmol, 1.00 equiv.) was redissolved in 
25% TFA acid in DCM.  The solution was stirred for approximately 30 min.  The reaction 
was concentrated in vacuo, redissolved in DCM and reconcentrated.  The residue was 
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dissolved in 10% potassium carbonate solution and cooled to 0oC in an ice bath.  Fmoc-
OSu (2.16 g, 6.40 mmol, 1.10 equiv.) was dissolved in minimal acetonitrile and the 
solution was added to the reaction dropwise at 0 oC.  The reaction was stirred at 0 oC 
for 30 min. then it was stirred at room temperature for 4-5 hours.  The reaction was 
filtered through celite, and the aqueous filtrate was collected.  The aqueous layer was 
suspended with ethyl acetate in an Erlenmeyer flask.  The aqueous layer was acidified 
to a pH of 2-3 using 2 M HCL.  The ethyl acetate was collected and the aqueous was 
extracted twice with ethyl acetate (40 mL).  The organic extracts were combined, dried 
over anhydrous sodium sulfate and concentrated in vacuo.  The product was purified by 
column chromatography over silica gel eluting with 2 hexane: 1 ethyl acetate: 0.1 acetic 
acid to provide 1.69 g  the desired product (89%). 1H NMR (400MHz, CD3OD):  δ 3.70 
(m, 2H), 4.25 (t, 1H, J = 6.8 Hz), 4.38 (d, 2H, J = 6.8 Hz), 4.43 (t, 1H, J = 5.25 Hz), 7.32 
(t, 2H, J = 7.5 Hz), 7.40 (t, 2H, J = 7.5 Hz), 7.69 (m, 2H), 7.80 (d, 2H, J = 7.5 Hz).  13C 
NMR (100MHz, CD3OD):  δ 51.5, 54.1, 66.9, 119.6, 124.9, 126.9, 127.5, 141.3, 143.9, 
157.2, 171.3.  HRMS-DART ([M]-): for C18H16O4N4, Calculated 351.1093, Found 
351.1088.   
Boc-L-2-Amino-4-Aminobutanoic Acid. (Figure 2-2, Entry 10) Boc-L-glutamine 
(2.00 g, 0.00861 moles, 1.00 equiv.) was weighed out into a 100 mL roundbottom flask 
with a stirbar.  Ethyl acetate (20 mL), acetonitrile (20 mL), and 1-2 mL of water were 
added and the solution was stirred at room temperature until all of the amino acid was 
dissolved.  The solution was cooled to 0 oC in an ice water bath.  Once the solution 
reached 0 oC, phenyl iododiacetate (3.30 g, 10.3 mmoles, 1.20 equiv.) was added to the 
reaction all at once.  The reaction was stirred at 0 oC for 30 min. and then warmed to 
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room temperature.  The reaction was then stirred at room temperature for five to six 
hours.  During the reaction time, some product occasionally precipitated from the 
reaction solution.  The ethyl acetate and acetonitrile were then removed in vacuo.  The 
concentrated solution was then cut with pure acetonitrile until precipitation was 
observed.  Once precipitation began another 5-8 mL of acetonitrile was added and the 
solution was cooled to 0 oC to ensure complete precipitation of the product.  The white 
solid was collected on a fritted filter funnel and dried on a vacuum line to afford 1.42 g of 
the desired amine (76%).  HRMS-DART ([M]+): for C9H18N2O4 Calculated 219.1344, 
Found 219.1343. 
Boc-L-2-amino-4-azidobutanoic acid.  (Figure 2-2, Entry 12) Boc-L-2-amino-4-
aminobutanoic acid (1.42 g, 6.5 mmol, 1.0 equiv.) was weighed into a roundbottom flask 
and suspended in methanol.  Potassium carbonate (2.44 g, 18.0 mmol, 2.70 equiv.) and 
copper sulfate (0.0160 g, 0.0650 mmol, 0.0100 equiv.) were added to the solution.  The 
mixture was stirred until all of the materials had mostly dissolved.  Imidazole sulfonyl 
azide (1.65 g, 7.80 mmol, 1.20 equiv.) was then added to the reaction.  The reaction 
solution was stirred at room temperature for 6-8 hours until TLC showed the 
consumption of all starting material.  The organic layer was removed on a rotovap and 
the residue was taken up in aqueous potassium carbonate, and extracted with ethyl 
acetate (3 x 30 mL).  The ethyl acetate was discarded and the aqueous layer was 
acidified to a pH of approximately 2.  The organic layer was extracted with ethyl acetate 
(3 x 30 mL).  The ethyl acetate extracts were combined dried over sodium sulfate, and 
concentrated on a rotovap.  Crude Yield 93%. 
 31
Fmoc-L-2-amino-4-azidobutanoic acid. (Figure 2-2, Entry 14) The residue of 
Boc-L-2-amino-4-azidobutanoic acid (6.10 mmol, 1.00 equiv.) was redissolved in 25% 
TFA acid in DCM.  The solution was stirred for approximately 30 min.  The reaction was 
concentrated in vacuo, redissolved in DCM and reconcentrated.  The residue was 
dissolved in 10% potassium carbonate solution and cooled to 0 oC in an ice bath.  
Fmoc-OSu (2.25 g, 6.60 mmol, 1.10 equiv.) was dissolved in a minimal amount of 
acetonitrile and the solution was added to the reaction dropwise at 0 oC.  The reaction 
was stirred at 0 oC for 30 min., and then stirred at room temperature for 4-5 hours.  The 
reaction was filtered through celite, and the aqueous filtrate was collected.  The 
aqueous layer was suspended with ethyl acetate in an Erlenmeyer flask.  The aqueous 
layer was acidified to a pH of 2-3 using 2 M HCL.  The ethyl acetate was collected and 
the aqueous layer was extracted twice with ethyl acetate (40 mL).  The organic extracts 
were combined, dried over anhydrous sodium sulfate and concentrated in vacuo.  The 
product was purified by column chromatography over silica gel eluting with 2 hexane: 1 
ethyl acetate: 0.1 acetic acid to provide 1.99 g of the desired product (89%).  1H NMR 
(400 MHz, CD3OD):  δ 1.78-1.92 (m, 1H), 1.99-2.12 (m, 2H), 3.27-3.42 (m, 2H), 4.12-
4.19 (t,1H, J = 7 Hz), 4.18-4.24 (m, 1H), 4.29-4.34 (d, 2H, J = 7 Hz), 7.21-7.27 (t, 2H, J 
= 7.45 Hz), 7.29-7.35 (t, 2H, J = 7.48 Hz), 7.57-7.63 (t, 2H, J = 6.2 Hz), 7.70-7.75 (d, 
2H, J = 7.5 Hz).  13C NMR (100MHz, CD3OD):  δ 31.8, 48.4, 52.7, 67.9, 120.9, 126.2, 
128.1, 128.7, 142.6, 145.1, 145.3, 158.6, 175.1.  HRMS-DART ([M]-): for C19H18N4O4, 
Calculated 365.1250, Found 365.1232. 
Boc-D-2-amino-4-aminobutanoic acid. (Figure 2-2, Entry 10) Boc-D-glutamine 
(2.00 g, 8.60 mmoles, 1.00 equiv.) was weighed out into a 100 mL roundbottom flask 
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with a stirbar.  Ethyl acetate (20 mL), acetonitrile (20 mL), and 1-2 mL of water were 
added and the solution was stirred at room temperature until all of the amino acid was 
dissolved.  The solution was cooled to 0 oC in an ice water bath.  Once the solution 
reached 0 oC, phenyl iododiacetate (3.30 g, 10.3 mmoles, 1.20 equiv.) was added to the 
reaction all at once.  The reaction was stirred at 0 oC for 30 min. and then warmed to 
room temperature.  The reaction was then stirred at room temperature for five to six 
hours.  During the reaction some product occasionally precipitated from the reaction 
solution.  The ethyl acetate and acetonitrile were then removed in vacuo.  The 
concentrated solution was then cut with pure acetonitrile until precipitation was 
observed.  Once precipitation began another 5-8 mL of acetonitrile was added and the 
solution was cooled to 0 oC to ensure complete precipitation of the product.  The white 
solid was collected on a fritted filter funnel and dried on a vacuum line to afford 1.57 g of 
the desired amine (86%). HRMS-DART ([M]+): for C9H18N2O4 Calculated 219.1344, 
Found 219.1347. 
Boc-D-2-amino-4-azidobutanoic acid. (Figure 2-2, Entry 12) Boc-D-2-amino-4-
aminobutanoic acid (1.42 g, 6.50 mmol, 1.00 equiv.) was weighed into a roundbottom 
flask and suspended in methanol.  Potassium carbonate (2.44 g, 18.0 mmol, 2.70 
equiv.) and copper sulfate (0.0160 g, 0.0650 mmol, 0.0100 equiv.) were added to the 
solution.  The mixture was stirred until all of the reagents had mostly dissolved.  
Imidazole sulfonyl azide (1.65 g, 7.80 mmol, 1.20 equiv.) was then added to the 
reaction.  The reaction solution was stirred at room temperature for 6-8 hours until TLC 
showed the consumption of all starting material.  The organic layer was removed on a 
rotovap and the residue was taken up in aqueous potassium carbonate, extracted with 
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ethyl acetate.  The ethyl acetate was discarded and the aqueous layer was acidified to a 
pH of approximately 2.  The organic layer was extracted 3 times with ethyl acetate.  The 
ethyl acetate extracts were combined dried over anhydrous sodium sulfate, and 
concentrated on a rotovap.  Crude Yield 93%. 
Fmoc-D-2-amino-4-azidobutanoic acid. (Figure 2-2, Entry 14) The residue of 
Boc-D-2-amino-4-azidobutanoic acid (6.10 mmol, 1.00 equiv.) was redissolved in 25% 
TFA in DCM.  The solution was stirred for approximately 30 min.  The reaction was 
concentrated in vacuo, redissolved in DCM and reconcentrated.  The residue was 
dissolved in 10% potassium carbonate solution and cooled to 0 oC in an ice bath.  
Fmoc-OSu (2.25 g, 6.60 mmol, 1.10 equiv.) was dissolved in a minimal amount of 
acetonitrile and the solution was added to the reaction dropwise at 0 oC.  The reaction 
was stirred at 0 oC for 30 min. then it was stirred at room temperature for 4-5 hours.  
The reaction was filtered through celite, and the aqueous filtrate was collected.  The 
aqueous layer was suspended with ethyl acetate in an Erlenmeyer flask.  The aqueous 
layer was acidified to a pH of 2-3 using 2 M HCL.  The ethyl acetate was collected and 
the aqueous layer was extracted twice with ethyl acetate (40 mL).  The organic extracts 
were combined, dried over anhydrous sodium sulfate and concentrated in vacuo.  The 
product was purified by column chromatography over silica gel eluting with 2 hexane: 1 
ethyl acetate: 0.1 acetic acid to provide 1.99 g of the desired product (89%).   1H NMR 
(400 MHz, CD3OD):  δ 1.78-1.92 (m, 1H), 1.99-2.12 (m, 2H), 3.27-3.42 (m, 2H), 4.12-
4.19 (t,1H, J = 7 Hz), 4.18-4.24 (m, 1H), 4.29-4.34 (d, 2H, J = 7 Hz), 7.21-7.27 (t, 2H, J 
= 7.45Hz), 7.29-7.35 (t, 2H, J = 7.48 Hz), 7.57-7.63 (t, 2H, J = 6.2 Hz), 7.70-7.75 (d, 2H, 
J = 7.5 Hz).  13C NMR (100 MHz, CD3OD):  δ 31.8, 48.4, 52.7, 67.9, 120.9, 126.2, 
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128.1, 128.7, 142.6, 145.1, 145.3, 158.6, 175.1.  HRMS-DART ([M]-): for C19H18N4O4, 
Calculated 365.1250, Found 365.1230. 
Fmoc-D-2-amino-5-azidopentanoic acid. Fmoc-D-ornithine-Boc-OH (1.41 g, 
2.50 mmol, 1.00 equiv.) was weighed out into a roundbottom flask with a stirbar.  The 
amino acid was dissolved in 25% TFA in dichloromethane.  The solution was stirred for 
approximately 30 min.  The reaction was concentrated in vaccuo, redissolved in DCM 
and reconcentrated.  The residue of Fmoc-ornithine-OH (1.10 g, 2.50 mmol, 1.00 
equiv.) was dissolved in ~75mL of 10% potassium carbonate solution.  Copper sulfate 
pentahydrate (0.126 g, 0.500 mmol, 0.200 equiv.) was added to the solution and the 
mixture was stirred until most of the copper sulfate was dissolved.  The mixture was 
cooled to 0 oC and then triflyl azide in toluene (10.5 mL, 1.00 M, 10.1 mmol, 4.00 equiv.) 
was added slowly to the reaction mixture.  The reaction was stirred at room temperature 
for 30 min. and then for another 6-8 hours at room temperature.  The reaction was then 
suspended with ethyl acetate and acidified to a pH of 2.  The reaction was extracted 
twice more with ethyl acetate.  The organic extracts were combined, dried over 
anhydrous sodium sulfate, and concentrated to provide 0.900 g of the product as a 
white solid (91%).  1H NMR (400 MHz, CD3OD):  δ 1.51-1.92 (m, 4H), 3.24-3.27 (m, 
2H), 3.98-407(m, 1H), 4.12-4.19 (m, 1H), 4.245-4.404 (m, 2H), 7.22-7.29 (t, 2H, J = 7.4 
Hz), 7.30-7.37 (t, 2H, J = 7.4 Hz), 7.53-7.63 (m, 2H), 7.71-7.76 (d, 2H, J = 7.4)  13C 
NMR (100 MHz, CD3OD):  δ 22.4, 30.5, 48.4, 52.1, 67.7, 120.9, 126.1, 128.1, 128.7, 
142.6, 145.2, 174.4.  HRMS-DART ([M]-): for C20H20N4O4, Calculated 379.1406, Found 
379.1410. 
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Fmoc-L-2-amino-6-azido-hexanoic acid. Fmoc-lysine-OH (1.00 g, 2.70 mmol, 
1.00 equiv.) was dissolved in ~75mL of 10% potassium carbonate solution.  Copper 
sulfate pentahydrate (0.136 g, 0.540 mmol, 0.200 equiv.) was added to the solution and 
the mixture was stirred until most of the copper sulfate was dissolved.  The mixture was 
cooled to 0 oC and then triflyl azide in toluene (11.0 mL, 1.00 M, 11.0 mmol, 4.00 equiv.) 
was added slowly to the reaction mixture.  The reaction was stirred at room temperature 
for 30 min. and then for another 6-8 hours at room temperature.  The reaction was then 
suspended with ethyl acetate and acidified to a pH of 2.  The reaction was extracted 
twice more with ethyl acetate.  The organic extracts were combined, dried over 
anhydrous sodium sulfate, and concentrated to provide 1.01 g of the product as a white 
solid (94%).  1H NMR (400 MHz, CDCl3):  δ 1.42-1.53 (m, 2H), 1.56-1.68 (m, 2H), 1.68-
1.80 (m, 1H), 1.88-2.00 (m, 1H), 3.25-3.53 (t, 1H, J = 6.6 Hz), 4.20-4.27 (t, 1H, J = 7.2 
Hz), 4.40-4.47 (d, 2H, J = 6.6 Hz), 7.29-7.36 (t, 2H, J = 7.2 Hz), 7.37-7.44 (t, 2H, J = 7.3 
Hz), 7.55-7.67 (d, 2H, J = 7.4 Hz), 7.74-7.83 (d, 2H, J = 7.2 Hz).  13C NMR (121MHz, 
CDCl3):  δ 22.3, 28.2, 31.8, 47.1, 51.0, 67.1, 119.9, 125.0, 127.0, 127.7, 141.3, 143.6, 
156.1.  HRMS-DART ([M]-): for C21H22N4O4, Calculated 393.1563, Found 393.1565. 
Copper (II) lysine monohydrochloride complex. Copper (II) sulfate 
pentahydrate (0.984 g, 3.30 mmol, 1.20 equiv.) and potassium carbonate (1.82 g, 13.0 
mmol, 4.00 equiv.) were weighed into a 100 mL roundbottom flask.  Water (8 mL) was 
added and the solution was stirred until most all of the potassium carbonate was 
dissolved.  L-Lysine mono hydrochloride was added and the reaction was stirred at 
room temperature for 1-2 hours.  The azide reaction was continued in same pot. 
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Copper (II) 2-amino-6-azidohexanoic acid complex. Copper (II) sulfate 
pentahydrate (0.218 g, 0.850 mmol, 0.260 equiv.) and potassium carbonate (1.82 g, 
13.0 mmol, 4.00 equiv.) were added to the solution.  The solution was stirred for 5-10 
min. and then imidazolium-1-sulfonyl azide (1.99 g, 11.5 mmol, 3.50 equiv.) was added 
to the reaction.  The reaction was stirred at room temperature overnight.  The desired 
product was filtered out of the reaction solution as a pale blue powder (0.972 g, 73% 
yield).   
Fmoc-2-Amino-6-Azidohexanoic Acid. The blue copper (II) 6-azido-2-amino-
hexanoic acid complex was dried and crushed into a powder.  The powdered complex 
was placed into a 50 mL roundbottom flask.  A saturated aqueous solution of EDTA was 
prepared by adding (2.53 g, 8.60 mmol) of EDTA to a solution of 1.42 g of sodium 
bicarbonate in 20 mL of water slowly in batches.  The solution was stirred vigorously 
until all of the EDTA had dissolved.  The EDTA solution was added to the copper (II) 6-
azido-2-amino-hexanoic acid complex and the solution was shaken for approximately 1 
hour.  During this time the solution turned a deep blue color.  The resulting solution was 
filtered and transferred to a 250 mL roundbottom flask.  The pH was tested and 
adjusted to around a pH of 8 using 10% potassium carbonate solution.  A solution of 
FmocOSu in acetonitrile was made.  The solution of 2-amino-6-azido-hexanoic acid was 
cooled to 0 oC in an ice water bath and the FmocOSu solution was added dropwise.  
The reaction was stirred at 0 oC for 30 min. and then warmed to room temperature.  The 
reaction was stirred for another 4-6 hours at room temperature.  The reaction was 
filtered through celite, and the aqueous filtrate was collected.  The aqueous layer was 
suspended with ethyl acetate in an erlenmeyer flask.  The aqueous layer was acidified 
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to a pH of 2-3 using 2M HCL.  The ethyl acetate was collected and the aqueous layer 
was extracted twice with ethyl acetate (40 mL).  The organic extracts were combined, 
dried over anhydrous sodium sulfate and concentrated in vacuo.  The product was 
purified by column chromatography over silica gel eluting with 2 hexane: 1 ethyl acetate: 
0.1 acetic acid to provide 0.930 g of the desired product (97%).  1H NMR (400 MHz, 
CDCl3):  δ  1.42-1.53 (m, 2H), 1.56-1.68 (m, 2H), 1.68-1.80 (m, 1H), 1.88-2.00 (m, 1H), 
3.25-3.53 (t, 1H, J = 6.6 Hz), 4.20-4.27 (t, 1H, J = 7.2 Hz), 4.40-4.47 (d, 2H, J = 6.6 Hz), 
7.29-7.36 (t, 2H, J = 7.2 Hz), 7.37-7.44 (t, 2H, J = 7.3 Hz), 7.55-7.67 (d, 2H, J = 7.4 Hz), 
7.74-7.83 (d, 2H, J = 7.2 Hz).  13C NMR (100 MHz, CDCl3):  δ 22.3, 28.2, 31.8, 47.1, 
51.0, 67.1, 119.9, 125.0, 127.0, 127.7, 141.3, 143.6, 156.1.  HRMS-DART ([M]-): for 
C21H22N4O4, Calculated 393.1563, Found 393.1565. 
S-N-Benzyl Proline. L-Proline (20.0 g, 174 mmol, 1.00 equiv.) was suspended in 
95 mL of dry methanol in a 500 mL roundbottom flask.  The roundbottom flask was fitted 
with a pressure equalizing addition funnel and the system was purged with nitrogen for 
15-20 min.  The addition funnel was charged with 5.3 M sodium methoxide in methanol 
(65.5 mL, 347 mmol, 2.00 equiv.).  The sodium methoxide solution was added to the 
suspension of L-proline dropwise at room temperature.  The addition funnel was rinsed 
three times with 5 mL of dry methanol.  The reaction was then heated to 48 oC.  Once 
the solution had reached 48 oC benzyl chloride (20.5 mL, 117 mmol, 1.10 equiv.) was 
added to the reaction dropwise under nitrogen.  The reaction was stirred overnight at 48 
oC.  The reaction was cooled to room temperature and quenched by dropwise addition 
of conc. hydrochloric acid to a pH of 4.  Chloroform (200 mL) was then added and the 
mixture was stirred at room temperature for 1 hour.  The precipitate was filtered, rinsed 
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well with chloroform and discarded.  The filtrate was concentrated on a rotovap.  The 
residue was taken up in acetone and mixed vigorously with a spatula leading to the 
formation a fine white precipitate.  The precipitate was collected on a filter funnel and 
rinsed thoroughly with acetone to provide 28 g of product (79%).  The precipitated 
benzyl proline was used without further purification.  1H NMR (CDCl3):  δ 1.93-2.06 (2H, 
m), 2.27-2.35 (2H, m), 2.90 (1H, dd, J = 18.3, 9.9 Hz), 3.64 (1H, ddd J = 9.9, 7.1, 3.6 
Hz), 3.82 (1H, dd, J = 14.1, 7.1 Hz) 4.21, 4.34 (2H, AB, J = 12.9 HZ), 7.37-7.42 (5H, m).  
HRMS-DART ([M]+): for C12H15NO2, Calculated 206.1181, Found 206.1187. 
Benzyl Proline Benzophenone. (Figure 2-5, Entry 19) Benzyl proline (6.94 g, 
34.0 mmol, 1.00 equiv.) was weighed out into a roundbottom flask with a stirbar.  It was 
suspended in DCM, and n-methyl imidazole (5.93 mL, 74.4 mmol, 2.20 equiv.) was then 
added.  The mixture was cooled to 0 oC in an ice water bath.  Mesyl chloride (2.63 mL, 
34.0 mmol, 1.00 equiv.) was added to the reaction dropwise under nitrogen.  The 
reaction was removed from the ice bath, and 2-aminobenzophenone (6.00 g, 30.4 
mmol, 0.900 equiv.) was added.  The reaction was heated to 45 oC and was stirred at 
that temperature overnight.  The reaction was quenched with saturated ammonium 
chloride solution.  The aqueous phase was then extracted three times with 
dichloromethane.  The organic extracts were combined, dried over sodium sulfate, and 
concentrated on a rotovap.  The resulting residue was taken up in methanol sonicated 
for 20-30 min. and then placed in a freezer for 2-3 hours.  The precipitated ligand was 
collected by filtration and rinsed thoroughly with cold methanol to give 7.8 g of BPB as 
an off-yellow solid (61%).  The recovered ligand was used without further purification.  
1H NMR (400MHz, CDCl3)  δ 1.73–1.86 (2H, m), 1.96 (1H, ddd, J = 4.4, 8.4, 16.8 Hz), 
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2.25 (1H, ddd, J = 9.8, 13.0, 18.1 Hz), 2.41 (1H, dt, J = 6.8, 9.6 Hz), 3.21 (1H, ddd, J = 
2.4, 6.8, 9.2 Hz), 3.32 (1H, dd, J = 4.7, 10.2 Hz), 3.59 (1H, d, J = 12.8 Hz), 3.92 (1H, d, 
J = 12.8 Hz), 7.07–7.62 (12H, m), 7.78 (1H, d, J = 7.9 Hz), 8.56 (1H, d, J = 8.5 Hz), 
11.52 (1H, s); 13C NMR δ (100 MHz, CDCl3): 24.1, 30.9, 53.8, 59.8, 68.2, 121.4, 122.1, 
125.2, 127.0, 128.1, 128.2, 129.0, 130.1, 132.5, 132.5, 133.3, 138.1, 138.5, 139.1, 
174.6, 198.0.  HRMS-DART ([M]+): for C25H24N2O2, Calculated 385.1916, Found 
385.1918. 
Nickel Benzylproline Benzophenone Glycine Complex. (Figure 2-5, Entry 18) 
A solution of benzyl proline benzophenone (6.50 g, 17.0 mmol, 1.00 equiv.), nickel 
nitrate hexahydrate (9.21 g, 34.0 mmol, 2.00 equiv.), and glycine (6.36 g, 85.0 mmol, 
5.00 equiv.) in dry methanol was heated to 65 oC under nitrogen.  A solution of 
potassium hydroxide (6.66 g, 119 mmol, 7.00 equiv.) in dry methanol was added all at 
once to the heated solution.  The resulting solution was stirred at 65 oC under nitrogen 
for 3-4 hours.  The reaction was neutralized with conc. acetic acid and then diluted to 
three times the volume with slow dropwise addition of water.  The resulting slurry was 
extracted three times with DCM.  The organic extracts were combined, dried over 
sodium sulfate, and concentrated on a rotovap.  Drying on a high vacuum line provided 
8.11 g of the product as a fluffy, foamy red solid which could be used without further 
purification (94%).  HRMS-DART ([M]+): for C27H25N3NiO3 Calculated 498.1327, Found 
498.1320. 
Nickel Benzylproline Benzophenone Propargyl Glycine. Nickel benzylproline 
benzophenone (2.70 g, 5.40 mmol, 1.00 equiv.) was placed in a roundbottom flask with 
a stirbar.  The flask was purged with nitrogen and then acetonitrile (20 mL) was added 
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to the flask via syringe.  Powdered sodium hydroxide (0.790 g, 14.0 mmol, 2.50 equiv.) 
was then added to the solution and the mixture was stirred under nitrogen for 10-15 
min.  Propargyl bromide (0.870 mL, 8.10 mmol, 1.50 equiv.) was then added to the 
reaction via syringe.  The reaction was stirred at room temperature under nitrogen for 2-
3 hours.  The reaction was quenched by the addition of 0.1 M hydrochloric acid (150 
mL).  The reaction was extracted three times with 20 mL of DCM.  The DCM extracts 
were combined, dried over anhydrous sodium sulfate and concentrated to yield the 
deep red product complex.  The complex was purified by chromatography over silica gel 
using 4 DCM: 1 acetone as an eluent to provide 2.62 g of the deep red product complex 
(90 %).  HRMS-DART ([M]+):  for C30H27N3NiO3 Calculated 536.1484, Found 536.1478. 
Propargyl Glycine.  Methanol (16mL) and 2 M hydrochloric acid were added to 
a roundbottom flask with a stirbar.  The solution was heated to 60 oC in an oil bath.  The 
nickel benzylproline benophenone propargyl glycine complex was dissolved in 12 mL of 
a 2 methanol to 1 DCM solution.  The nickel benzylproline benophenone propargyl 
glycine solution was added dropwise to the heated acid solution.  The resulting red 
solution was stirred at 60 oC for 1-2 hours.  As the hydrolysis occurred the red solution 
slowly turned to an emerald green colored solution.  Once the entire complex had been 
consumed as determined by TLC the reaction was cooled to room temperature, and the 
methanol and water were removed on a rotovap.  The residue was taken back up in 
25% aqueous ammonium hydroxide and reconcentrated.  The residue was taken back 
up in water.   The aqueous layer was extracted 3-4 times with DCM to remove the 
liberated Benzyl Proline Benzophenone which was collected and recrystallized to be 
reused for complex formation.  The aqueous layer was concentrated to ~ 10 mL.  The 
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amino acid was purified by ion exchange chromatography using Dowex 50X ion 
exchange resin and using pure water as a flush and 25% aqueous ammonium 
hydroxide to recover 0.540 g of the purified amino acid (94%).   
Fmoc-Propargyl Glycine. The purified propargyl glycine (400 mg, 3.50 mmol, 
1.00 equiv.) was dissolved in 7-8 mL of 10% potassium carbonate solution.  FmocOSu 
(1.24 g, 3.70 mmol, 1.10 equiv.) was dissolved in 7-8 mL of acetonitrile.  The propargyl 
glycine solution was cooled to 0 oC in an ice water bath.  Once the propargyl glycine 
solution was cooled, the FmocOSu solution was added dropwise.  The reaction was 
stirred for 30 min. at 0 oC and then warmed to room temperature.  The reaction was 
stirred at room temperature for another 4-6 hours.  Once most all of the starting amine 
was consumed by TLC analysis the reaction was quenched with water and the 
acetonitrile was removed on a rotovap.  The basic solution was extracted once with 20 
mL of ethyl acetate.  The aqueous layer was collected, acidified to a pH of 2 with 3 M 
HCl, and extracted 3 times with ethyl acetate (40 mL).  The acidic ethyl acetate 
extractions were combined, washed with water twice, dried over anhydrous sodium 
sulfate and concentrated on a rotovap.  The product’s purity was then checked by TLC 
and HPLC.  If needed the product was purified by flash chromatography over silica gel 
using 3 hexane: 1 ethyl acetate: 0.1 acetic acid as an eluent.  1H NMR (400 MHz, 
CD3OD):  δ  2.32-2.33 (t, 1H, J = 2.6 Hz), 2.62-2.69 (ddd, 1H, J = 2.55 Hz, J = 7.4 Hz, J 
= 16.8 Hz), 2.70-2.77 (ddd, 1H, J = 2.52 Hz, J = 5.22 Hz,  J = 16.9 Hz), 4.18-4.23 (t, 1H, 
J = 5.6 Hz), 4.28-4.36 (m, 1H), 7.24-7.32 (t, 2H, J = 7.4 Hz), 7.33-7.39 (t, 2H, J = 7.4 
Hz), 7.62-7.69 (d, 2H, J = 6.9 Hz), 7.74-7.79 (d, 2H, J = 7.4 Hz).  13C NMR (100 MHz, 
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CD3OD):  δ 22.6, 48.3, 54.2, 68.1, 72.0, 80.3, 120.9, 126.2, 128.1, 128.7, 197.5, 207.1.  
HRMS-DART ([M]-): for C20H17NO4 Calculated 334.108, Found 334.107. 
Nickel Benzylproline Benzophenone Pentynyl Glycine. Nickel benzylproline 
benzophenone (2.37 g, 4.80 mmol, 1.00 equiv.) was placed in a roundbottom flask with 
a stirbar.  The flask was purged with nitrogen and then acetonitrile (20 mL) was added 
to the flask via syringe.  Powdered sodium hydroxide (0.690 g, 11.9 mmol, 2.50 equiv.) 
was then added to the solution and the mixture was stirred under nitrogen for 10-15 
min.  TMS-pentynyl bromide (1.25 g, 5.70 mmol, 1.20 equiv.) was then added to the 
reaction via syringe.  The reaction was stirred at room temperature under nitrogen for 2-
3 hours.  The reaction was quenched by the addition of 0.1 M hydrochloric acid (150 
mL).  The reaction was extracted three times with 20 mL of DCM.  The DCM extracts 
were combined, dried over anhydrous sodium sulfate and concentrated to yield the 
deep red product complex.  The complex was purified by chromatography over silica gel 
using 4 DCM: 1 Acetone as an eluent to provide 2.72 g of product complex (90%).  
HRMS-DART ([M]+) for C32H31N3NiO3, Calculated 564.1797, Found 564.1772. 
Pentynyl Glycine. Methanol (16mL) and 2 M hydrochloric acid were added to a 
roundbottom flask with a stirbar.  The solution was heated to 60 oC in an oil bath.  The 
nickel benzylproline benophenone pentynyl glycine complex was dissolved in 12 mL of 
a 2 methanol to 1 DCM solution.  The nickel benzylproline benophenone pentynyl 
glycine solution was added dropwise to the heated acid solution.  The resulting red 
solution was stirred at 60 oC for 1-2 hours.  As the hydrolysis occurred the red solution 
slowly turned to an emerald green colored solution.  Once the entire complex had been 
consumed as determined by TLC, the reaction was cooled to room temperature, and 
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the methanol and water were removed on a rotovap.  The residue was taken back up in 
25% aqueous ammonium hydroxide and reconcentrated.  The residue was taken back 
up in water.   The aqueous layer was extracted 3-4 times with DCM to remove the 
liberated Benzyl Proline Benzophenone which was collected and recrystallized to be 
reused for complex formation.  The aqueous layer was concentrated to ~10 mL.  The 
amino acid was purified by ion exchange chromatography using Dowex 50X ion 
exchange resin and using pure water as a flush and 25% aqueous ammonium 
hydroxide to recover 0.700 g of the purified amino acid (92%).   
Fmoc-Pentynyl Glycine. The purified pentynyl glycine (400 mg, 0.00350 mol, 
1.00 equiv.) was dissolved in 7-8 mL of 10% potassium carbonate solution.  FmocOSu 
(1.24 g, 0.00371 mol, 1.05 equiv.) was dissolved in 7-8 mL of acetonitrile.  The pentynyl 
glycine solution was cooled to 0 oC in an ice water bath.  Once the pentynyl glycine 
solution was cooled, the FmocOSu solution was added dropwise.  The reaction was 
stirred for 30 min. at 0 oC and then warmed to room temperature.  The reaction was 
stirred at room temperature for another 4-6 hours.  Once most all of the starting amine 
was consumed by TLC analysis, the reaction was quenched with water and the 
acetonitrile was removed on a rotovap.  The basic solution was extracted once with 20 
mL of ethyl acetate.  The aqueous layer was collected, acidified to a pH of 2 with 3M 
HCl, and extracted 3 times with ethyl acetate (40 mL).  The acidic ethyl acetate 
extractions were combined, washed with water twice, dried over anhydrous sodium 
sulfate and concentrated on a rotovap.  The product’s purity was then checked by TLC 
and HPLC.  If needed the product was purified by flash chromatography over silica gel 
using 3 hexane: 1 ethyl acetate: 0.1 acetic acid as an eluent to provide 0.900 g of 
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desired product (87%).  1H NMR (300 MHz, DMSO):  δ 1.41-1.58 (m, 2H), 1.59-1.76 (m, 
1H), 1.76-1.89 (m, 1H), 2.10-2.22 (m, 2H), 3.91-4.02 (m, 1H), 4.18-4.26 (t, 1H, J = 6.0 
Hz), 4.26-4.34 (d, 1H, J = 5.8 Hz), 7.28-7.37 (t, 2H, J = 7.1 Hz), 7.37-7.45 (t, 2H, J = 7.4 
Hz), 7.67-7.77 (t, 2H, J = 7.6 Hz), 7.85-7.92 (d, 2H, J = 7.1 Hz).  13C NMR (75 MHz, 
DMSO):  δ 17.3, 22.8, 24.7, 46.6, 53.4, 65.1, 71.4, 121.4, 132.0, 132.1, 161.2, 185.3, 
214.3.  HRMS-DART ([M]-): for C22H21NO4 Calculated 362.1392, Found 362.1394. 
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Chapter 3: Synthesis of Aryl Triazoles and Tryptophan Containing 
Peptides Bearing Aryl Triazoles 
 
Background and Significance 
 
 Fluorescent probe molecules have become powerful tools for the monitoring of 
molecular structure and the activity of biomolecules.  These processes have been 
applied successfully to nucleic acid detection of the presence of specific DNA or RNA 
target by changes in fluorescence.37 However, the design of peptide-based probes 
(peptide beacons) that report on binding to, and dissociation from, specific protein 
targets has been more challenging due to the lack of a universal peptide recognition 
code.38, 39 Many of the successful approaches to peptide-beacons rely on strategic 
positioning of interacting fluorescent dyes so that changes in the peptide  structure,  due 
to target binding and dissociation, lead to changes in the fluorescence intensity, via 
photo-induced electron transfer (PET), or shifts in the fluorescence wavelength, via 
fluorescence resonance energy transfer (FRET).    
 We then looked at the possibility of using our clickable amino acids used to 
design a method of introducing fuorophoric probe molecules.  This chemistry provides 
the capability to place clickable amino acids into the sequences of peptides and 
peptidomimetics.  Fluorescent probe molecules could then be attached to the 
constructed peptidomimetics via click chemistry.  For this to be a valid approach for 
peptide labeling, the constructed triazole attachments would have to function as 
interactive fluorescent dyes.  The best possibility for the generation of triazole 
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chromophores was to synthesize and analyze the absorbance and fluorescence 
character of a variety of triazoles and triazole containing peptides. 
A series of aryl triazoles and triazole containing peptides were synthesized on-
resin for the analysis of their absorbance and fluorescent properties, which is discussed 
in Chapter 4.  These studies are to analyze the potential use of triazoles as fluorescent 
probes for peptide structure and binding.  The on-resin approach was chosen for the 
ease of the synthesis, the ability to use an excess of reagent, and for the ease of 
purification.  In many cases the products were pure enough for study without any 
purification after cleavage from resin.   
Synthesis of Simple Aryl Triazoles 
  
The synthesis of the aryl triazoles was accomplished on modified Wang resin 
and is outlined in Figure 3-1.  The resin was converted to a more reactive resin by the 
attachment of trichloroacetonitrile.  The trichloroacetimidate resin (TCA resin) was 
prepared by the reaction of commercial Wang resin with a large excess of 
trichloroacetonitrile and a catalytic amount of 1, 8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
in dry dichloromethane (DCM).  The resin was then drained, rinsed well with DCM, dried 
and stored.  The dried TCA resin was converted to an alkyne functionalized resin by the 
reaction with propargyl alcohol and a catalytic amount of boron trifluoride diethyl 
etherate in a 50:50 mixture of dry DCM and dry tetrahydrofuran (THF).  The aryl 
triazoles were then assembled by on-resin click with a variety of aryl azides with the 
propargyl Wang resin 1.  The click reactions were carried out on the resin bound 








Figure 3-1.  General Reaction Scheme for the Synthesis of Aryl Triazoles on TCA 
Modified Wang Resin 
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proceeded efficiently to give products that in many cases required no further 
purification.  A list of synthesized aryl triazoles is provided in Table 3-1. 
Synthesis of Small Aryl Triazole Functionalized Peptides 
 
An initial series of short peptides was synthesized in order to test the feasibility of 
using the aryl triazoles as fluorophore partners for tryptophan residues. A standard 
peptide 2 containing no aryl triazole was synthesized on Knorr Rink resin using 
standard solid phase peptide synthesis (Figure 3-2).  The remaining test peptides were 
all assembled from an aryl triazole base structure.  The aryl triazole was assembled 
utilizing the propargyl modified Wang resin as shown in Figure 3-3. 
 The two aryl triazole functionalized peptides 3 and 4 were synthesized by clicking 
p-nitrophenyl azide (Table 3-1, Entry 3) to the previously prepared propargyl resin to 
give the triazole functionalized resin 5 as shown in Figure 3-3.  Reduction of the nitro 
group gave the aryl amine 6.  The first amino acid residue was coupled using 2-(7-aza-
1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) to 
activate the acid.  The amino acid coupling to the aryl amine was sluggish even with the 
use of the stronger coupling reagent HATU.  The coupling of the first amino acid was 
performed three times to ensure efficient loading before moving to the next residue.  
The remaining portion of each peptide sequence was synthesized using standard solid 
phase peptide conditions.  The entire synthetic scheme for the two peptides is outlined 
in Figure 3-3.  The two peptides, 3 and 4, were synthesized using the same aryl triazole, 





















Figure 3-3.  Scheme for the Synthesis of Triazole Containing Peptides 3 and 4 
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 The last peptide was synthesized with a biaryl triazole.  The synthesis of this 
peptide involved the substitution of TCA resin with p-iodophenol.  The p-iodophenol 
resin was then coupled with trimethylsilylacetylene (TMS) via sonogishira coupling.  The 
TMS protected phenyl acetylene resin was then deprotected with tetrabutylammonium 
fluoride and then clicked with the p-nitrophenyl azide.  Reduction of the azide followed 
by amino acid coupling provided the biaryl triazole peptide 7.  The synthetic scheme for 
the biaryl triazole peptide 7 is shown in Figure 3-4. 
Synthesis of Longer Peptides Containing Side Chain Aryl Triazoles 
 
 The two base peptides 8 and 9 were synthesized using a Protein Technologies 
Inc. Prelude peptide synthesizer (Figure 3-5).  The program was set to couple using 
standard peptide coupling conditions and was set to couple each amino acid residue 
twice.  Once the base sequence was synthesized the last alkyne containing residue was 
added manually to the resin using a 1:3 mixture of HATU to O-Benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU) respectively as the coupling 
reagents to provide peptides 10 and 11.  Once the final residue was in place, the two 
peptide resins were split into two batches.  Each peptide was then clicked with two 
different azides.  One batch of each peptide was set to click with p-chlorophenyl azide 
to give peptides 12 and 13.  The second batch of each peptide was set to click with the 
coumarin, 3-azido-7-hydroxy-2H-chromen-2-one, to give peptides 14 and 15.  After the 
click reaction, all of the peptides were 9-fluorenylmethoxycarbonyloxy (Fmoc) 



























Figure 3-6.  Formation of Clicked p-Chlorobenzyl Triazole Peptides 12 and 13 and 
Coumarin Triazole Peptides 14 and 15 
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either preparatory HPLC or by solid phase extraction.  The formation of the clicked 
peptides 12, 13, 14, and 15 is shown in Figure 3-6.   
Experimental 
 
 General Considerations.  Amino acid starting materials, coupling reagents, and 
solid phase synthesis solvents were purchased from Advanced Chem Tech. and used 
as received.  Reagents were used as is without additional purification.  Unnatural amino 
acids were synthesized as described in Chapter 2.  Dry solvents were obtained from a 
Grubb’s Solvent system and used immediately or stored over activated 4Å molecular 
sieves.  Samples were purified by HPLC using a Hewlett Packard Series 1100 HPLC 
fitted with a Varian Dynamax Microsorb 100-5 C8 column or by solid phase extraction 
using Peninsula Labs C18 Sep-columns.  High resolution mass spectroscopy (HRMS) 
was performed in the Mass Spectrometry Center located in the Chemistry Department 
of the University of Tennessee on a JOEL JMS-T100CC ACCU-TOF using DART 
ionization or on a MALDI-TOF. 
General Conditions for Standard Solid Phase Peptide Synthesis. The resin 
to be coupled (1.0 Equiv.) was allowed to swell in dichloromethane (DCM) for 5-10 min 
and then drained.  The amino acid (4.0 Equiv.) to be coupled was activated by 
dissolving in N-Methylpyrolidinone (NMP) and the adding diisopropylethylamine 
(DIPEA) (8.0 Equiv.), HBTU (3.9 Equiv.)  and N-Hydroxybenzotriazole (HOBt) (2 
Equiv.).  The amino acid solution was allowed to mix for 15-20 min.  The activated 
amino acid solution was added to the resin and the mixture was shaken for 30-45 min.  
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The resin was drained rinsed with NMP, DCM, and methanol.  The process was 
repeated once. 
Trichloroacetimidate Wang Resin.  TCA Wang Resin (2.00 g, resin loading 
0.650 mmol/g, 1.30 mmol, 1.00 equiv.) was weighed out into a dry roundbottom flask 
with a stirbar.  The flask was capped with a septum and purged well with nitrogen.  Dry 
DCM (20 mL) was added to the flask via syringe and the mixture was stirred under 
nitrogen for 15 to 20 min. in order to swell the resin. The resin mixture was then cooled 
to 0 oC in an ice bath.  TCA (4.65 mL, 52.0 mmol, 40.0 equiv.) was then added to the 
reaction flask via syringe followed by a solution of 1, 8-diazabicyclo[5.4.0]undec-7-ene 
(0.195 mL, 1.29 mmol, 0.990 equiv.) in 4 mL of dry DCM.  The reaction was stirred 
under nitrogen for approximately 1 hour.  The solution was then filtered through a solid 
phase synthesis vessel in order to collect the resin.  The resin was rinsed well with DCM 
and methanol and then dried and stored.   
Propargyl Wang Resin.    TCA Wang resin (0.400 g, 0.254 mmol, 1.00 equiv) 
was weighed out into a 20 mL scintillation vial.  A stir bar was added and the vial was 
fitted with a septum and purged well with nitrogen.  A 50:50 mixture of dry THF and dry 
DCM (6 mL) was added to the resin and the mixture was allowed to stir for 20-30 min. in 
order to swell the resin.  Propargyl alcohol was then added to the resin solution which 
was allowed to stir for another 5-10 min.  A second vial was fitted with a septum and 
purged with nitrogen.  3 mL of dry tetrahydrofuran (THF), 3 mL of dry DCM, and 0.12 
mL of boron trifluoride diethyl etherate were added to the second vial via syringe and 
the solution was mixed well.  The boron trifluoride diethyl etherate solution was then 
added dropwise to the solution of resin.  The reaction was allowed to stir for 
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approximately 1 hour at room temperature.  The resin was collected in a solid phase 
synthesis vessel and rinsed well with DCM and methanol.  The resin was dried well and 
stored for later use. 
General Conditions for the On-Resin Click (ORC) Reaction of Aryl Azides 
with Propargyl Wang Resin.    Propargyl Wang resin (0.025 g, 0.017 mmol, 1 equiv.) 
was weighed out into a peptide synthesis vessel.  2-5 mL of N-methyl pyrolidinone was 
added to the resin which was allowed to swell in the solvent for 20-30 min.  In a 
scintillation vial, copper iodide (0.00940 g, 0.0500 mmol, 3.00 equiv.) was suspended in 
~1 mL of NMP.  Piperidine (9.80 uL, 0.100 mmol, 6.00 equiv.) was added to the 
suspension and the solution was mixed until all of the copper iodide had dissolved and 
the solution had turned a deep greenish brown.  The aryl azide (0.0500 mmol, 3.00 
equiv.) was then added to the copper iodide solution and mixed until dissolved.  The 
propargyl wang resin was drained and the copper iodide solution was added.  The vial 
was rinsed with ~1 mL of NMP and the rinse was also added to the resin.  The reaction 
was shaken overnight (16-18 hours).  Once finished, the resin was drained and rinsed 
with NMP, methanol, and DCM.  The resin was allowed to swell in DCM for 20-30 min.  
The product was then cleaved from the resin using a cocktail of 75% trifluoroacetic acid 
(TFA) in DCM with 5-8 drops of triisopropyl silane.  The mixture was shaken for 45 min 
to 1 hour and then drained and repeated twice more.  In cases where purification was 
needed the compounds were purified by HPLC on a C8 column using an acetonitrile 
and 0.1% aqueous TFA eluent system.  The HPLC was run using a gradient from 5% 
acetonitrile  to 95% acetonitrile over 15 min. 
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(1-(4-ethylphenyl)-1H-1,2,3-triazol-4-yl)methanol. (Table 3-1, Entry 1) was 
synthesized by the reaction of p-azido ethylbenzene with propargyl Wang resin.  The 
product was recovered from resin in 90% yield.  HRMS-DART ([M]+): Calculated for 
C11H13N3O, 204.1137, Found 204.1131. 
(1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methanol. (Table 3-1, Entry 2) was 
synthesized from the reaction of p-azido chlorobenzene with propargyl Wang resin.  The 
product was recovered from resin in 81% yield.  HRMS-DART ([M]+): Calculated for 
C9H8ClN3O, 210.0434, Found 210.0432. 
(1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methanol. (Table 3-1, Entry 3) was 
synthesized from the reaction of p-azido nitrobenzene with propargyl Wang resin.  The 
product was purifed by preparatory HPLC.  The product was recovered from column in 
47% yield.  HRMS-DART ([M]+): Calculated for C9H8N4O3, 221.0675, Found 221.0671. 
(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol. (Table 3-1, Entry 
4)  was synthesized from the reaction of 3,4,5,-trimethoxyphenyl azide with propargyl 
Wang resin.  The product was recovered from resin in 88% yield.  HRMS-DART ([M]+): 
Calculated for C12H15N3O4, 266.1141, Found 266.1133. 
(1-(naphthalen-2-yl)-1H-1,2,3-triazol-4-yl)methanol. (Table 3-1, Entry 5) was 
synthesized from the reaction of 2-Azido napthylene with propargyl Wang resin.  The 
product was recovered from resin in 93% yield.  HRMS-DART ([M]+): Calculated for 
C11H13N3O, 226.0980, Found 226.0982. 
7-hydroxy-3-(4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl)-2H-chromen-2-one. 
(Table 3-1, Entry 6) was synthesized from the reaction of 3-azido-7-hydroxy-2H-
 60
chromen-2-one with propargyl Wang resin.  The product was recovered from resin in 
85% yield.  HRMS-DART ([M]-) Calculated for C11H13N3O, 258.0515, Found 258.0520. 
(1-(pyridin-2-yl)-1H-1,2,3-triazol-4-yl)methanol. (Table 3-1, Entry 7) was 
synthesized from the reaction of 2-azidopyridine with propargyl Wang resin.  The 
product was recovered from resin in 79% yield.  HRMS-DART ([M]-): Calculated for 
C11H13N3O, 175.0620, Found 175.0616. 
Synthesis of Peptide 2 (Trp-Ala-Pro-Gly-Ala). The peptide was synthesized on 
Knorr Rink resin using standard solid phase peptide synthesis (SPPS) conditions.  Each 
amino acid residue was added by activating the acid in an NMP solution containing 4 
equivalents of amino  acid, 3.9 equivalents of O-Benzotriazole-N,N,N’,N’-tetramethyl-
uronium-hexafluoro-phosphate (HBTU), 2 equivalents of N-Hydroxybenzotriazole 
(HOBt), and 8 equivalents of diisopropylethylamine (DIPEA).  The activated solution 
was then added to the resin and the mixture was shaken for 30-45 min.  MS MALDI 
(H+): Calculated for C24H33N7O5, 500.26214, Found 500.26. 
Synthesis of Peptides 3 and 4 (Trp-Ala-Pro-Gly-Ala-MonoArylTriazole) and 
(Trp-Ala-Gly-Gly-Ala-MonoArylTriazole). (1-(4-nitrophenyl)-1H-1,2,3-triazol-4-
yl)methanol resin (0.250 g, loading 0.650 mmol/g, 0.160 mmol, 1.00 equiv.) was 
weighed out into a peptide synthesis vessel.  Tin (II) chloride dehydrate (0.147 g, 0.650 
mmol, 4.00 equiv.) was weighed out into a scintillation vial and 2 mL of THF was added 
followed by thiophenol (0.201 mL, 1.95 mmol, 12.0 equiv.).  Triethylamine (0.343 mL, 
2.40 mmol, 15.0 equiv.) was then added to the solution.  The solution was mixed well 
and the added to the(1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methanol resin.  The 
reaction was allowed to shake for 16-18 hours.  The resin was drained and then rinsed 
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well with water, methanol, NMP, DCM, and ether.  Peptides 3 and 4 were synthesized 
using standard Fmoc solid phase peptide synthesis.  The peptides were synthesized off 
of the aryl amine that was obtained from the reduction of (1-(4-nitrophenyl)-1H-1,2,3-
triazol-4-yl)methanol.  The peptides were cleaved from resin using a cocktail of 75% 
TFA in DCM with 1% triisopropylsilane.  The cleaved peptides were purified by HPLC 
on a C8 column using an acetonitrile and 0.1% aqueous TFA eluent system. Peptide 3 
MS MALDI (Na+): Calculated for C30H36N10O6, 655.8323, Found 655.83.  Peptide 4 MS 
MALDI (H+): Calculated for C33H40N10O6, 673.3215, Found 673.32. 
Synthesis of Peptide 7 (Trp-Ala-Pro-Gly-Ala-BiArylTriazole).  The previously 
prepared TCA wang resin (0.400 g, 0.250 mmol, 1.00 equiv.) was weighed out into a 20 
mL scintillation vial.  A stir bar was added and the vial was fitted with a septum and 
purged well with nitrogen.  A 50:50 mixture of dry THF and dry DCM (6 mL) was added 
to the resin and the mixture was allowed to stir for 20-30 min. in order to swell the resin.  
A solution of p-iodophenol in DCM was then added to the resin solution which was 
allowed to stir for another 5-10 min.    A second vial was fitted with a septum and 
purged with nitrogen.  Dry THF (3 mL), dry DCM (3 mL), and 0.12 mL of boron trifluoride 
diethyl etherate were added to the second vial via syringe and the solution was mixed 
well.  The boron trifluoride diethyl etherate solution was then added dropwise to the 
solution of resin.  The reaction was allowed to stir for approximately 1 hour at room 
temperature.  The resin was collected in a solid phase synthesis vessel and rinsed well 
with DCM and methanol.  The resin was dried well and stored for later use.   
The prepared p-iodophenol resin (0.250 g, loading 0.65 mmol/g, 0.16 mmol, 1 
equiv.) was weighed out into a scintillation vial.  The resin was allowed to swell in 
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tetrahydrofuran (THF) for 5-10 min.  Bis(triphenylphosphine)palladium(II) dichloride 
(0.057 g, 0.08 mmol, 0.5 equiv.) was dissolved in THF (2 mL).  Piperidine (80 uL, 0.813 
mmol, 5 equiv.) was added to the solution and the solution was mixed for 5-10 min.  The 
catalyst solution was then added to the p-iodophenol resin and the mixture was stirred 
for 20-30 min.  TMS (0.231 mL, 1.63 mmol, 10.0 equiv.) was diluted in 1 mL of THF and 
the solution was added slowly to the resin mixture.  The reaction was allowed to stir for 
30-45 min.  The reaction was then drained through a peptide synthesis vessel in order 
to collect the resin.   
The protected alkyne resin was rinsed well with THF, DCM, and methanol, then 
deprotected by shaking the resin in a solution of 0.170 g of tetrabutylammonium fluoride 
in 2 mL of THF for 1-2 hours.  The resin was then drained and rinsed well with DCM.  
The deprotected alkyne was the reacted with p-azido nitrobenzene using the general 
on-resin click conditions in order to provide the nitro substituted biaryl triazole. 
The resin was weighed out into a peptide synthesis vessel.  Tin (II) chloride 
dehydrate (0.147 g, 0.65 mmol, 4 equiv.) was weighed out into a scintillation vial and 2 
mL of THF was added followed by thiophenol (0.200 mL, 1.95 mmol, 12.0 equiv.).  
Triethylamine (0.343 mL, 2.44 mmol, 15.0 equiv.) was then added to the solution.  The 
solution was mixed well and the added to the (1-(4-nitrophenyl)-1H-1,2,3-triazol-4-
yl)methanol resin.  The reaction was allowed to shake for 16-18 hours.  The resin was 
drained and then rinsed well with water, methanol, NMP, DCM, and ether. 
Peptide 7 was then synthesized on the biaryl triazole resin using standard Fmoc 
solid phase petide synthesis.  The peptide was cleaved from resin using a cocktail of 
75% TFA in DCM with 1% triisopropylsilane.  The cleaved peptides were purified by 
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HPLC on a C8 column using an acetonitrile and 0.1% aqueous TFA eluent system.  MS 
MALDI (H+): Calculated for C38H42N10O6, 735.3367, Found 735.33. 
Click Reactions of Peptides 10 and 11 with p-Chlorophenyl Azide and 3-
Azido-7-Hydroxy-2H-Chromen-2-one.  The batches of resins containing peptides 10 
and 11 were each split into two batches of 100mg of resin.  One 100 mg batch of 
peptides 10 and 11 were reacted with p-azido chlorobenzene using the general on-resin 
click (ORC) condition to give peptides 12 and 13 (p-Chloroclicked PentynylGlycine-
Val-Lys-Ala-Pro-Gly-Lys-Phe-Val-Trp) and (p-Chloroclicked PentynylGlycine-Val-
Lys-Ala-Gly-Gly-Lys-Phe-Val-Trp) The second 100 mg batches of the two peptides 
were reacted with 3-Azido-7-Hydroxy-2H-Chromen-2-one using the same on-resin click 
(ORC) conditions to yield peptides 14 and 15 (Coumarin Clicked PentynylGlycine-
Val-Lys-Ala-Pro-Gly-Lys-Phe-Val-Trp). (Coumarin Clicked PentynylGlycine-Val-
Lys-Ala-Gly-Gly-Lys-Phe-Val-Trp).   The peptides were cleaved from resin using a 
cocktail of 75% TFA in DCM with 7-8 drops of triisopropylsilane.  The cleaved peptides 
were purified by HPLC on a C8 column using an acetonitrile and 0.1% aqueous TFA 
eluent system.  Peptide 12 MS MALDI (H+): Calculated for C66H94N17O10, 1320.7136, 
Found 1320.70. Peptide 13 MS MALDI (H+): Calculated for C63H90N17O10, 1280.6823, 
Found 1280.69.  Peptide 14 MS MALDI (H+): Calculated for C69H95N17O13, 1370.7374, 
Found 1370.72.  Peptide 15 MS MALDI (Na+): Calculated for C66H91N17O13, 1352.6880, 
Found 1352.69. 
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Chapter 4:  Absorbance and Fluorescence Studies of Aryl Triazoles 
and Tryptophan Containing Peptides Bearing Aryl Triazoles 
 
Backround and Significance 
 
Fluorescence spectroscopy provides a variety of tools to measure distances, 
monitor dynamics, or observe molecular interactions with sensitivity far beyond that of 
other biophysical methods.40  The use of fluorophore donor-acceptor pairs as sensitive 
molecular reporters, termed molecular beacons, are an attractive approach to monitor 
molecular interactions.  Molecular beacons rely on electron transfer processes which 
are the distance-dependant interactions between a fluorophore donor with a quenching 
or resonating acceptor molecule or fragment.41  The interactions are observed as 
fluorescence changes, such as fluorescence resonance energy transfer (FRET) or 
resonance energy transfer (RET).40  These processes are capable of providing 
information on the nanometer length scale, well below the detection limit of optical 
techniques.40 
The basic principle of RET consists of a nonradiative transfer of energy from a 
chromophore in an excited state, called a donor, to an acceptor molecule.42  A result of 
this interaction is a decrease in the fluorescence of donor molecule.43  The energy 
transfer for RET (ERET) is inversely proportional to the sixth power of the distance 
between the donor and acceptor chormophores 
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where Ro is the distance at which there is 50% energy transfer from the donor 
chromophore to the acceptor chromophore.43  This distance is usually between 2-5 nm 
and the maximum distance for any observable energy transfer is usually around 10 nm.  
The FRET methodology has become a common approach to the study of protein-
protein interactions. 
 Molecular beacons have found much success in the field of oligonucleotides.41, 44 
Oligonucleotide molecular beacons utilize the incorporation of a fluorophore-quencher 
pair at opposing ends of a nucleotide strand.  The nucleotides form a stem-loop 
structure which places the fluorophore and quencher in close proximity, thus exhibiting 
no overall fluorescence.  When the nucleotide strand is equilibrated with its target, the 
helix of the stem is opened in order to bind its target, and the fluorophore-quencher pair 
are moved apart which restores the fluorescence of the fluorophore    (Figure 4-1).  This  
technique is finding more use as an efficient method to monitor specific binding 
interactions between nucleotides and DNA or RNA targets.41, 44 
 While the application of molecular beacons has mostly been limited to the field of 
oligonucleotides, this technology is beginning to find uses in the field of peptides.  The 
use of fluorophoric probes can provide crucial information about peptide structure and 
folding (Figure 4-1).  The spacing of a fluorophore and either a quenching molecule or a 
FRET acceptor within a peptide sequence can provide vital information about peptide 
conformations and secondary structures, as well as providing information on target 
binding.  When the fluorescent dye molecules are close together, electron transfer takes 
place, which leads to either a shift in the fluorescent emission (FRET) or quenching of 










Figure 4-1 General Scheme for the Activity of Molecular Beacons and Peptide 
Beacons.  A) General Scheme for the Fluorescent Activation of Molecular Beacons 
Upon Target Binding   B) General Scheme for the Fluorescence Quenching of Peptide 
Beacons Upon Formation of Secondary Structure 
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each other, then normal fluorescence is regained.  This approach has been used by 
Plaxco et al., who have recently found success in labeling the ends of a six-residue 
peptide epitope of HIV protein p17.45  The residue is consistently quenched in the 
absence of its target antibody due to the molecular mobility.  When bound to its target, 
however, the epitope adopts a very extended and rigid conformation that segregates the 
quencher from the fluorophore which enhances the fluorescence.45  
In order to develop a versatile method for the introduction of fluorophores into 
peptides, our click peptide motif was used for the incorporation of probe compounds into 
peptides.  This would provide a reliable and tunable method for the synthesis of peptide 
beacons.  Tryptophan is naturally fluorescent, and is therefore a readily available 
fluorophore for testing the FRET capability of various triazoles.  Initially it was decided 
that a series of four small peptides could be used to determine the feasibility of using 
aryl triazoles as charge transfer companions for tryptophan.  The use of triazoles allows 
for the introduction of fluorophores into peptides through the use of clickable unnatural 
amino acids.  This chemistry will allow for a wide variety of tunable probe molecules to 
be incorperated into any peptide sequence.  
Absorbance and Fluorescent Properties of Initial Small Peptides 
 
It is known that tryptophan fluorescence is dependant on the protein or peptide in which 
it is contained.46  This is partially due to the fact that the fluorescence of tryptophan can 
be internally quenched by carbonyl groups.47-50  Because of this, a sample peptide with 
no triazole would be needed to provide a standard for tryptophan fluorescence in the 
sequence used.  The first series of peptides are shown in Figure 4-2 and their synthesis
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Figure 4-2.  Initial Set of Small Peptides Tested for Electron Transfer Properties 
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is discussed in Chapter 3.  The initial peptide 2 bearing no triazole was constructed as a 
control to provide the fluorescence intensity of tryptophan for the amino acid sequence 
used.  It was then used as a relative control for full tryptophan fluorescence for 
comparison to the aryl triazole containing sequences used.  The mono aryl and biaryl 
triazole peptides, 3 and 7 respectively, containing a proline turn, were both expected to 
provide either quenching or FRET activity due to the proximity of the aryl triazoles to the 
tryptophan.  A short six to seven residue sequence coupled with the forced proline turn 
was assumed to provide the suitable distance of 2-10 nanometers between the triazole 
and tryptophan residue for any electron transfer phenomena to be observed.40, 44, 51, 52  
The mono aryl peptide 4 was constructed by replacing the proline turn of peptide 3 with 
a glycine residue.  It was expected that the removal of the proline turn would add 
flexibility to the peptide and allow it to extend in water, moving the aryl triazole and 
tryptophan residues apart and thus restoring the tryptophan fluorescence of the peptide.   
 The fluorescence was measured on the peptides at a concentration of 10 
uM by excitation of the tryptophan residue at 280 nm and is shown in Figure 4-3.  It was 
observed that both proline containing aryl triazole peptides 3 and 7 demonstrated 
fluorescence quenching, meaning that the triazoles were involved in FRET.  This means 
that it is possible that the proline turn did bring the triazoles in close proximity to the 
tryptophan residue.  The fluorescence intensity of the tryptophan was decreased to 
almost half of that seen in the non triazole containing peptide 2.  Unexpectedly, 
however, the glycine containing peptide 4 showed fluorescence quenching comparable 
to that of the two peptides containing a proline turn.  This indicated that either the 

















residue (Figure 4-2), or that the quenching of the tryptophan fluorescence was not the 
result of a true electron transfer process.   
Upon reflection of the peptide design, it was noticed that the construction of the 
peptides placed the aryl triazoles in the backbone portion of the sequence.  It is possible 
that having the aryl triazole incorporated into the backbone of the sequence made the 
tryptophan residue incapable of being moved far enough away from the triazole to 
restore the tryptophan fluorescence.  It was decided that a longer peptide sequence and 
incorporation of the aryl triazole as a side chain substituent would help to ensure the 
separation between it and the tryptophan residue.  It was also decided that a series of 
small molecule aryl triazoles should be analyzed to determine the tunabilty of the 
absorbance and fluorescence behavior of the triazoles. 
Absorbance and Fluorescent Properties of Small Molecule Aryl 
Triazoles 
 
A library of chromophores with a wide variety of electronic properties would provide the 
opportunity to match probes to specific uses.  For example, the studies presented rely 
on the natural fluorescence of tryptophan; however, it might be useful to have 
fluorophores which have higher fluorescent emissions or which have higher quantum 
yields and produce fluorescence at lower concentrations.  In order to investigate the 
tunability of the triazole chromophores, a series of small molecule aryl triazoles was 
constructed on the solid phase using propargyl modified Wang resin.  The absorption 
was measured to determine the wavelength at which to apply the fluorescence 
excitation, as well as, to determine the molar extinction coefficients for calculating more
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accurate solution concentrations.  The fluorescence data was used to determine 
whether or not the triazole itself possessed any fluorescent character.  Triazoles with no 
fluorescence of their own could be used as possible quenching chromophores, while 
fluorescent triazoles could be used with another fluorophore as part of a FRET pair.  
 The first two triazoles synthesized were the mono aryl triazole present in 
peptides 3 and 4 and the biaryl triazole present in initial peptide 7. These were 
synthesized using the p-nitrophenyl azide as described in Chapter 2.  The triazole was 
cleaved; however, after the first alanine residue was coupled and deprotected.  The 
absorbance data showed that both of these pieces had a peak absorbance at around 
260 nm, which overlaps that of tryptophan (Figure 4-4).  Neither of the pieces alone 
displayed any fluorescence even in solutions as concentrated as 200 uM.  Since the 
triazole pieces absorb in the same region as the tryptophan, the observed quenching 
could be a product of the overlapping absorbances rather then electron transfer.  
  In order to verify that the quenching phenomena observed in the peptides was 
indeed due to electron transfer and not just the overlapping absorbance of the triazoles 
with tryptophan, the fluorescence of a series of standard solutions of the two aryl 
triazole pieces with tryptophan in a 1:1 ratio was examined.  Solutions of triazole and 
tryptophan as well as a solution of only tryptophan were made at 50 uM and then 
serially diluted by half to produce solutions of 25 uM, 12.5 uM and 6.25 uM.  The 
fluorescence of each solution was then taken and the spectra were compared to ensure 
that the quenching observed was not just a product of the overlap of the aryl triazoles 
absorbance with that of tryptophan.  The obtained data shows no quenching of 
tryptophan fluorescence in the solutions of free triazole, with tryptophan at any of the  
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Figure 4-4.  Graphs of Monoaryl and Biaryl Triazole Absorbance Data 
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concentrations (Figure 4-5). This would indicate that the quenching observed in 
peptides 2, 3, 4, and 7 was indeed be due to electron transfer and not just a result of the 
triazole absorbances overlapping that of tryptophan.  
In order to analyze the effects of substituted aryl rings on the absorbance and 
fluorescence characteristics of triazoles a series of small molecule triazoles was 
constructed (Table 3-1).  Of the seven constructed triazoles the p-ethylphenyl triazole 
(Table 3-1, Entry 1), the p-chlorophenyl triazole (Table 3-1, Entry 2), and the 2-pyridyl 
triazole (Table 3-1, Entry 7) had the lowest absorbances.  The 2-pyridyl triazole showed 
only mild absorbance from 200nm to 240nm and both the p-chlorophenyl triazole and p-
ethylphenyl triazole showed a peak absorbance at 247nm (Figure 4-6).  The 3,4,5,-
trimethoxyphenyl triazole (Table 3-1, Entry 4) showed slightly increased absorbance at 
253 nm, while the p-nitrophenyl triazole (Table 3-1, Entry 3) provided a considerable 
increase to 283 nm (Figure 4-7).  The napthyl triazole (Table 3-1, Entry 5) exhibited 
three absorbance bands at 215 nm, 243, nm and 280 nm, and the coumarin  triazole 
(Table 3-1, Entry 6) provided the largest absorbance at 343nm which falls in range of 
tryptophanemission (Figure 4-8). 
The fluorescent properties for each of the triazole pieces were then examined by 
excitation of each triazole at its recorded absorbance values.  Of the seven triazoles, 
the p-ethylphenyl, 2-pyridyl, and p-chlorophenyl triazoles showed little to no 
fluorescence in solutions up to 100 uM (Figure 4-9).  The p-nitrophenyl triazole showed 
a moderate fluorescence band at around 378 nm, and the 3,4,5-trimethoxyphenyl 
triazole demonstrated a greater fluorescence band at around 378 nm (Figure 4-10).  





































Figure 4-10.  Fluorescence Emission Spectra for p-Nitrophenyl, and  
3,4,5-Trimethoxyphenyl Triazoles 
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concentrations (Figure 4-11).  The coumarin triazole demonstated the highest 
fluorescence with a strong fluorescence band at around 470 nm.  Excitation of the 
napthyl triazole at the three absorbances indicated that the fluorescence at 380 nm 
resulted from the absorbance at 243 nm (Figure 4-11).   
Of the screened triazoles, the coumarin triazole was the most likely to provide any kind 
of FRET activity due to the fact that its absorbance overlapped with the emission of 
tryptophan at around 340 nm, and it had a much higher emission band than tryptophan 
at around 480 nm.  For this reason the coumarin triazole was chosen to be attached to 
one of the longer peptides to investigate possible FRET interactions between 
tryptophan and the coumarin triazole. 
 Absorbance and Fluorescence Properties of Long Aryl Triazole 
Peptides 
 
To determine if increasing the distance between the tryptophan residue and the 
aryl triazole would provide a system where the quenching and fluorescence could be  
controlled by the rigidity of the sequence, two sets of longer ten residue peptides were 
synthesized. In order to add to the distance and mobility, the aryl triazole moiety was 
constructed as a side chain functionality rather than being contained in the backbone of 
the peptides.  The peptides were again synthesized as pairs with one of each pair 
containing a proline residue and the other containing a glycine residue in its place.  The 
peptides contained an unnatural alkyne amino acid as the final residue which allowed 
for triazole functionalization with any desired aryl azide via click chemistry.  




Figure 4-11.  Fluorescence Emission Spectra for Napthyl, and Coumarin Triazoles  
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 expected to produce a quenching compound, while incorporation of the coumarin 
triazole which had absorbance at the same wavelength as the tryptophan fluorescence 
was expected to be a possible fluorescent FRET companion for tryptophan.   
The four peptides are pictured in Figure 3-6 in Chapter 3.  The p-chlorophenyl 
azide was chosen to form the quenching peptide because its absorbance was at a lower 
wavelength than tryptophan and because it had very little fluorescence of its own.  The 
fluorescence of all of the peptides were examined in aqueous solution as well as in 
varying solutions of trifluoroethanol (TFE) in water.  TFE solutions add hydrophobic 
interactions and cause peptides to fold into secondary structure, so this was employed 
as a secondary method of bringing the two fluorophoric ends of the peptides closer 
together.  The fluorescent analysis of the coumarin peptides was slightly inhibited by the 
fact that the coumarin moiety had a mild fluorescence absorbance at 280 nm which was 
the excitation wavelength used for tryptophan.  There was still, however, a noticeable 
difference in the fluorescence between the proline containing peptide and the glycine 
containing peptide (Figure 4-12).  The glycine containing peptide showed a moderate 
tryptophan fluorescence peak at 318 nm as well as the coumarin fluorescence at 455 
nm.  In the proline containing peptide, the typtophan fluorescence was weakened and 
leveled off and the coumarin fluorescence peak was intensified (Figure 4-12).  
Interestingly, increasing the hydrophobicity with the addition of TFE provided almost no 
change in the fluorescence data. It could be that the ends of the peptides, where the 
fluorophore groups are still mobile enough that changes in the hydrophobicity made little 
change in fluorescence compared to the forcing of a turn by the addition of proline.  It is 




Figure 4-12.  Fluorescence Graph of the Proline and Glycine Coumarin Peptides 
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structure than the hydrophobic interctions provided by the TFE solution.   This data also 
strongly suggest that modification of the coumarin triazole moiety could provide a 
comparable FRET partner for tryptophan.  The overlapping absorbances make this 
particular system less useful; however, chemical modification of the coumarin 
fluorophore could be used to adjust its fluorescence properties, or a fluorescence donor 
could be employed. 
 The fluorescence data for the p-chlorophenyl triazole was more distinct and 
informative due to the fact that the triazole had no absorbance or fluorescence that 
interfered with the fluorescence readings of tryptophan (Figure 4-13).  The glycine 
containing peptide exhibited considerable yet broad tryptophan fluorescence peak at 
around 314 nm (Figure 4-13).  The fluorescence signal was seen both in water and in 
TFE solution.  The proline containing peptide also showed a tryptophan fluorescence at 
314nm, but the intensity was greatly diminished compared to that of the glycine 
containing peptide.  The TFE solutions still provided little improvement to the quenching.  
Unlike the coumarin peptide, however, the TFE did produce a slight difference in the 












Absorption measurements were taken on a Thermo Science Evolution 600 UV-
Visual Spectrometer in water at 20oC.  Initial absorption measurements were taken for 
all small molecules and peptides in order to determine the molar absorption coefficients 
(280).  The molar absorption coefficients were taken at 280 nm the wavelength for the 
excitation of tryptophan.  For the small click reactions the molar absorption coefficient 
was also measured at the wavelength of the maximum absorption.  The molar 
absorption coefficients were then used to measure the concentration for all of the 
working analytical samples used for measurements.   
 Fluorescence measurements were taken on a Perkin-Elmer LS 55 
Spectrofluorimeter.  Samples were prepared to the desired concentrations in either 
deionized water or a mixture of deionized water and trifluoroethanol.  Fluorescence 
measurements for all compounds were taken at several concentrations for correlation.  
The concentrations of samples were determined and adjusted based on the molar 
absorption coefficients.  All measurements involving tryptophan fluorescence were 
excited at 280 nm and the emission was recorded from 250 nm to 550 nm.  
Measurements on small triazole compounds were excited at the wavelength, or 
wavelengths, that corresponded to the specific absorption values for the compound.  
The emission was recorded from 250 nm to 850 nm.   
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Conclusions and Future Developments 
 
The data obtained from the synthesized peptides provides a basis for the use of 
aryl triazoles, formed via click chemistry, as fluorescent dye compounds for the use as 
probes of peptide and protein structure.  The non-fluorescent aryl triazoles have been 
proven to act as quenching chromophores for the natural fluorescence of tryptophan 
residues.   The ease of synthesis and availability of starting materials for aryl azides 
provides the possibility for the synthesis of a large library of aryl triazoles.  The 
applications of these compounds are even further expanded by the ability to incorporate 
the chromophore into the peptide at any time during the synthesis through the use of 
click chemistry, and the library of azide and alkyne functionalized amino acids provides 
the ability to incorporate triazole moieties at almost any position of a peptide sequence.   
This chemistry provides a basis for the formation of a modular approach to the 
formation of peptide beacons.  With modified coumarin azides it should also be possible 
to find an appropriate fluorophoric compound to function as an operational FRET 
partner for tryptophan.   
This chemistry does not need to be limited to the use of the natural fluorescence 
of tryptophan residues.  The ability to incorporate multiple “clickable” amino acids into a 
peptide allows for the introduction of both a synthetic fluorophore as well as a synthetic 
electron transfer partner.  The ability to rapidly and efficiently incorporate fluorophoric 
probe compounds would allow for a modular analysis of active peptide structure and 
binding modes.  
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 This methodology could be applied to monitoring the conditions of intramolecular 
click reactions of peptides.  In many cases it is desirable to lock peptides into their 
bioactive conformations.  This can be readily achieved by click chemistry, however 
monitoring these reactions can be costly and tedious.  For intramolecular click 
reactions, the mass of the product does not change from that of the starting material.  
This means that these reactions must be monitored by both mass and HPLC, which is 
time consuming.  Since the click reaction to close a peptide forms a triazole, placement 
of a complimentary fluorophore into the sequence of the peptide would produce a 
method for internal fluorescence quenching to monitor intramolecular peptide click. 
 It has been shown that aryl triazoles work as companion chromophores with 
tryptophan for the purpose of constructing peptide beacons.  These compounds are 
capable of taking place in electron transfer processes, thus making them useful as 
probes for analyzing the activity and structure of peptides.  The advantages of these 
groups are that they can be introduced into a peptide at any time under mild conditions.  
The availability of aryl azides and methods of synthesizing aryl azides coupled with click 
functionalized unnatural amino acids provides a method of incorporating probes into any 
position of a peptide sequence.  This methodology will provide a multitude of 
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Porphyrins and related tetrapyrrolic macrocycles are an important class of 
biologically relevant molecules that have found a broad spectrum of applications in 
various fields such as catalysis, materials and medicine. As a result, intense efforts 
have been made to synthesize porphyrins with tunable electronic and steric 
substituents. However, the classic synthesis of porphyrins typically gives low yields, 
requires tedious purification, and restrains effective preparation of porphyrin derivatives 
with functional and sensitive groups. Therefore, it is highly desirable to develop new 
strategies and alternative methods for efficient porphyrin synthesis.  By applying 
palladium-catalyzed amination and etheration to halogenated porphyrin precursors, our 
research group has successfully developed a series of general and efficient methods for 
the synthesis of novel porphyrins that contain nitrogen, oxygen, sulfur, and other 
functionalities. We continued to expand this porphyrin synthetic strategy through 
application of other types of metal-based catalytic reactions.    
Despite the well-known advantages of aziridines, they have received limited 
application in synthesis due to the difficulty in preparation and storage.53 Several factors 
have hindered the area of catalytic aziridination.  One of the major drawbacks is that 
most catalytic aziridination systems employ the use of the reagent [N-(p-
toluenesulfonyl)imino]phenyliodinane.  The drawbacks of using [N-(p-
toluenesulfonyl)imino]phenyliodinane are that it is commercially unavailable, it can be 
costly to make, it is insoluble in many common solvents.  To this end we have 
investigated the ability of metalloporphyrins to catalyze the aziridination of alkenes with 
a variety of alternate nitrene sources. 
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Chapter 5:  Iron (III) Porphyrin Catalyzed Aziridination of Alkenes 
using Bromamine-T as Nitrene Source 
 
This Chapter is a lightly revised version of a paper by the same name published in the 
journal Organic Letters in 2004 by Renu Vyas, Guang-Yao Gao, Jeremiah D. Harden, 
and X. Peter Zhang.  The major changes include 1) the exclusion of the abstract to the 
paper, 2) the reformatting of selected text to fit the guidelines of this dissertation, 3) 
reproduction and reformatting of the figures and tables, and 4) combination of the 
references in this work with those from the other chapters in this section. 
 
Renu Vyas, Guang-Yao Gao, Jeremiah D. Harden, and X. Peter Zhang.  Iron (III) 
Porphyrin Catalyzed Aziridination of Alkenes using Bromamine-T as Nitrene Source. 
Organic Letters, 2004 6(12), 1907. 
 
My use of we and us refers to the other coauthors and myself.  My primary contributions 
to this paper include 1) synthesis of the Bromamine-T reagent 2) repetition and 
verification of selected substrate reactions, and 3) characterization of some of the 
obtained products. 
 
Aziridination of alkenes mediated by a transition metal complex is one of the 
most attractive methods for the efficient and selective construction of synthetically and 
biologically important aziridines.54-58 The reagent [N-(p-toluenesulfonyl) 
imino]phenyliodinane (PhI=NTs) and related iminoiodane derivatives, aza-analogues of 
iodosylbenzene, have been extensively used as primary nitrene sources for catalytic 
aziridination.59-61  Although great progress has been made with PhI=NTs in a number of 
metal-catalyzed systems including asymmetric aziridination,54-58, 62-65 the reagent suffers 
from several drawbacks including its commercial unavailability, high cost, and 
insolubility along with generation of the heavy PhI byproduct.66-68  Consequently, there 
has been growing interest in developing metal-catalyzed aziridination of alkenes with 
alternative nitrene sources such as chloramine-T,69-76 bromamine-T,77-80 and azides. 81, 
82  
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Metalloporphyrins have played a pivotal role in the development of several 
important catalytic atom/group transfer reactions, including aziridination of alkenes.  
Metalloprophyrins were the first class of transition metal complexes that were 
demonstrated to catalyze the aziridination of alkenes.83, 84 Following this breakthrough, 
porphyrin complexes of several metal ions such as Fe, Mn, and Ru have been disclosed 
to have catalytic activity for aziridination when PhI=NTs was used as the nitrene 
source.85-89  As a part of our program of metalloporphyrin-based atom/group transfer 
catalysts,90-94 we became interested in developing practical catalytic aziridination 
processes with alternative nitrene sources.  To this end we developed iron(III) porphyrin 
complexes Fe(Por)Cl (Figure 5-1) that  are efficient and general catalysts for the 
aziridination of a wide variety of alkenes using bromamine-T as a nitrene source (Figure 
5-2).95 The reactions can be performed under mild conditions with alkenes as limiting 
reagents, and they proceed with moderate to low stereospecificity for 1,2-disubstituted 
alkenes.   
First the catalytic aziridination was surveyed using various metalloporphyrins with 
different nitrene sources.  These reactions were carried out at room temperature in 
acetonitrile in the presence of 5 Å molecular sieves using 5 mol % catalyst using a 
styrene to nitrene source mole ratio of 5: 1 (Table 5-1).  While chloramine-T was found 
to be an ineffective nitrene source under these conditions, bromamine-T was found to 
be a superior nitrene source compaired to PhI=NTs, affording the desired aziridine in 
60% isolated yield.  Other metal complexes of tetraphenylporphyrin (TPP) such as 
Mn(TPP)Cl, Ru(TPP)(CO) and Co(TPP) afforded the desired aziridine, but with less 















Table 5-1.   Aziridination of Styrene by Metalloporphyrinsa 
 
a Reactions were carried out for 12 h at room temperature in CH3CN under N2 in the presence of 5 Å 
molecular sieves with a styrene to nitrene source mole ratio of 5:1.  b Catalyst loading: 5 mol %; see 
Figure 5-1 for structures of metalloporphyrins.  cYields represent isolated yields of >95% purity as 
determined by 1H NMR.  d From ref 11. 
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have been known to catalyze aziridination,83-89 to the best of our knowledge this was the 
first example of cobalt porphyrins catalyzing the aziridination of alkenes.  It was also 
seen that the catalytic activity of Fe(Por)Cl with bromamine-T has a dramatic ligand 
dependence.  Both Fe(MeOPP)Cl and Fe(TDClPP)Cl were less effective than 
Fe(TPP)Cl and no activity was observed with Fe(OEP)Cl.  However, the electron-
deficient Fe(TPFPP)Cl improved the isolated yield of the desired aziridine to 80%(Table 
5-1).   
 The substrate scope of the aziridination reactions by Fe(TPP)Cl with bromamine-
T was explored using a variety of alkenes under the same conditions (Table 5-2). The 
catalytic system is suitable for a variety of styrene derivatives with para-substituted alkyl 
and halogen groups, affording the corresponding aziridines in yields similar to or better 
than that of the styrene reaction (Table 5-2).  Sterically hindered derivatives such as 
2,4,6-timethylstyrene could also be aziridinated, albeit in a lower yield.  Both α- and β-
subtituted styrenes including ethyl trans-cinnamate could be successfully converted to 
the desired aziridines in moderate to good yields (Table 5-2).  The stereospecificity 
ranged from low to moderate.  Like the ethyl trans-cinnamate, the α,β-unsaturated ester 
tert-butyl acrylate could also be aziridinated in moderate yield.  Cyclic alkenes with 
different ring sizes as well as straight-chain alkenes were also suitable substrates 
(Table 5-2).  Exo-methylene carbocycles such as methylenecyclohexene, however, 
could only be converted to the corresponding aziridine in trace amounts under these 
conditions (Table 5-2). 
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Table 5-2.  Aziridination of Alkenes with Bromamine-T Catalyzed by Fe(TPP)Cla 
 
a Carried out at room temperature in CH3CN for 12 hours under N2 in the presence of 5 Å molecular 
sieves using 5 mol% Fe(TPP)Cl.  Concentration: 0.1 mmol alkene/2mL CH3CN.  b Isolated yields with 
Bromamine-T as limiting reagent (alkene/Bromamine-T = 5:1).  c Isolated yields with alkene as limiting 
reagent (alkene/Bromamine-T = 1:2).  d cis:trans ratios.  e Performed at 60 oC.  f Fe(TPFPP)Cl was used.  
g Contaminated with small amount of side product. 
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To further improve the Fe(TPP)Cl/bromamine-T aziridination system, detailed 
optimization of various reaction parameters was carried out using styrene as the model 
substrate (Table 5-3).  Acetonitrile appeared to be the best solvent choice, as other 
solvents such as toluene, tetrahydrofuran, and dichloromethane gave none or only trace 
amounts of the desired aziridine (Table 5-3).  The reaction time could be shortened to 6 
hours without dramatically lowering the yield, however shorter times led to considerable 
loss in yield (Table 5-3).  An increase in reaction temperature typically led to higher 
yields, for example the isolated yields at 40oC and 80oC were 64% and 80% 
respectively (Table 5-3).  However temperatures in excess of 100oC resulted in a 
dramatic decrease in the yield of the desired aziridine and often led to the formation of 
otherwise unseen side products (Table 5-3).  There was an observed decrease in yield 
if the catalyst loading was decreased below 5 mol%, as well as when the styrene to 
bromamine-T ratio increased over 5:1 respectively (Table 5-3).    Alternatively the 
results improved if styrene was employed as the limiting reagent (Table 5-3).  However, 
increase in the styrene to bromamine-T ratio over 1:2 respectively led to the formation 
of side products and a decrease in the yield of the desired aziridine (Table 5-3).  The 
best isolated yield (82%) of the N-(p-tolylsulfonyl)-2-phenylaziridine was achieved when 
a higher catalyst loading was employed at room temperature with a 1:2 ratio of styrene 
to bromamine-T respectively (Table 5-3).  On the basis of the optimization results the 
aziridination of representative examples of alkenes with bromamine-T was carried out 
again at room temperature using the alkenes as the limiting reagents and employing 5 
mol% of Fe(TPP)Cl.  As summarized in Yield B of Table 5-2 the yields were improved in 
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Table 5-3.  Aziridination of Styrene with Bromamine-T Catalyzed by Fe(TPP)Cl under 
various conditionsa 
 
 a Reactions were carried out under N2 in the presence of 5 Å molecular sieves with a concentration of 0.1 
mmol styrene/2 mL solvent.  b S:BT = the mole ratio of styrene substrate to bromamine-T.  c Yields 
represent isolated yields of >95% purity as determined by 1H NMR. 
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all of the examined cases.  For example, a large increase in yields were obtained for 
styrene derivatives (Table 5-2, entries 1, 2, and 6).  For β-substituted styrenes, good 
yields were achieved in most cases, but stereospecificities remained almost the same 
(Table 5-2, entries 11-15).   Similar improvement in yield was also observed for cyclic 
and straight-chain alkenes (Table 5-2, entries 18-21).   Under the optimized conditions 
the previously unconverted methylenecyclohexene provided the desired spirocyclic 
aziridine in 50% yield (Table 5-2, entry 22). 
The catalytic aziridinations by iron (III) porphyrins with bromamine-T are 
assumed to proceed via a mechanism similar to that proposed for other 
metalloporphyrin systems with PhI=NTs.83-89  As shown in Figure 5-3, reaction of 
bromamine-T with an iron (III) porphyrin generates the iron-nitrene intermediate A with 
the associated  generation of NaBr.  Nitrene transfer from intermediate A to an alkene 
substrate produces the aziridine product and regenerates the iron (III) porphyrin catalyst 
to turn over the catalytic cycle.  However, the low to moderate stereoselectivity 
observed for the 1,2-disubstituted olefins could suggest a secondary nitrene or radicle 
intermediate. 
 Bromamine-T has been shown to be an effective nitrene source for the 
aziridination of alkenes by porphyrin complexes of transition metal ions such as Mn, Ru, 
Co, and Fe.  The utility of the Fe(TPP)Cl catalytic aziridination system employing 
alkenes as limiting reagents under mild and practical conditions was  demonstrated.  
The catalytic system is general and suitable for a wide range of alkene substrates, 








Figure 5-3.  Possible Mechanism for the Aziridination of Alkenes Catalyzed by 




 General Considerations.  All reactions were carried out under a nitrogen 
atmosphere in an oven dried Schlenk tube.  All olefins were purchased from Acros or 
Aldrich Chemicals and used without further purification.  Anhydrous acetonitrile was 
purchased from Aldrich Chemicals.  All metalloporphyrins were purchased from Strem 
or Midcentury Chemicals.  Bromamine-T was prepared from the commercially available 
Chloramine-T according to the literature procedure.96-98  Proton and carbon nuclear 
magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a Varian 
Mercury 300 spectrometer and referenced with respect to internal TMS standard or 
residual solvent.  Infrared spectra were obtained using a Bomen B100 FT-IR 
spectrometer.  Samples were prepared as films on a sodium chloride plate by 
evaporating THF solutions.  High resolution mass spectroscopy (HRMS) was performed 
by the Mass Spectrometry Center located in the Chemistry Department of the University 
of Tennessee on a VG Analytical hybrid high performance ZAB-EQ (B-E-Q geometry) 
instrument using electron impact (EI) ionization technique with a 70 eV electron beam.  
Thin layer chromatography was carried out on E. Merck Silica Gel 60 F-254 TLC plates. 
 General procedure for aziridination of olefins.  An oven dried Schlenk tube 
equipped with a stirring bar was degassed on a vacuum line and purged with nitrogen.  
The tube was charged with metalloporphyrin (5 mol%), Bromamine-T (0.1 mmol) and 
activated 5Å molecular sieves.  The tube was equipped with a Teflon screw cap, and 
evacuated on a vacuum line for 30 min.  The Teflon screw cap was replaced with a 
rubber septum then 2 mL of solvent and the olefin substrate (0.5mmol) were then added 
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successively.  The tube was purged with nitrogen for 1 minute and the contents were 
stirred at room temperature for 12 hours.  After completion of the reaction the solvent 
was concentrated under reduced pressure.  The solid residue was purified by flash 
chromatography (silica gel, 15% ethyl acetate: hexanes) to afford pure product. 
N-(p-Tolylsulfonyl)-2-phenylaziridine.63  (Table 5-2, Entry 1) was synthesized 
from styrene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.88 (d, 2H, J = 8.1Hz), 7.28 
(m, 7H), 3.79 (dd, 1H, J = 7.2, 4.5 Hz), 2.98 (d, 1H, J = 7.2 Hz), 2.42 (s, 3H), 2.39 (d, 
1H, J = 4.2 Hz).  13C NMR (75 MHz, CDCl3): δ 144.6, 135.0, 129.7, 128.5, 128.2, 127.9, 
126.5, 41.0, 35.9, 21.6.  FT-IR (film, cm-1):  3575, 1215, 1150, 916.  HRMS-EI ([M]+): 
Calculated for C15H15NO2S, 273.0823, Found 273.0821. 
 N-(p-Tolylsulfonyl)-2-(p-methylphenyl)aziridine.63  (Table 5-2, Entry 2) was 
synthesized from p-methylstyrene as a substrate.  1H NMR (300 MHz, CDCl3):    δ 7.85 
(d, 2H, J = 8.1 Hz), 7.32 (d, 2H J = 7.8 Hz), 7.09 (s, 4H), 3.74 (dd, 1H, J = 7.2, 4.5 Hz), 
2.96 (d, 1H, J = 7.2 Hz), 2.42 (s, 3H), 2.36 (d, 1H, J = 4.2 Hz), 2.31 (s, 3H).  FT-IR (film, 
cm-1): 3057, 1600, 1150, 916.  HRMS-EI ([M]+): Calculated for C16H17NO2S, 287.0430, 
Found 287.0441. 
 N-(p-Tolylsulfonyl)-2-(p-tert-butylphenyl)aziridine.  (Table 5-2, Entry 3) was 
synthesized from p-tert-butyltyrene as a substrate.  1H NMR  (300 MHz, CDCl3):  δ 7.84 
(d, 2H, J = 8.1 Hz), 7.28-7.33 (m, 4H), 7.12 (d, 2H, J = 8.1 Hz), 3.74 (dd, 1H, J = 7.2, 
4.8 Hz), 2.94 (d, 1H, J =  7.2 Hz), 2.42 (s, 3H), 2.36 (d, 1H, J = 4.2 Hz), 1.28 (s, 9H).  
13C NMR (75 MHz, CDCl3):  δ 142.0, 138.0, 135.0, 129.3, 127.5, 125.8, 40.5, 39.8, 35.3, 
30.8, 21.2.  HRMS-EI([M]+): Calculated for C19H22NO2S, 329.1450, Found 329.1454. 
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 N-(p-Tolylsulfonyl)-2-(p-chloromethylphenyl)aziridine.99  (Table 5-2, Entry 4) 
was synthesized from p-vinylbenzyl chloride as a substrate.  1H NMR (300 MHz, 
CDCl3):  δ  7.83 (d, 2H, J = 8.1 Hz), 7.31 (m, 4H), 7.19 (d, 2H, J = 7.8 Hz), 4.52 (s, 2H), 
3.74 (dd, 1H, J = 7.2, 4.5 Hz), 2.96 (d, 1H, J = 6.9 Hz), 2.42 (s, 3H), 2.34 (d, 1H, J = 4.2 
Hz).  13C NMR (75 MHz, CDCl3): δ 138.0, 131.0, 129.7, 128.8, 128.0, 127.9, 126.9, 
126.8, 45.7, 40.5, 36.0, 21.6.  FT-IR (film, cm-1): 3575, 2927, 2858, 1594, 1324, 1160, 
1091, 911, 814.  HRMS-EI ([M]+): Calculated for C15H12NO2SCl, 285.0824, found 
285.0817. 
 N-(p-Tolylsulfonyl)-2-(p-bromophenyl)aziridine.100  (Table 5-2, Entry 5)  was 
synthesized from p-bromostyrene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.84 (d, 
2H, J = 8.4 Hz), 7.40 (d, 2H, J = 8.7 Hz), 7.31 (d, 2H, J = 8.7 Hz), 7.06 (d, 2H, J = 8.4 
Hz), 3.70 (dd, 1H, J = 7.2, 4.2 Hz), 2.95 (d, 1H, J = 7.2 Hz), 2.42 (s, 3H), 2.32 (d, 1H, J 
= 4.5 Hz).  13C NMR (75 MHz, CDCl3): δ 144.0, 136.0, 134.0, 131.7, 131.6, 129.7, 
128.1, 127.9, 40.2, 35.9, 21.0.  HRMS-EI ([M]+): Calculated for C15H14NO2SBr, 
350.9929, Found 350.9926.   
 N-(p-Tolylsulfonyl)-2-(p-chlorophenyl)aziridine.63  (Table 5-2, Entry 6)  was 
synthesized from p-chlorostyrene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.85 (d, 
2H, J = 8.1 Hz), 7.32 (d, 2H, J = 8.1 Hz), 7.25 (d, 2H, J = 8.4 Hz), 7.12 (d, 2H, J = 8.7 
Hz), 3.71 (dd, 1H, J = 7.2, 4.5 Hz), 2.96 (d, 1H, J = 7.2 Hz), 2.43 (s, 3H), 2.33 (d, 1H, J 
= 4.2 Hz).  FT-IR (film, cm-1): 3575, 2361, 1771, 1540, 1092, 900.  HRMS-EI ([M]+): 
Calculated  for C15H14NO2SCl, 307.0434, Found 307.0431. 
 N-(p-Tolylsulfonyl)-2-(p-fluorophenyl)aziridine.100  (Table 5-2, Entry 7) was 
synthesized from p-fluorostyrene as a substrate.  1H NMR (300 MHz, CDCl3): δ  7.83 (d, 
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2H, J = 8.1 Hz), 7.33 (d, 2H, J = 8.4 Hz), 7.19 (m, 2H), 6.96 (m, 2H), 3.74 (dd, 1H, J = 
7.2, 4.2 Hz), 2.95 (d, 1H, J = 7.2Hz), 2.42 (s, 3H), 2.33 (d, 1H, J = 4.5 Hz).  13C NMR 
(75 MHz, CDCl3): δ 144.0, 132.0, 130.0, 128.5, 128.1, 115.9, 115.6, 40.5, 36.2, 21.9.  
HRMS-EI ([M]+): Calculated for C15H14NO2SF, 291.079, Found 291.741. 
 N-(p-Tolylsulfonyl)-2-(2’,4’,6’-trimethylphenyl)aziridine.  (Table 5-2, Entry 8) 
was synthesized from 2,4,6-trimethylstyrene as a substrate.  1H NMR (300 MHz, 
CDCl3): δ 7.85 (d, 2H, J = 8.1 Hz), 7.32 (d, 2H, J = 8.1 Hz), 6.77 (s, 2H), 3.83 (dd, 1H, J 
= 6.9, 4.2 Hz), 2.91 (d, 1H, 6.9 Hz), 2.44 (s, 3H), 2.27, (s, 6H), 2.21(s, 3H), 2.14 (d, 1H, 
J = 4.8 Hz).  13C NMR (75 MHz, CDCl3): δ 144.9, 137.7, 137.6, 135.2, 130.6, 129.9, 
128.5, 128.4, 38.9, 35.0, 21.2, 20.3, 19.0.  HRMS-EI ([M]+): Calculated for C18H17NO2S, 
315.1293, Found 315.1297. 
 N-(p-Tolylsulfonyl)-2-methyl-2-phenylaziridine.63  (Table 5-2, Entry 9) was 
synthesized from α-methylstyrene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.85 
(d, 2H, J = 6.6 Hz), 7.23-7.38 (m, 7H), 2.94 (s, 1H), 2.51 (s, 1H), 2.41 (s, 3H), 2.03 (s, 
3H).  13C NMR (75 MHz, CDCl3): δ 144.0, 142.0, 139.7, 130.0, 129.3, 128.8, 128.5, 
127.6, 52.0, 42.0, 21.9, 21.5.  FT-IR (film, cm-1): 3020, 2930, 1600, 1220, 1100, 920.  
HRMS-EI ([M]+): Calculated for C16H17NO2S, 287.0980, Found, 287.0976. 
 N-(p-Tolylsulfonyl)-2,2-diphenylaziridine.84  (Table 5-2, Entry 10) was 
synthesized from 1,1-dipenylethylene as a substrate.  1H NMR (300 MHz, CDCl3): δ 
7.62 (d, 2H, J = 7.8 Hz), 7.18-7.32 (m, 12H), 3.01 (s, 2H), 2.35 (s, 3H).  13C NMR (75 
MHz, CDCl3): δ 144.4, 138.3, 129.8, 129.1, 128.6, 128.5, 128.3, 128.2, 128.1, 57.4, 
40.8, 22.0.  HRMS-EI ([M]+): Calculated for C21H19NO2S, 349.1137, Found 349.1142. 
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 N-(p-Tolylsulfonyl)amino-1,2,3,4-tetrahydronapthalene-1,2-imine.63  (Table 5-
2, Entry 11) was synthesized from 1,2-dihydronapthalene as a substrate.  1H NMR (300 
MHz, CDCl3): δ 7.80 (d, 2H, J = 8.1 Hz), 7.01-7.30 (m, 6H), 3.80 (d, 1H, J = 6.9 Hz), 
3.54 (d, 1H, J = 6.9 Hz), 2.74 (dt, 1H, J = 15,  6.3 Hz), 2.54 (dd, 1H, J =15,  6.0 Hz), 
2.40 (s, 3H), 2.25 (dd, 1H, J = 14.1, 6.6 Hz), 1.66 (dt, 1H, J = 13.2, 5.4 Hz).  13C NMR 
(75 MHz, CDCl3): δ 144.0, 138.0, 135.0, 129.9, 129.4, 128.4, 128.2, 127.4, 126.0, 39.6, 
35.6, 21.9, 21.0, 20.3.  HRMS-EI ([M]+): Calculated for C17H17NO2S, 299.0980; Found 
299.0994. 
 N-(p-Tolylsulfonyl)-2-methyl-3-phenylaziridine.63  (mixture of cis- and trans- 
isomers) (Table 5-2, Entry 12, 13) was synthesized from cis-β-methylstyrene (Entry 12) 
or trans-β-methylstyrene (Entry 13) as a substrate and was a mixture of cis- and trans- 
isomers.  For cis- isomers: 1H NMR (300 MHz, CDCl3): δ 7.86 (d, 2H, J = 8.4 Hz), 7.17-
7.32 (m, 7H), 3.90 (d, 1H, J = 7.5 Hz), 3.18 (dq, 1H, J = 7.2, 5.7 Hz), 2.42 (s, 3H), 1.01 
(d, 3H, J = 5.7 Hz).  13C NMR (75 MHz, CDCl3): δ 144.0, 137.0, 132.0, 129.2, 129.0, 
127.3, 45.6, 41.4, 24.0, 11.5.  FT-IR (film,   cm-1): 3013, 1600, 1414, 1100, 920.  HRMS-
EI ([M]+): calcd for C16H17NO2S, 287.0974; found 287.0974.  For trans- isomers:  1H 
NMR (300 MHz, CDCl3): δ 7.84 (d, 2H, J = 8.7 Hz), 7.24-7.27 (m, 5H), 7.15 (m, 2H), 
3.80 (d, 1H, J = 3.9 Hz), 2.89 (dq, 1H, J = 6.6, 4.4 Hz), 2.37 (s, 3H), 1.83 (d, 3H, J = 6.0 
Hz).  13C NMR (75 MHz, CDCl3): δ 140.0, 137.0, 135.0, 129.0, 128.0, 127.0, 126.0, 
49.0, 21.0, 14.0.  HRMS-EI ([M]+): Calculated for C16H17NO2S, 287.0974, found 
287.0973. 
 N-(p-Tolylsulfonyl)-2,3-diphenylaziridine.63  (mixture of cis- and trans- 
isomers) (Table 5-2, Entry 14, 15) was synthesized from cis-stilbene (Entry 14) or trans-
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stilbene (Entry 15) as a substrate and the product was a mixture of cis- and trans- 
isomers.  For cis- isomers: 1H NMR (300 MHz, CDCl3): δ 7.95 (d, 2H, J = 8.1 Hz), 7.34 
(d, 2H, J = 8.1 Hz), 7.01-7.11 (m, 10H), 4.20 (s, 2H), 2.43 (s, 3H).  13C NMR (75 MHz, 
CDCl3): δ 129.8, 129.3, 128.6, 128.4, 128.2, 127.9, 127.7, 127.4, 47.4, 21.6.  FT-IR 
(film, cm-1): 3017, 3001, 1320, 974, 819.  HRMS-EI ([M]+): calcd for C20H16NO2S, 
349.1137; found 349.1133.  For trans- isomers:  1H NMR (300 MHz, CDCl3): δ 7.60 (d, 
2H, J = 8.1 Hz), 7.32-7.42 (m, 10H), 7.18 (d, 2H, J = 8.4 Hz), 4.24 (s, 2H), 2.37 (s, 3H).  
13C NMR (75 MHz, CDCl3): δ 3017, 3000, 1322, 927, 707.  HRMS-EI ([M]+): Calculated 
for C20H16NO2S, 349.1137, Found 349.1132. 
 N-(p-Tolylsulfonyl)-3-phenyl-2-aziridinecarboxylic acid, ethyl ester.101, 102  
(mixture of cis- and trans- isomers) (Table 5-2, Entry 16) was synthesized from ethyl 
trans-cinnamate as a substrate and the product was a mixture of two isomers.  For cis- 
isomers: 1H NMR (300 MHz, CDCl3): δ 7.90 (d, 2H, J = 8.1 Hz), 7.35 (d, 2H, J = 8.1 Hz), 
7.25-7.32 (m, 5H), 4.10 (d, 1H, J = 7.2 Hz), 3.90 (m, 2H), 3.66 (d, 1H, J = 7.8Hz), 2.43 
(s, 3H), 0.92 (t, 3H, J = 7.2 Hz).  For trans- isomers:  1H NMR (300 MHz, CDCl3): δ 7.76 
(d, 2H, J = 8.1 Hz), 7.25-7.32 (m, 7H), 4.42 (d, 1H, J = 4.2 Hz), 4.30 (m, 2H), 3.49 (d, 
1H, J = 4.2 Hz), 2.40 (s, 3H), 1.33 (t, 3H, J = 7.2 Hz).  13C NMR (75 MHz, CDCl3): δ 
166.0, 144.0, 136.0, 132.0, 129.8, 128.8, 128.5, 127.4, 127.3, 61.5, 47.0, 45.2, 43.3, 
21.6, 13.7.  FT-IR (film, cm-1): 3068, 1749, 1333, 1162, 554, 421.  HRMS-EI ([M]+): 
Calculated for C18H19NO4S, 345.1035, Found 345.1053. 
 N-(p-Tolylsulfonyl)-2-aziridinecarboxylic acid, tert-butyl ester.103  (Table 5-2, 
Entry 17) was synthesized from tert-butyl acrylate as a substrate.  1H NMR (300 MHz, 
CDCl3): δ 7.82 (d, 2H, J = 8.4 Hz), 7.34 (d, 2H, J = 8.1 Hz), 3.20 (q, 1H, J = 4.2 Hz), 
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2.66 (d, 1H, J = 6.6 Hz), 2.48 (d, 1H, J = 4.2 Hz), 2.44 (s, 3H), 1.41 (s, 9H).  13C NMR 
(75 MHz, CDCl3): δ 145.0, 134.0, 128.0, 83.0, 35.0, 31.0, 27.0, 21.0.  FT-IR (film, cm-1): 
3523, 2900, 1740, 1600, 1165.  HRMS-EI ([M]+): Calculated for C14H19NO2S, 297.1035, 
Found 297.1025. 
 N(p-Tolylsulfonyl)-6-azabicyclo[3.1.0]hexane.64  (Table 5-2, Entry 18) was 
synthesized form cyclopentene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.78 (d, 
2H, J = 8.1 Hz), 7.28 (d, 2H, J = 7.8 Hz), 3.31 (s, 2H), 2.42 (s, 3H), 1.92 (m, 4H), 1.6 (m, 
2H).  13C NMR (75 MHz, CDCl3): δ 144.0, 135.0, 129.5, 127.5, 46.7, 26.9, 21.6, 19.4.  
HRMS-EI ([M]+): Calculated for C12H15NO2S, 237.0824, Found 237.0828. 
 N-(p-Tolylsulfonyl)-7-azabicyclo[4.1.0]heptane.63  (Table 5-2, Entry 19) was 
synthesized from cyclohexene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.79 (d, 
2H, J = 7.8 Hz), 7.30 (d, 2H, J = 8.1 Hz), 2.95 (s, 2H), 2.42 (s, 3H), 1.75 (m, 4H), 1.39 
(m, 2H), 1.20 (m, 2H).  13C NMR (75 MHz, CDCl3): δ 143.0, 141.0, 129.0, 127.0, 39.3, 
22.3, 21.9, 18.9.  FT-IR (film, cm-1): 3000, 1600, 1392, 1155, 920.  HRMS-EI ([M]+): 
Calculated for C13H17NO2S, 251.0723, Found 251.0731. 
 N-(p-Tolylsulfonyl)-9-azabicyclo[6.1.0]nonane.64  (Table 5-2, Entry 20) was 
synthesized from cyclooctene as a substrate. 1H NMR (300 MHz, CDCl3): δ 7.80 (d, 2H, 
J = 8.4 Hz), 7.30 (d, 2H, J = 7.8 Hz), 2.75 (d, 1H, J = 4.2 Hz), 2.42 (s, 3H), 1.98 (d, 1H, 
J = 13.5 Hz), 1.55-1.23 (m, 12H).  13C NMR (75 MHz, CDCl3): δ 144.0, 129.6, 127.5, 
43.9, 26.3, 26.1, 25.1, 21.6.  HRMS-EI ([M]+): Calculated for C15H21NO2S, 279.1293; 
Found 279.1297. 
 N-(p-Tolylsulfonyl)-9-heptylaziridine.104  (Table 5-2, Entry 21) was synthesized 
from 1-nonene as a substrate.  1H NMR (300 MHz, CDCl3): δ 7.80 (d, 2H, J = 6.6 Hz), 
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7.30 (d, 2H, J = 8.1 Hz), 2.68 (m, 1H), 2.62 (d, 1H, J = 6.9 Hz), 2.42 (s, 3H), 2.03(d, 1H, 
J = 4.5 Hz), 1.2-1.4 (m, 12H), 0.84 (t, 3H, J = 7.2 Hz).  13C NMR (75 MHz, CDCl3): δ 
144.0, 135.0, 129.5, 127.9, 40.4, 33.7, 31.6, 31.2, 29.0, 28.9, 26.7, 22.5, 21.6, 14.0.  
HRMS-EI ([M]+): Calculated for C16H25NO2S, 295.1606, Found 295.1610. 
 N-(p-Tolylsulfonyl)-1-azaspiro[2.5]octane.105  (Table 5-2, Entry 22) was 
synthesized from methylene cyclohexane as a substrate.  1H NMR (300 MHz, CDCl3): δ 
7.84 (d, 2H, J = 8.1 Hz), 7.31 (d, 2H, J = 8.1 Hz), 2.43 (s, 3H), 2.40 (s, 2H), 1.93 (s, 2H), 
1.7-2.0 (m, 6H), 1.2-1.5 (m, 4H).  13C NMR (75 MHz, CDCl3): δ 129.0, 126.8, 53.5, 40.6, 
32.6, 24.9, 24.7, 21.1.  FT-IR (film, cm-1): 2900, 1600, 1300, 900.  HRMS-EI ([M]+): 
Calculated for C14H19NO2S, 265.1137, Found 265.1140. 
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Chapter 6:  Cobalt-Catalyzed Efficient Aziridination of Alkenes 
 
This chapter is a revised version of  a paper by the same name published in the journal 
Organic Letters in 2005 by authors Guang-Yao Gao, Jeremiah D. Harden, and X. Peter 
Zhang.  The major changes include 1) the exclusion of the abstract to the paper, 2) the 
reformatting of selected text to fit the guidelines of this dissertation, 3) reproduction and 
reformatting of the figures and tables, and 4) combination of the references in this work 
with those from the other chapters in this section. 
 
Guang-Yao Gao, Jeremiah D. Harden, and X. Peter Zhang.  Cobalt Catalyzed Efficient 
Aziridination of Alkenes.  Organic Letters  2005, 7(15), 3191. 
 
My use of we and us refers to the other coauthors and myself.  My primary contributions 
to this paper include 1) synthesis of the Co(TDClPP) porphyrin catalyst 2) synthesis of 
the Bromamine-T reagent 3) execution and analysis of screening reaxction, 4) 
execution and analysis of substrate reactions,  and 5) characterization of some of the 
obtained products. 
 
Aziridines are a class of synthetically and biologically important three-membered 
heterocyclic compounds that have found many applications.58, 106-108  Among synthetic 
methodologies, transition metal complex mediated aziridination of alkenes with a nitrene 
source represents a direct and powerful approach for the construction of the aziridine 
rings.54-57  The most widely used nitrene sources for aziridination are the reagent [N-(p-
toluenesulfonyl)imino]phenyliodinane (PhI=NTs) and related iminoiodane derivatives.59-
61  To overcome several limitations associated with the use of PhI=NTs,66-68 alternative 
nitrene sources such as chloramine-T,73, 95, 109 bromamine-T,77, 78 and tosyl azide82, 110 
have also been actively pursued.  With these nitrene sources, complexes of Mn, Fe, Ru, 
Rh, and Cu that are supported by different ligands have been identified to catalyze 
aziridination.54-63, 65-68, 73, 77, 78, 82, 95, 106-110   
 The unique ligand environment and metal coordination mode of 
metalloporphyrins render them a class of attractive catalysts for aziridination and related 
atom/group transfer reactions.111  Indeed, the first transition metal complexes that were 
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discovered for aziridination catalytic activity are metalloporphyrins.83, 84  To date, 
porphyrin complexes of Fe, Mn, and Ru have been known to catalyze aziridination.85-89  
As part of our ongoing efforts in developing metalloporphyrin-based practical 
atom/group transfer catalytic systems,90-94, 112-114 we reveal herein the first cobalt-based 
catalytic system that is efficient for the aziridination of different alkenes.115-117  Cobalt(II) 
porphyrins (Figure 6-1) were shown to be effective catalysts for the aziridination of a 
wide variety of alkenes with bromamine-T (Figure 6-2).  Using styrene as a model 
substrate, we first evaluated the catalytic aziridination activities of Co complexes 
supported by various porphyrins under practical conditions (room temperature, one-pot 
protocol, and styrene as the limiting reagent). The results are summarized in Table 6-1. 
Although the Co complex of the most common porphyrin Co(TPP) could aziridinate 
styrene in a low yield, the Co complexes of electron-rich porphyrins such as 
Co(TTMeOPP) and Co(TMeOPP) furnished no or only a trace amount of the desired 
product (Table 6-1, entries 1-3). The production of aziridine, however, was tripled when 
the reaction was catalyzed by the Co complex of an electron-deficient porphyrin 
Co(TPFPP) (Table 6-1, entry 4). Significant further improvement was achieved with the 
Co complex of an electron-deficient and sterically hindered porphyrin Co(TDClPP) as 
the catalyst, producing the desired aziridine in 83% isolated yield (Table 6-1, entry 5). 
Whereas change in the ratio of styrene to bromamine-T from 1:2 to 1:1.2 had no 
















Table 6-1.  Aziridination of Styrene by Cobalt Porphyrinsa 
 
a Carried out under N2 in the presence of 5 Å molecular sieves with a concentration of 0.1 mmol styrene/2 




relatively lower yield (Table 6-1, entries 6 and 7). Acetonitrile appeared the solvent of 
choice for the catalytic reaction, as the uses of other solvents such as tetrahydrofuran, 
methylene chloride, or toluene gave no or only a trace amount of the desired product 
(Table 6-1, entries 8-10).  Although a slightly better yield was obtained at 40°C, further 
increase in reaction temperature caused a lower yield (Table 6-1, entries 11 and 12). 
The room temperature reaction could be effectively carried out at a lower catalyst 
loading without affecting the yield (Table 6-1, entry 13). A relatively lower yield was 
observed when the reaction time was shortened (Table 6-1, entry 14). The employment 
of higher catalyst loading, however, could allow the reaction to be finished in a short 
time without decrease of the yield (Table 6-1, entry 15).  Using the above optimized 
reaction conditions, the new Co(TDClPP)-based catalytic system was found to be 
suitable for many different types of alkene substrates (Table 6-2).  In addition to styrene, 
derivatives of styrene with alkyl substituents could be equally aziridinated to afford the 
desired products in high yields (Table 6-2, entries 1-4). Functional groups in styrene 
derivatives could be well tolerated to cleanly generate the corresponding aziridines 
(Table 6-2, entries 5-7). Sterically hindered derivatives such as 2,4,6-trimethylstyrene as 
well as 2-vinylnaphthalene could also be catalytically aziridinated, albeit in lower yields 
(Table 6-2, entries 8 and 9).  Halogenated styrenes including highly electron-deficient 
pentafluorostyrene could be successfully converted to the desired aziridines in good to 
high yields (Table 6-2, entries 10-13). To the best of our knowledge, this represents the 
first example of aziridination of pentafluorostyrene.  In addition, both R-substituted and 
α-substituted (cyclic and acyclic) styrenes were suitable substrates for the catalytic 
process (Table 6-2, entries 14-21).  Whereas a competitive amidation was presumably 
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Table 6-2.  Aziridination of Different Alkenes by Co(TDClPP) 
 a Carried out at room temperature in CH3CN overnight under N2 with alkenes as limiting reagent 
(alkene/bromamine-T = 1:2) using 5 mol% Co(TDClPP) in the presence of 5 Å molecular sieves at a 
concentration of 0.2 mmol/4-5 mL of CH3CN.  b Isolated Yields.  c Performed with alkene/bromamine-T = 
5:1.  d Performed with alkene/bromamine-T = 1:3 using 10 mol% Co(TDClPP).  e cis:trans = 9:91.  f 
cis:trans = 47:53.  g cis:trans = 8:92.  h cis:trans = 58:42. 
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 responsible for the low aziridination yield of 1,2-dihydronaphthalene (Table 6-2, entry 
16), excellent yields were obtained for acyclic α-substituted styrenes in both cis- and 
trans- forms (Table 6-2, entries 18-21). For the latter substrates, the catalytic reactions 
by Co(TDClPP) appeared to lack stereospecificity, although high trans-stereoselectivity 
was observed for both cis- and trans-α-methylstyrenes. In addition to aromatic and 
conjugated alkenes, acyclic and cyclic aliphatic alkenes with different ring sizes are 
suitable substrates for the catalytic system (Table 6-2, entries 22-25). Under similar 
conditions, exomethylene carbocycles such as methylenecyclohexane could also be 
successfully aziridinated to afford the desired spirocyclic aziridine in 67% isolated yield 
(Table 6-2, entry 26). 
 In summary, we have developed the first Co-based catalytic system that is 
efficient for aziridination of various alkenes.115-117  We demonstrated that the new 
Co(TDClPP)/bromamine-T catalytic system can be effectively operated under mild and 
practical conditions with alkenes as limiting reagents and is generally suitable for a wide 
variety of alkene substrates. Further improvement of the catalytic system including 
stereospecificity and the development of its asymmetric variant are in progress. The 
successful demonstration of the catalytic capability of Co(II) porphyrins for aziridination 
will also likely stimulate future studies to address some interesting mechanistic issues. 
Experimental Section  
 
 General Considerations. All reactions were carried out under nitrogen 
atmosphere in an oven dried Schlenk tube. All olefins were purchased from Acros or 
Aldrich Chemicals and used without further purification. Acetonitrile was dried with 
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calcium hydride in reflux. All metalloporphyrins were purchased from Strem or 
Midcentury Chemicals. Bromamine-T was prepared from Chloramine-T according to the 
literature procedure and dried at 80 oC in vacuum overnight before use.96-98 Proton and 
carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
a Varian Mercury 300 spectrometer and referenced with respect to residual solvent. 
Infrared spectra were obtained using a Bomen B100 Series FT-IR spectrometer. 
Samples were prepared as films on a NaCl plate with chloroform as solvent. Thin layer 
chromatography was carried out on E. Merck Silica Gel 60 F-254 TLC plates.  
 General Procedure for Aziridination of Alkenes. An oven dried Schlenk tube 
equipped with stirring bar was degassed on vacuum line and purged with nitrogen. The 
tube was charged with metalloporphyrin (5 mol %), Bromamine-T (0.4 mmol) and 
activated 5 Å molecular sieves (500 mg). The tube was capped with a Teflon screw cap, 
evacuated on vacuum line for 30-45 min. The Teflon screw cap was replaced with a 
rubber septum and 3-5 mL of solvent and substrate (0.2 mmol) were then added 
successively. The tube was purged with nitrogen for 1-2 min and the contents were 
stirred overnight at ambient temperatures. After completion of the reaction, molecular 
sieves were removed by filtration and the filtrate was concentrated under vacuum. The 
solid residue was purified by flash chromatography (silica gel, ethyl acetate:hexanes 
(V:V) = 3:7) to afford the pure product. 
 N-(p-Tolylsulfonyl)-2-phenylaziridine.63, 113 (Table 6-2, Entry 1) was 
synthesized from styrene as substrate and the product obtained as a yellow oil (45 mg, 
yield 83%). 1H NMR (300 MHz, CDCl3): δ 7.83 (d, 2H, J = 8.1Hz), 7.17-7.31 (m, 7H), 
3.73 (dd, 1H, J = 7.2, 4.5 Hz), 2.94 (d, 1H, J = 7.2 Hz), 2.39 (s, 3H), 2.35 (d, 1H, J = 4.5 
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Hz).  13C NMR (75 MHz, CDCl3): δ 144.6, 140.5, 135.0, 134.8, 129.7, 128.5, 128.3, 
127.9, 126.5, 41.0, 35.9, 21.6.  FT-IR (film, cm-1): 3064, 3034, 2924, 2855, 1597, 1495, 
1459, 1385, 1324,1292, 1232, 1190, 1160, 978, 909, 815, 775, 758, 715, 696, 665. 
 N-(p-Tolylsulfonyl)-2-(p-methylphenyl)aziridine.63, 113 (Table 6-2, Entry 2) was 
synthesized from p-methylstyrene as substrate and the product obtained as a yellow oil 
(43 mg, yield 76%).  1H NMR (300 MHz, CDCl3): δ 7.84 (d, 2H, J = 8.1 Hz), 7.31 (d, 2H, 
J = 8.4. Hz), 7.08 (s, 4H), 3.73 (dd, 1H, J = 7.2, 4.5 Hz), 2.95 (d, 1H, J = 7.2 Hz), 2.41 
(s, 3H), 2.36 (d, 1H, J = 4.5 Hz), 2.29 (s, 3H).  13C NMR (75 MHz, CDCl3): δ 144.6, 
140.5, 138.1, 134.9, 131.9, 129.7, 129.2, 127.9, 126.4, 41.0, 35.8, 21.6, 21.1.  FT-IR 
(film, cm-1): 2922, 2857, 1597, 1517, 1494, 1453, 1381, 1324, 1292, 1232, 1186, 1160, 
1118, 1093, 1019, 979, 911, 815, 731, 716, 693, 665. 
 N-(p-Tolylsulfonyl)-2-(p-tert-butylphenyl)aziridine.113 (Table 6-2, Entry 3) was 
synthesized from p-tert-butylstyrene as substrate and the product obtained as a yellow 
oil (53 mg, yield 81%).  1H NMR (300 MHz, CDCl3): δ 7.85 (d, 2H, J = 8.1 Hz), 7.29-7.33 
(m, 4H), 7.13 (d, 2H, J = 8.1 Hz), 3.75 (dd, 1H, J = 7.2, 4.5 Hz), 2.94 (d, 1H, J = 7.2 Hz), 
2.42 (s, 3H), 2.37 (d, 1H, J = 4.8 Hz), 1.28 (s, 9H).  13C NMR (75 MHz, CDCl3): δ 151.4, 
147.4, 144.6, 134.9, 131.9, 129.7, 127.9, 126.2, 125.8, 40.9, 35.8, 34.5, 31.2, 21.6.  FT-
IR (film, cm-1): 3281, 2962, 2869, 1688, 1599, 1511, 1459, 1410, 1332, 1271, 1161, 
1093, 1019, 958, 834, 757, 725, 705, 663. 
 N-(p-Tolylsulfonyl)-2-(3-methylphenyl)aziridine.113, 118 (Table 6-2, Entry 4) was 
synthesized from 3-methylstyrene as substrate and the product obtained as a yellow oil 
(51 mg, yield 89%). 1H NMR (300 MHz, CDCl3): δ 7.85 (d, 2H, J = 8.4 Hz), 7.31 (d, 2HJ 
= 8.7. Hz), 7.01-7.16 (m, 4H), 3.73 (dd, 1H, J = 7.2, 4.5 Hz), 2.94 (d, 1H, J = 6.9 Hz), 
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2.42 (s, 3H), 2.36 (d, 1H, J = 4.5 Hz), 2.29 (s, 3H).  13C NMR (75 MHz, CDCl3): δ 144.6, 
138.3, 134.8, 129.7, 129.0, 128.4, 127.9, 127.1, 123.6, 41.0, 35.9, 21.6, 21.2.  FT-IR 
(film, cm-1): 3292, 2922, 2362, 1688, 1596, 1492, 1453, 1382, 1325, 1292, 1215, 1184, 
1160, 1093, 1039, 1019, 981, 929, 867, 816, 787, 720, 692, 666. 
 N-(p-Tolylsulfonyl)-2-(p-chloromethylphenyl)aziridine.99, 113 (Table 6-2, Entry 
5) was synthesized from p-vinylbenzyl chloride as substrate and the product obtained 
as a yellow oil (55 mg, yield 86%).  1H NMR (300 MHz, CDCl3): δ 7.85 (d, 2H, J = 8.4 
Hz), 7.30 (m, 4H), 7.20 (d, 2H, J = 7.8 Hz), 4.54 (s, 2H), 3.76 (dd, 1H, J = 4.5, 7.2 Hz), 
3.00 (d, 1H, J = 6.9 Hz), 2.44 (s, 3H), 2.36 (d, 1H, J = 4.2 Hz).  13C NMR (75 MHz, 
CDCl3): δ 145.3, 135.4, 129.8, 128.8, 128.0, 127.9, 126.9, 45.7, 40.5, 36.0, 21.6.  FT-IR 
(film, cm-1): 2362, 1596, 1519, 1493, 1453, 1383, 1324, 1268, 1187, 1161, 1093, 1019, 
981, 909, 815, 750, 715, 674. 
 N-(p-Tolylsulfonyl)-2-(4-trifluoromethylphenyl)aziridine.113, 118 (Table 6-2, 
Entry 6) was synthesized from 4-(trifluoromethyl)styrene as substrate and the product 
obtained as a yellow oil (61 mg, yield 90%).  1H NMR (300 MHz, CDCl3): δ 7.86 (d, 2H, 
J = 8.1 Hz), 7.54 (d, 2H, J = 8.1 Hz), 7.34 (d, 4H, J = 8.1 Hz), 3.80 (dd, 1H, J = 4.2, 7.2 
Hz), 3.01 (d, 1H, J = 7.2 Hz), 2.44 (s, 3H), 2.37 (d, 1H, J = 4.5 Hz).  13C NMR (75 MHz, 
CDCl3): δ 147.4, 145.0, 139.2, 134.6, 129.8, 127.9, 126.9, 125.6, 125.5, 125.4, 40.1, 
36.2, 21.6.  19F NMR (75 MHz, CDCl3): -63.1.  FT-IR (film, cm-1): 2926, 2362, 1621, 
1597, 1494, 1454, 1421, 1383, 1325, 1233, 1163, 1121, 1093, 1067, 1018, 982, 911, 
840, 817, 751, 697, 661. 
 N-(p-Tolylsulfonyl)-2-(4-acetoxylphenyl)aziridine.88, 101 (Table 6-2, Entry 7) 
was synthesized from 4-acetoxystyrene as substrate and the product obtained as a 
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yellow oil (61 mg, yield 92%).  1H NMR (300 MHz, CDCl3): δ 7.86 (d, 2H, J = 8.1 Hz), 
7.33 (d, 2H, J = 8.1 Hz), 7.21 (d, 4H, J = 8.4 Hz), 7.01 (d, 4H, J = 8.4 Hz), 3.75 (dd, 1H, 
J = 4.2, 7.2 Hz), 2.97 (d, 1H, J = 7.2 Hz), 2.43 (s, 3H), 2.35 (d, 1H, J = 4.5 Hz), 2.27 (s, 
3H).  13C NMR (75 MHz, CDCl3): δ 169.4, 150.5, 144.7, 134.7, 132.6, 129.8, 127.9, 
127.6, 121.7, 40.4, 36.0, 21.6, 21.0.  FT-IR (film, cm-1): 3583, 2925, 1762, 1597, 1510, 
1453, 1371, 1325, 1194, 1162, 1093, 1016, 982, 911, 852, 816, 724, 710, 694, 666. 
 N-(p-Tolylsulfonyl)-2-(2’,4’,6’-trimethylphenyl)aziridine.113 (Table 6-2, Entry 8) 
was synthesized from 2,4,6-trimethylstyrene as substrate and the product obtained as a 
yellow oil (39 mg, yield 61%).  1H NMR (300 MHz, CDCl3) : δ 7.88 (d, 2H, J = 8.4 Hz), 
7.35 (d, 2H, J = 7.8 Hz), 6.79 (s, 2H), 3.86 (t, 1H, J = 4.8 Hz), 2.93 (d, 1H, J = 7.5 Hz), 
2.46 (s, 3H), 2.31 (s, 6H), 2.24 (s, 3H), 2.16 (d, 1H, J = 4.5 Hz).  13C NMR (75 MHz, 
CDCl3): δ 144.9, 139.8, 137.4, 135.2, 129.7, 129.1, 128.8, 128.2, 127.1, 38.9, 35.4, 
21.7, 20.9, 20.1.  FT-IR (film, cm-1): 3583, 3282, 2923, 1711, 1610, 1449, 1331, 1160, 
1092, 934, 852, 814, 754, 665. 
 N-(p-Tolylsulfonyl)-2-(2-naphthyl)aziridine.81, 113 (Table 6-2, Entry 9) was 
synthesized from 2-vinylnapthalene as substrate and the product obtained as a yellow 
oil (34 mg, yield 53%).  1H NMR (300 MHz, CDCl3): δ 7.87 (d, 2H, J = 8.1 Hz), 7.71-7.79 
(m, 4H), 7.46 (m, 2H), 7.30 (d, 2H, J = 8.4 Hz), 7.26 (s, 1H), 3.80 (d, 1H, J = 7.2, 4.5 
Hz), 3.05 (d, 1H, J = 7.2 Hz), 2.47 (d, 1H, J = 4.5 Hz), 2.40 (s, 3H).  13C NMR (75 MHz, 
CDCl3): δ 144.7, 134.9, 133.1, 133.0, 132.4, 129.8, 128.5, 127.9, 127.8, 127.7, 126.4, 
126.3, 126.1, 123.6, 41.3, 36.0, 21.6.  FT-IR (film, cm-1): 3583, 3056, 2923, 2362, 1685, 
1597, 1509, 1453, 1398, 1324, 1160, 1093, 1019, 953, 920, 858, 816, 751, 722, 666. 
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 N-(p-Tolylsulfonyl)-2-(p-bromophenyl)aziridine.100, 113 (Table 6-2, Entry 10) 
was synthesized from 4-bromostyrene as substrate and the product obtained as a 
yellow oil (49 mg, yield 70%).  1H NMR (300 MHz, CDCl3): δ 7.83 (d, 2H, J = 8.4 Hz), 
7.40 (d, J = 8.4 Hz), 7.31 (d, 2H, J = 8.4 Hz), 7.06 (d, 2H, J = 8.4 Hz), 3.70 (dd, 1H, J = 
4.2, 7.2 Hz), 2.95 (d, 1H, J = 7.2 Hz), 2.42 (s, 3H), 2.32 (d, 1H, J = 4.5 Hz).  13C NMR 
(75 MHz, CDCl3): δ 144.8, 134.7, 134.1, 131.7, 129.7, 128.2, 127.9, 122.3, 40.2, 35.9, 
21.6.  FT-IR (film, cm-1): 2922, 1491, 1453, 1407, 1377, 1325, 1229, 1186, 1161, 1115, 
1093, 1071, 1012, 981, 910, 816, 769, 727, 705, 693, 665. 
 N-(p-Tolylsulfonyl)-2-(p-chlorophenyl)aziridine.63, 113 (Table 6-2, Entry 11) 
was 
synthesized from 4-chlorostyrene as substrate and the product obtained as a yellow oil 
(44 mg, yield 71%). 1H NMR (300 MHz, CDCl3): δ 7.85 (d, 2H, J = 8.4 Hz), 7.33 (d, 2H, 
J = 8.1 Hz), 7.27 (d, 2H, J = 8.7 Hz), 7.16 (d, 2H, J = 8.4 Hz), 3.73 (dd, 1H, J = 4.2, 7.2 
Hz), 2.97 (d, 1H, J = 6.9 Hz), 2.44 (s, 3H), 2.34 (d, 1H, J = 4.2 Hz).  13C NMR (75 MHz, 
CDCl3): δ 144.8, 134.7, 134.1, 133.6, 129.8, 128.7, 127.9, 40.2, 36.0, 21.6.  FT-IR (film, 
cm-1): 2924, 2361, 1597, 1494, 1454, 1414, 1378, 1325, 1306, 1230, 1188, 1162, 1092, 
1016, 981, 911, 816, 776, 729, 708, 694, 669. 
 N-(p-Tolylsulfonyl)-2-(p-fluorophenyl)aziridine.100, 113  (Table 6-2, Entry 12) 
was synthesized from 4-fluorostyrene as substrate and the product obtained as a yellow 
oil (50 mg, yield 86%).  1H NMR (300 MHz, CDCl3): δ 7.83 (d, 2H, J = 8.1 Hz), 7.31 (d, 
2H, J = 8.4 Hz), 7.16 (m, 2H), 6.96 (m, 2H), 3.74 (dd, 1H, J = 4.5, 7.2 Hz), 2.94 (d, 1H, J 
= 7.2 Hz), 2.42 (s, 3H), 2.32 (d, 1H, J = 4.5 Hz).  13C NMR (75 MHz, CDCl3): δ 144.8, 
134.7, 130.7, 129.8, 128.3, 128.2, 127.9, 115.7, 115.4, 40.2, 36.0, 21.6.  FT-IR (film, 
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cm-1): 3583, 3069, 2924, 1600, 1513, 1454, 1379, 1325, 1235, 1188, 1162, 1093, 1017, 
982, 912, 839, 818, 720, 692, 665. 
 N-(p-Tolylsulfonyl)-2-(pentafluorophenyl)aziridine.119, 120 (Table 6-2, Entry 13) 
was synthesized from pentafluorostyrene as substrate and the product obtained as a 
yellow oil (45 mg, yield, 61%).  1H NMR (300 MHz, CDCl3): δ 7.83 (d, 2H, J = 8.1 Hz), 
7.34 (d, 2H, J = 8.1 Hz), 3.77 (dd, 1H, J = 4.5, 7.2 Hz), 3.01 (d, 1H, J = 7.2 Hz), 2.77 (d, 
1H, J = 4.2 Hz), 2.44 (s, 3H).  13C NMR (75 MHz, CDCl3): δ 145.2, 134.1, 129.8, 128.3, 
32.4, 31.9, 21.7.  19F NMR (75 MHz, CDCl3): -142.6, -153.1, -161.8.  FT-IR (film, cm-1): 
2926, 1656, 1597, 1525, 1504, 1456, 1379, 1333, 1307, 1230, 1186, 1164, 1131, 1093, 
1023, 975, 943, 873, 816, 778, 747, 711, 696, 673. 
 N-(p-Tolylsulfonyl)-2-methyl-2-phenylaziridine.63, 113 (Table 6-2, Entry 14) was 
synthesized from α-methylstyrene as substrate and the product obtained as a yellow oil 
(42 mg, yield, 73%).  1H NMR (300 MHz, CDCl3): δ 7.85 (d, 2H, J = 8.4 Hz), 7.28-7.36 
(m, 7H), 2.95 (s, 1H), 2.51 (s, 1H), 2.42 (s, 3H), 2.03 (s, 3H).  13C NMR (75 MHz, 
CDCl3): δ 144.0, 141.0, 137.6, 129.5, 128.4, 127.7, 127.5, 126.5, 51.8, 41.8, 21.6, 20.9.  
FT-IR (film, cm-1): 3276, 2362, 1598, 1495, 1447, 1326, 1159, 909, 815, 765, 703, 666. 
 N-(p-Tolylsulfonyl)-2,2-diphenylaziridine.84, 113 (Table 6-2, Entry 15) was 
synthesized from 1,1-diphenylethylene as substrate and the product obtained as a 
yellow oil (57 mg, yield 81%).  1H NMR (300 MHz, CDCl3): δ 7.45 (d, 2H, J = 7.8 Hz), 
7.00-7.14 (m, 12H), 2.83 (s, 2H), 2.18 (s, 3H).  13C NMR (75 MHz, CDCl3): δ 147.4, 
129.7, 129.4, 128.8, 128.6, 128.2, 128.1, 127.9, 40.8, 21.6.  FT-IR (film, cm-1): 3273, 
3061, 2362, 1722, 1597, 1557, 1542, 1492, 1448, 1398, 1327, 1279, 1159, 1090, 1020, 
943, 917, 814, 756, 700, 673. 
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 N-(p-Tolylsulfonyl)amino-1,2,3,4-tetrahydronapthalene-1,2-imine.63, 113  
(Table 6-2, Entry 16) was synthesized from 1,2-dihydronapthalene as substrate and the 
product obtained as a yellow oil (20 mg, yield 33%).  1H NMR (300 MHz, CDCl3): δ7.82 
(d, 2H, J = 8.1 Hz), 7.30 (d, 2H, J = 8.1 Hz), 7.03-7.25 (m, 4H), 3.81 (d, 1H, J = 7.2 Hz), 
3.55 (d, 1H, J = 6.9 Hz), 2.72 (dt, 1H, J = 13.5, 6.3 Hz), 2.5 (dd, 1H, J = 13.5, 5.4 Hz), 
2.42 (s, 3H), 2.24 (dd, 1H, J = 14.8, 6.3 Hz), 1.62 (m, 1H).  13C NMR (75 MHz, CDCl3): δ 
144, 136.6, 135.5, 129.7, 129.4, 128.5, 128.4, 127.6, 126.3, 114.3, 42.0, 41.7, 24.7, 
21.6, 19.9.  FT-IR (film cm-1): 3585, 3026, 2925, 2854, 1598, 1494, 1433, 1398, 1321, 
1229, 1157, 1091, 1028, 989, 945, 908, 877, 814, 754, 731, 715, 670. 
 2,2-Dimethyl-1-(toluene-4-sulfonyl)-1,1a,2,7b-tetrahydro-3-oxa-1-azacyclo-
propa[a]naphthalene-6-carbonitrile.62, 82, 113 (Table 6-2, Entry 17) was synthesized 
from 2,2-dimethyl-2H-1-benzopyran-6-carbonitrile (185 mg, 1.0 mmol) and bromamine-
T (54.4 mg, 0.2 mmol) and the product obtained as a yellow oil (47 mg, yield 66%).  1H 
NMR (300 MHz, CDCl3): δ 7.80 (d, 2H, J = 8.1 Hz), 7.53 (d, 1H, J = 1.8 Hz), 7.46 (dd, 
2H, J = 8.4, 1.8 Hz), 7.31 (d, 2H, J = 8.1 Hz), 6.80 (d, 1H, J = 8.4 Hz), 3.86 (d, 1H, J = 
7.2 Hz), 3.35 (d, 1H, J = 7.5 Hz), 2.43 (s, 3H), 1.29 (s, 3H), 1.24 (s, 3H).  13C NMR (75 
MHz, CDCl3): δ 145.2, 134.4, 134.2, 133.2, 129.8, 128.0, 119.3, 119.2, 104.7, 73.2, 
49.2, 38.7, 25.8, 23.8, 21.7.  FT-IR (film, cm-1): 2980, 2925, 2854, 2360, 2227, 1615, 
1598, 1579, 1492, 1461, 1328, 1276, 1251, 1208, 1159, 1092, 1025, 962, 935, 874, 
850, 833, 784, 768, 717, 674. 
 trans-N-(p-Tolylsulfonyl)-2-methyl-3-phenylaziridine.63, 113 (Table 6-2, Entry 
18) was synthesized from cis-β-methystyrene as substrate and the product obtained as 
a yellow oil (54 mg, yield 94%).  1H NMR (300 MHz, CDCl3): δ 7.84 (d, 2H, J = 8.4 Hz), 
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7.24-7.30 (m, 5 H), 7.15-7.19 (m, 2H), 3.81 (d, 1H, J = 4.2 Hz), 2.93 (dq, 1H, J = 6.3, 
4.8 Hz), 2.40 (s, 3H), 1.85 (d, 3H, J = 5.7 Hz).  13C NMR (75 MHz, CDCl3): δ 143.9, 
137.8, 135.5, 129.5, 128.5, 128.0, 127.1, 126.2, 49.1, 49.0, 21.5, 14.1.   FT-IR (film, cm-
1): 2929, 1598, 1497, 1455, 1413, 1383, 1321, 1239, 1205, 1184, 1159, 1091, 1059, 
1037, 971, 890, 815, 749, 697, 685. 
 (cis- & tran)-N-(p-Tolylsulfonyl)-2,3-diphenylaziridine.63, 113  (Table 6-2, Entry 
19) was synthesized with cis-stilbene (36 μL, 0.2 mmol) with bromamine-T (163.0 mg, 
0.6 mmol) in the presence of 10 mole% Co(DClTPP) (19 mg, 0.2 mmol), and the 
products obtained as a mixture of cis- and trans- aziridine (65 mg, yield 92%). For cis-N-
(p-Tolylsulfonyl)-2,3-diphenylaziridine 1H NMR (300 MHz, CDCl3): δ 7.96 (d, 2H, J = 8.4 
Hz), 7.47 (d, 2H, J = 8.7 Hz), 7.03-7.13 (m, 10H), 4.23 (s, 2H), 2.45 (s, 3H). For trans-N-
(p-Tolylsulfonyl)-2,3-diphenylaziridine 1H NMR (300 MHz, CDCl3): δ 7.63 (d, 2H, J = 8.4 
Hz), 7.34-7.44 (m, 10H), 7.20 (d, 2H, J = 8.4 Hz), 4.27 (s, 2H), 2.38 (s, 3H).  13C NMR 
(75 MHz, CDCl3): δ 144.7, 143.9, 137.3, 137.0, 134.8, 133.0, 132.0, 129.8, 129.4, 
128.6, 128.4, 128.2, 128.0, 127.9, 127.7, 127.6, 127.5, 126.5, 50.3, 47.4, 21.7, 21.6.  
FT-IR (film, cm-1): 3061, 3031, 2923, 2854, 1598, 14957, 1452, 1401, 1327, 1160, 1090, 
1026, 908, 813, 785, 760,697, 674. 
 trans-N-(p-Tolylsulfonyl)-2-methyl-3-phenylaziridine.63, 113  (Table 6-2, Entry 
20) was synthesized from trans-β-methystyrene as substrate and the product obtained 
as a yellow oil (51 mg, yield 87%).  1H NMR (300 MHz, CDCl3): δ 7.84 (d, 2H, J = 8.4 
Hz), 7.24-7.30 (m, 5 H), 7.15-7.19 (m, 2H), 3.81 (d, 1H, J = 4.2 Hz), 2.93 (dq, 1H, J = 
6.3, 4.8 Hz), 2.40 (s, 3H), 1.85 (d, 3H, J = 5.7 Hz).  13C NMR(75 MHz, CDCl3): δ 143.9, 
137.8, 135.5, 129.5, 128.5, 128.0, 127.1, 126.2, 49.1, 49.0, 21.5, 14.1.  FT-IR (film, cm-
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1): 3583, 2928, 1598, 1497, 1456, 1413, 1383, 1320, 1238, 1205, 1184, 1159, 1091, 
1059, 1037, 971, 890, 815, 748, 697, 685, 665. 
 (cis- & trans)-N-(p-Tolylsulfonyl)-2,3-diphenylaziridine.63, 113  (Table 6-2, 
Entry 21) was synthesized with trans-stilbene (36 mg, 0.2 mmol) with bromamine-T 
(163.0 mg, 0.6 mmol) in the presence of 10 mole% Co(DClTPP) (19 mg, 0.2 mmol), and 
the products obtained as a mixture of cis- and trans- aziridine (66 mg, yield 94%). For 
cis-N-(p-Tolylsulfonyl)-2,3-diphenylaziridine 1H NMR (300 MHz, CDCl3): δ 7.96 (d, 2H, J 
= 8.4 Hz), 7.47 (d, 2H, J = 8.7 Hz), 7.03-7.13 (m, 10H), 4.23 (s, 2H), 2.45 (s, 3H). For 
trans-N-(p-Tolylsulfonyl)-2,3-diphenylaziridine 1H NMR (300 MHz, CDCl3): δ 7.63 (d, 2H, 
J = 8.4 Hz), 7.34-7.44 (m, 10H), 7.20 (d, 2H, J = 8.4 Hz), 4.27 (s, 2H), 2.38 (s, 3H).  13C 
NMR (75 MHz, CDCl3): δ 144.7, 143.9, 137.3, 137.0, 134.8, 133.0, 132.0, 129.8, 129.4, 
128.6, 128.4, 128.2, 128.0, 127.9, 127.7, 127.6, 127.5, 126.5, 50.3, 47.4, 21.7, 21.6.  
FT-IR (film, cm-1): 3583, 3273, 3062, 3032, 1723, 1598, 1495, 1451, 1399, 1327, 1160, 
1092, 1025, 906, 813, 785, 752, 699, 669. 
 N-(p-Tolylsulfonyl)-6-(azabicyclo)[3.1.0]hexane.  (Table 6-2, Entry 22) was 
synthesized from cyclopentene as substrate and the product obtained as a yellow oil 
(29 mg, yield 61%).  1H NMR (300 MHz, CDCl3): δ 7.80 (d, 2H, J = 8.4 Hz), 7.31 (d, 2H, 
J = 8.1 Hz), 3.33 (s, 2H), 2.44 (s, 3H), 1.95 (m, 2H), 1.61 (m, 4H).  13C NMR (75 MHz, 
CDCl3): δ 144.1, 135.9, 129.6, 127.6, 46.7, 26.9, 21.6, 19.5.  FT-IR (film, cm-1): 3271, 
2958, 2925, 2854, 1598, 1494, 1439, 1367, 1320, 1303, 1157, 1093, 1075, 1009, 977, 
931, 874, 832, 815, 723, 673. 
 N-(p-Tolylsulfonyl)-7-azabicyclo[4.1.0]heptane.64, 113  (Table 2, Entry 23) was 
synthesized from cyclohexene as substrate and the product obtained as a yellow oil (33 
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mg, yield 66%).  1H NMR (300 MHz, CDCl3): δ 7.79 (d, 2H, J = 7.8 Hz), 7.30 (d, 2 H, J = 
8.1 Hz), 2.96 (s, 2H), 2.42 (s, 3H), 1.77 (m, 4H), 1.39 (m, 2H), 1.20 (m, 2H).  13C NMR 
(75 MHz, CDCl3): 143, 141, 129, 127, 39.3, 22.3, 21.9, 18.9.  FT-IR (film, cm-1): 3280, 
2927, 2856, 2361, 2340, 1598, 1494, 1440, 1399, 1320, 1239, 1184, 1157, 1091, 1020, 
965, 921, 847, 816, 793, 724, 667. 
 N-(p-Tolylsulfonyl)-9-azabicyclo[6.1.0]nonane.63, 113 (Table 6-2, Entry 24) was 
synthesized from cyclooctene as substrate and the product obtained as a yellow oil (44 
mg, yield 79%).  1H NMR (300 MHz, CDCl3): δ 7.80 (d, 2H, J = 8.1 Hz), 7.31 (d, 2H, J = 
7.8 Hz), 2.76 (d, 1H, J = 9.9 Hz), 2.43 (s, 3H), 1.99 (d, 1H, J = 14.1 Hz), 1.55-1.23 (m, 
12H).  13C NMR (75 MHz, CDCl3): δ 144.0, 135.8, 129.6, 127.5, 43.9, 26.3, 26.1, 25.2, 
21.6.  FT-IR (film cm-1): 2927, 2857, 1598, 1494, 1468, 1449, 1425, 1320, 1158, 1092, 
1016, 985, 933, 889, 869, 856, 825, 815, 796, 764, 750, 720, 668. 
 N-(p-Tolylsulfonyl)-2-heptylaziridine.104, 113  (Table 6-2, Entry 25) was 
synthesized from 1-nonene as substrate and the product obtained as a yellow oil (33 
mg, yield 56%).  1H NMR (300 MHz, CDCl3): δ 7.82 (d, 2H, J = 6.6 Hz), 7.33 (d, 2H, J = 
8.1 Hz), 2.68 (m, 1H), 2.63 (d, 1H, J = 6.9 Hz), 2.44 (s, 3H), 2.05 (d, 1H, J = 4.2 Hz), 1.2 
(m, 12H), 0.87 (t, 3H, J = 6.3 Hz).  13C NMR (75 MHz, CDCl3): δ 144.4, 129.6, 128.0, 
40.5, 33.8, 31.6, 31.3, 29.1, 28.9, 26.8, 22.6, 21.6, 14.1.  FT-IR (film, cm-1): 2926, 2856, 
1725, 1598, 1494, 1458, 1401, 1325, 1232, 1161, 1092, 1020, 929, 869, 815, 768, 747, 
715, 694, 662. 
 N-(p-Tolylsulfonyl)-1-azaspiro[2.5]octane.105, 113 (Table 6-2, Entry 26) was 
synthesized from methylene cyclohexane as substrate and the product obtained as a 
yellow oil (36 mg, yield 67%).  1H NMR (300 MHz, CDCl3): δ 7.82 (d, 2H, J = 7.8 Hz), 
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7.30 (d, 2H, J = 8.1 Hz), 2.43 (s, 3H), 2.40 (s, 2H), 1.72-1.97 (m, 6H), 1.50 (m, 4H).  13C 
NMR (75 MHz, CDCl3): δ 143.7, 137.7, 129.4, 127.3, 54.0, 41.0, 33.0, 25.4, 25.2, 21.6.  
FT-IR (film, cm-1): 3287, 2934, 2857, 1598, 1495, 1448, 1386, 1318, 1252, 1209, 1158, 
1129, 1092, 1002, 943, 867, 840, 816, 793, 723, 664. 
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Chapter 7:  Cobalt-Catalyzed Intermolecular C-H Amination with 
Bromamine-T as a Nitrene Source 
 
This Chapter is a lightly revised version of a paper by the same name published in the 
journal Chemical Communications  in 2007 by authors Jeremiah D. Harden, Joshua V. 
Ruppel, Guanyo-Gao and X. Peter Zhang.  The major changes include 1) the exclusion 
of the abstract to the paper, 2) the reformatting of selected text to fit the guidelines of 
this dissertation, 3) reproduction and reformatting of the figures and tables, and 4) 
combination of the references in this dissertation with those from the other chapters in 
this section. 
 
Jeremiah D. Harden, Joshua V. Ruppel, Guang-Yao Gao and X. Peter Zhang.  Cobalt 
Catalyzed Intermolecular C-H Amination with Bromamine-T as a Nitrene Source.  
Chemical Communications  2007, 4644. 
 
My use of we and us refers to the other coauthors and myself.  My primary contributions 
to this paper include 1) synthesis of several of the porphyrin catalysts 2) synthesis of the 
Bromamine-T reagent 3) execution and analysis of all screening reactions, 4) execution 
and analysis of all substrate reactions, 5) characterization of all products, and 6) writing 
of the majority of the text. 
 
 
Cobalt, supported by porphyrin ligands, is capable of catalyzing intermolecular 
nitrene insertion of sp3 C–H bonds with bromamine-T as the nitrene source, forming the 
desired tosyl-protected amines with NaBr as the by-product.  Nitrogen containing 
molecules are abundant in nature and their importance in biology and medicine has 
been widely documented.  Among modern amination methods,121-124 metal-catalyzed 
nitrene insertion provides an attractive strategy for direct transformation of ubiquitous 
C–H bonds to value-added amine functionalities through the use of appropriate nitrene 
sources.54, 59, 60, 125  The reagent PhI=NTs and related iminoiodane derivatives have 
been widely used as primary nitrene sources,54, 59, 60, 125-129 resulting in significant 
advances in amination of C–H bonds.85, 89, 130-134  In view of some limitations associated 
with the use of the hypervalent iodine reagents, including their instability and the 
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generation of ArI as a byproduct, considerable efforts have been made to develop 
alternative nitrene sources for catalytic C–H amination.  One such remarkably 
successful effort has been the approach of in situ iminoiodane generation from amides 
using terminal oxidants such as the combination of sulfamates with PhI(OAc)2 or 
sulfonamides with PhI=O.66, 126-128, 135-137  In addition, efforts have been devoted to 
employ other potential nitrene sources that obviate the need of terminal oxidants for the 
catalytic amination process, including chloramine-T,134, 138 bromamine-T,77 
tosyloxycarbamates,139-141 and azides.81, 142  Using these nitrene sources, complexes of 
manganese, iron, ruthenium, rhodium, and copper supported by various ligands have 
been identified to catalyze C–H amination reactions, with dirhodium tetracarboxylates 
being the most widely used catalysts.54, 59, 60, 66, 85, 89, 125-127, 129-137  In the light of various 
remaining challenges in intermolecular C–H amination,54, 59, 60, 66, 85, 89, 125-127, 129-137 it is 
desirable to search for new catalytic systems based on other metal ions in combination 
with alternative nitrene sources.  To this end, silver143 - and cobalt115, 144 -based systems 
were recently reported to aminate C–H bonds with PhI=NTs and aryl azides, 
respectively.   
Attracted by their practical attributes as alternative nitrene sources, we recently 
initiated a research project on the development of catalytic nitrene transfer processes 
using bromamine-T and azides.  In connection with our studies on catalytic carbene 
transfer reactions by cobalt porphyrins [Co(Por)],93, 94, 112, 145, 146 we documented new 
Co-based catalytic systems that can catalyze aziridination of alkenes with 
diphenylphosphoryl azide (DPPA)147 and bromamine-T.148  The Co(Por)/bromamine-T 
system, which proved to be superior to the Fe(Por)Cl/bromamine-T system,148 can be 
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effectively operated under mild conditions with alkenes as the limiting reagent, 
generating NaBr as the by-product, and is generally suitable for a wide range of alkene 
substrates.  While the desired aziridines were formed in high yields for most of the 
substrates, low aziridination yields were obtained from certain substrates containing 
activated C–H bonds, such as 1,2-dihydronaphthalene.  At that time, without being able 
to obtain concrete experimental data, we presumed a competitive amination reaction to 
be the cause of low yields. Since then, we have carried out a thorough study on the 
possibility of catalytic C–H amination by Co(Por) with bromamine-T as the nitrene 
source (Figure 7-1).  Herein, we wish to report our findings.  
 Using indan as a model substrate, we systematically evaluated its catalytic C–H 
nitrene insertion with bromamine-T under different conditions by cobalt complexes of 
porphyrin ligands possessing varied electronic and steric environments (Figure 7-2).  
Selected results are summarized in Table 7-1.  While most of the tested cobalt 
complexes exhibited poor catalytic activity toward C–H amination, the cobalt complex of 
electron-deficient porphyrin Co(TPFPP) was found to aminate one of the benzylic C–H 
bonds of indan effectively to form the desired product 2a in 66% yield at room 
temperature (Table 7-1, entries 9–13).  Further experiments indicated the use of 
electron-deficient as well as more sterically demanding porphyrin TDClPP could further 
improve the cocatalyzed amination reaction, producing 2a in 75% yield (Table 7-1, entry 
3).  This reaction was performed with a 1a : bromamine-T ratio of 10 : 1 since the use of 
other reactant ratios appeared to give lower yields of 2a (Table 7-1, entries 1–3).  
Among the solvents examined, CH3CN proved to be the best for the catalytic process 











Figure 7-2.  Structures of Cobalt (II) Complexes of Porphyrins 
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Table 7-1.  Intermolecular C–H amination of indan with bromamine-T by cobalt(II) 
porphyrinsa 
 aReactions were carried out at room temperature under N2 with bromamine-T in the presence of 5 Å 
molecular sieves at a concentration of 2.0 mmol substrate/3–5 mL solvent. bThe mole ratio of indan 




 in the formation of the desired amination product (Table 7-1, entry 8), 5 mol% of 
Co(TDClPP) was needed for an effective transformation (Table 7-1, entry 3).  
 Under the optimized catalytic conditions derived from the above experiments for 
the amination of indan, the Co(TDClPP)/bromamine-T catalytic systems could also be 
applied to aminate other substrates at room temperature (Table 7-2).  While the isolated 
yield of 2a was 73% (Table 7-2, entry 1), the corresponding amination product 2b from 
1,2,3,4-tetrahydronaphthalene (1b) was isolated in 66% yield (Table 7-2, entry 2).  In 
both of the cases, high chemoselectivity toward benzylic C–H bonds was observed.  
The benzylic C–H bond of the cyclic ether 1c seemed to be similarly aminated with 
bromamine-T.  The reaction, however, didn’t afford the corresponding amine product. 
Instead, the corresponding imine product 2c was isolated in 50%yield (Table 7-2, entry 
3), presumably formed from the initial amine via a secondary reaction.149  Although 
fluorene 1d contains more activated benzylic C–H bonds, its catalytic amination reaction 
by Co(TDClPP) gave the C–H insertion product 2d in a much lower yield (Table 7-2, 
entry 4).  Steric hindrance is likely responsible for the adverse outcome.  When 
substrates that contain both secondary benzylic and primary C–H bonds such as 1- and 
2-ethylnaphthalene (1e and 1f) were used, the corresponding amination products of the 
benzylic C–H bonds 2e and 2f were produced as the major products, albeit in lower 
yields (Table 7-2, entries 5–6), affirming the high chemoselectivity towards benzylic C–
H bonds.  
  In summary, we have demonstrated the capability of cobalt porphyrins in 
catalyzing intermolecular nitrene insertion of sp3 C–H bonds with bromamine-T at room 
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Table 7-2. Co(TDClPP)-Catalyzed Intermolecular C–H Amination Reactions with 
Bromamine-Ta 
 aReactions were carried out at room temperature in CH3CN under N2 with bromamine-T as the limiting 
reagent (substrate/bromamine- T = 10 : 1) using 5 mol% Co(TDClPP) in the presence of 5 Å molecular 
sieves at a concentration of 2.0 mmol substrate/3–5 mL CH3CN. bYields represent isolated yields in 95% 
purity as determined by 1H NMR. 
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temperature.  In addition to mild conditions, the cobalt-based catalytic system enjoys the 
use of bromamine-T as the nitrene source since it produces innocent NaBr as the by-
product.  Furthermore, the current Co(TDClPP)/ bromamine-T catalytic intermolecular 
amination system has high chemoselectivity towards benzylic C–H bonds.  Efforts are 
underway to design and synthesize new porphyrin ligands to further improve the scope 
and efficacy of the Co-catalyzed intermolecular C–H amination system. 
Experimental Section 
 General Considerations. All reactions were carried out under nitrogen 
atmosphere in an oven dried Schlenk tube.  All alkanes were purchased from Acros or 
Aldrich Chemicals and used without further purification.  Acetonitrile and methylene 
chloride were dried by refluxing over calcium hydride.  Toluene and tetrahydrofuran 
were dried by refluxing over sodium benzophenone.  Metalloporphyrins were purchased 
from Strem or Midcentury Chemicals.  Bromamine-T was prepared from Chloramine-T 
according to the literature procedure and dried at 80ºC in vacuum overnight before 
use.150  Proton and carbon nuclear magnetic resonance spectra (1H NMR and 13C 
NMR) were recorded on a Varian Mercury 300 or Varian Inova400 spectrometer and 
referenced with respect to residual solvent.  Infrared spectra were measured with a 
Nicolet Avatar 320 spectrometer with a Smart Miracle accessory.  High resolution mass 
spec. (HRMS) data was obtained on an Agilent 1100 LC/MS ESI/TOF mass 
spectrometer with electrospray ionization.  Thin layer chromatography was carried out 
on E. Merck Silica Gel 60 F-254 TLC plates. 
 General Procedure for Amination. An oven dried Schlenk tube equipped with a 
stirring bar was degassed on vacuum line and purged with nitrogen.  The tube was 
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charged with metalloporphyrin (5 mol %), Bromamine-T (0.2 mmol) and activated 5 Å 
molecular sieves (200 mg).  The tube was capped with a Teflon screw cap and 
evacuated on vacuum line for 30-45 min.  The Teflon screw cap was replaced with a 
rubber septum and 0.5 mL of solvent and substrate (2 mmol) followed by the remaining 
solvent (total 2 mL) were then added successively.  The tube was purged with nitrogen 
for 1-2 min and the contents were stirred overnight at ambient temperatures.  After 
completion of the reaction, molecular sieves were removed by filtration and the filtrate 
was concentrated under vacuum.  The residue was purified by flash chromatography, 
and the fractions containing product were collected and concentrated by rotary 
evaporation to afford the pure compound. 
 N-(p-Toluenesulfonyl)-1-aminoindan.77, 89, 151-153 (Table 7-2, Entry 1) 1-5 was 
synthesized using indan as the substrate and the product was obtained as a tan-white 
solid (42.1 mg, 72.8%). 1H NMR (300 MHz, CDCl3): δ 7.84 (d, J = 8.1 Hz, 2H), 7.34 (d, 
J = 8.1 Hz, 2H), 7.07-7.22 (m, 4H), 4.84 (dd, J1 = 7.5 Hz, J2 = 15.9 Hz, 1H), 4.71 (d, J = 
8.7 Hz, 1H), 2.85-2.97 (m, 1H), 2.67-2.78 (m, 1H), 2.45 (s, 3H), 2.28-2.39 (m, 1H), 1.68-
1.81 (m, 1H). 13C NMR (75 MHz, CDCl3): δ 143.43, 142.79, 141.96, 138.16, 129.75, 
128.24, 127.10, 126.81, 124.76, 124.06, 58.68, 34.66, 29.92, 21.53. IR (neat, cm–1): 
3257 (N-H), 1158 (S=O). HRMS (ESI): Calculated For C16H21N2O2S ([M+NH4]+) m/z 
305.13183, Found 305.13292.  
 N-(p-Toluenesulfonyl)-1-amino-1,2,3,4-tetrahydronaphthalene.73, 77, 150, 151 
(Table 7-2, Entry 2) 1,2,4- 6 was synthesized using 1,2,3,4-tetrahydronaphthalene as 
the substrate and the product was obtained as a tan-white solid (40.1 mg, 66%) 1H 
NMR (300 MHz, CDCl3): δ 7.82 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 7.8 Hz, 2H), 7.12 (m, 
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2H), 7.05 (t, J = 7.5 Hz, 1H), 6.92 (d, J = 8.1 Hz, 1H), 4.62 (d, J = 7.8 Hz, 1H), 4.44 (m, 
1H), 2.71 (m, 2H), 2.46 (s, 3H), 1.72-1.86 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 
143.40, 137.55, 135.57, 129.76, 129.21, 128.76, 127.64, 127.14, 126.30, 51.89, 30.75, 
28.86, 21.56, 19.08. IR (neat, cm–1) 3258 (N-H), 1153 (S=O). HRMS (ESI): Calculated 
for C17H19NO2SNa ([M+Na]+) m/z 324.10287, Found 324.10191.  
 N-(isobenzofuran-1(3H)-ylidene)-4-methylbenzenesulfonamide. (Table 7-2, 
Entry 3) was synthesized using phthalan as the substrate and the product was 
recovered as a dark tan solid (29.1 mg, 50%). 1H NMR (400 MHz, CDCl3): δ 7.97 (d, J 
= 8.0 Hz, 1H), 7.92 (d, J = 7.2 Hz, 1H), 7.68 (t, J = 7.2 Hz, 1H), 7.53-7.46 (m, 2H), 7.31 
(d, J = 7.6 Hz, 1H), 5.59 (s, 2H), 2.42 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 134.51, 
129.39, 129.25, 127.52, 125.66, 121.42, 76.25, 29.68. IR (neat, cm–1): 1634 (C=N), 
1297 (C-O), 1152 (S=O). HRMS (ESI): Calculated for C15H14NO3S ([M+H]+) m/z 
288.06889, Found 288.06848.  
 N-(p-Toluenesulfonyl)-1-aminofluorene.154 (Table 7-2, Entry 4) 7 was 
synthesized using fluorene as the substrate and the product was recovered as a dark 
tan solid (9.4 mg, 14%). 1H NMR (300 MHz, CDCl3): δ 7.97 (d, J = 8.4 Hz, 2H), 7.63 (d, 
J = 7.2 Hz, 2H), 7.42 (d, J = 7.8 Hz, 2H), 7.36 (m, 2H), 7.23 (m, 4H), 5.41 (d, J = 9.6 Hz, 
1H), 4.75 (d, J = 9.3 Hz, 1H), 2.51 (s, 3H). 13C NMR (CDCl3): δ 144.06, 143.55, 
138.60, 130.22, 129.24, 128.11, 127.58, 125.43, 120.19, 58.62, 21.89. IR (neat, cm–1): 
3303 (N-H), 1155 (S=O). HRMS (ESI): Calculated for C20H21N2O2S ([M+NH4]+) m/z 
353.13183, Found 353.13296. 
 N-(p-Toluenesulfonyl)-1-amino-2-ethylnaphthalene.89, 150, 153, 155, 156 (Table 7-
2, Entry 5) was synthesized using 2-ethylnaphthalene as the substrate and the product 
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was recovered as a dark tan solid (22.1 mg, 34%). 1H NMR (300 MHz, CDCl3): δ 7.75 
(t, J1 = 6 Hz, J2 = 3.3 Hz, 1H), 7.66 (d, J = 8.7 Hz, 2H), 7.57 (d, J = 10 Hz, 2H), 7.41-
7.47 (m, 3H), 7.20 (d, J = 8.7 Hz, 1H), 7.03 (d, J = 8.4 Hz, 2H), 4.92 (d, J = 7.2 Hz, 1H), 
4.64 (dt, J1 = 13.5 Hz, J2 = 6.6 Hz, 1H), 2.25 (s, 3H), 1.51 (d, J = 6.6 Hz, 3H). 13NMR 
(75 MHz, CDCl3): δ 143.11, 138.98, 137.50, 133.03, 132.67, 129.28, 128.44, 127.49, 
127.06, 126.17, 125.96, 125.03, 124.03, 53.78, 23.44, 21.31. IR (neat, cm–1): 3267 (N-
H), 1155 (S=O). HRMS (ESI): Calculated for C19H23N2O2S ([M+NH4]+) m/z 
343.14748, Found 343.14775. 
 N-(p-Toluenesulfonyl)-1-amino-1-ethylnaphthalene.153, 157 (Table 7-2, Entry 6) 
5,10 was synthesized using 1-ethylnaphthalene as the substrate and the product was 
recovered as a dark tan solid (21.4 mg, 33%). 1H NMR (300 MHz, CDCl3): δ 7.88 (d, J 
= 7.2 Hz, 1H), 7.80 (d, J = 6 Hz, 1H), 7.60 (d, J = 8.1 Hz, 2H), 7.57 (d, J = 8.4 Hz, 2H), 
7.44 (m, 2H), 7.35 (m, 2H), 7.07 (d, J =8.1 Hz, 2H), 5.28 (dt, J1 = 13.5 Hz, J2 = 6.6 Hz, 
1H), 5.0 (d, J = 6.9 Hz, 1H), 2.33 (s, 3H), 1.59 (d, J = 6.9 Hz, 3H). 13C NMR (75 MHz, 
CDCl3): δ 143.07, 137.56, 137.38, 133.77, 130.10, 129.26, 128.82, 128.14, 127.04, 
126.27, 125.63, 125.21, 123.33, 122.59, 49.76, 23.20, 21.40. IR (neat, cm–1): 3268 (N-
H), 1155 (S=O). HRMS (ESI): Calculated for C19H23N2O2S ([M+NH4]+) m/z 
343.14748, Found 343.14831. 
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Chapter 8:  Cobalt-Catalyzed Aziridination with Diphenylphosphoryl 
Azide (DPPA): Direct Synthesis of N- Phosphorous – Substituted 
Aziridines from Alkenes 
 
This Chapter is a lightly revised version of a paper by the same name published in the 
Journal of Organic Chemistry in 2006 by Guang-Yao Gao, Jess E. Jones, Renu Vyas, 
Jeremiah D. Harden, and X. Peter Zhang.  The major changes include 1) the exclusion 
of the abstract to the paper, 2) the reformatting of selected text to fit the guidelines of 
this work, 3) reproduction and reformatting of the figures and tables, and 4) combination 
of the references in this work with those from the other chapters in this section. 
 
Guang-Yao Gao, Jess E. Jones, Renu Vyas,  Jeremiah D. Harden, and X. Peter Zhang.  
Cobalt-Catalyzed Aziridination with Diphenylphosphoryl Azide (DPPA): Direct Synthesis 
of N-Phosphorous-Substituted Aziridines from Alkenes.  Journal of Organic Chemistry  
2006, 71, 6655. 
 
My use of we and us refers to the other coauthors and myself.  My primary contributions 
to this paper include 1) synthesis of porphyrin catalyst, and 2) repetition and verification 
of select reactions.  
 
 
Aziridines, the smallest nitrogen-containing heterocyclic compounds, have 
received considerable research interests because of their fundamental and practical 
importance.55, 106-108  In addition to being an important motif in many biologically and 
pharmaceutically interesting compounds, aziridines are notably known as a class of 
versatile synthons for preparation of functionalized amines.  Of known synthetic 
strategies, catalytic nitrene transfer from a suitable nitrene source to alkene substrates 
by transition metal complexes is considered the most attractive approach for the 
construction of the three-membered ring structures.54, 56, 57  Compared to the 
considerable advances in analogous epoxidation and cyclopropanation reactions, 
catalytic aziridination is much less developed, presumably due to the lack of suitable 
nitrene sources.  [N-(p-Toluenesulfonyl)imino]phenyliodinane (PhI=NTs) has been 
extensively used as the primary nitrene source for metal-catalyzed aziridination.59-61  
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While notable results have been obtained with PhI=NTs in several metal catalyzed 
systems,62-64 the nitrene source suffers from several drawbacks: commercial 
unavailability, costly synthesis, short shelf life, insolubility in common solvents, and 
generation of PhI as a byproduct.67, 68, 153  To this end, recent efforts have been made to 
develop alternative nitrene sources that can be used in metal-catalyzed aziridination, 
including chloramine-T,73, 95 bromamine-T,77, 78 and tosyl azide.81, 110 
Supported by different ligands, complexes of several transition metals, including 
Mn, Fe, Cu, Ru, and Rh, have been demonstrated to catalyze aziridination of alkenes 
with these nitrene sources.54, 56-65, 67, 68, 73, 77, 78, 81, 95, 106-108, 110, 153  Most of these catalytic 
systems lead to the formation of N-sulfonylated aziridines.  Different from N-sulfonylated 
aziridines in which the deprotection of N-sulfonyl groups normally requires harsh 
conditions,158, 159 N-phosphorylated and N-phosphinylated aziridines offer advantages 
as synthetic building blocks since the phosphoryl and phosphinyl groups bring suitable 
activation to the aziridine ring and can be easily deprotected.160-170  Although several 
methods are available for the preparation of N-phosphorus-substituted aziridines,160-168, 
171 their direct synthesis from alkenes via transition metal-catalyzed aziridination has not 
been developed.172 
Attracted by their unique ligand environments and metal coordination modes,173 
we90-94, 112-114, 148, 174, 175 and others83, 84, 86-89, 176 have been interested in developing 
metalloporphyrin-based catalytic systems for aziridination.  Previously, we reported that 
iron and cobalt porphyrins can effectively catalyze aziridination reactions of a wide 
variety of alkenes with bromamine-T as an alternative nitrene source.113, 148  We reveal 
herein that cobalt(II) porphyrin complex Co(TPP) (Figure 8-1) can catalyze aziridination 
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of alkenes using diphenylphosphoryl azide (DPPA) as a convenient new nitrene 
source,61, 177-179 leading to the formation of N-phosphorylated aziridines with dinitrogen 
as the byproduct (Figure 8-2).  To the best of our knowledge, this represents one of the 
few catalytic aziridination systems that use cobalt-based catalysts113, 148, 180 or that 
employ azides as nitrene sources.81, 110, 115 
 To explore the possibility of DPPA as an effective nitrene source, we initially 
carried out systematic studies on aziridination of styrene as a model reaction using 
different metalloporphyrins as potential catalysts under various conditions.  Among 
porphyrin complexes of different metal ions that were evaluated, cobalt ion seems 
essential to successful aziridination of styrene with DPPA.  While Co(TPP) could 
catalyze the formation of the desired product (Table 8-1), employment of other 
metalloporphyrins, including Cr(TPP)Cl, Mn(TPP)Cl, Fe(TPP)Cl, Ni(TPP), and 
Ru(TPP)(CO) (Figure 8-1), produced only trace amounts of the N-phosphorylated 
aziridine.  It should be noted that no aziridines were observed without a catalyst.  Strong 
solvent effects were also noticed for the aziridination process.  Of the common solvents 
used, chlorobenzene appeared the solvent of choice for the reaction, forming the 
desired N-phosphorylated aziridine as the major product.  Use of other solvents, 
including acetonitrile, dichloromethane, dimethylformamide, tetrahydrofuran, and 
toluene, gave little or no amount of the desired product.   
 As summarized in Table 8-1, a styrene to DPPA ratio of 5:1 gave the best result 
for the Co(TPP)-catalyzed aziridination in chlorobenzene.  An increase or decrease in 
























Table 8-1.  Aziridination of Styrene with DPPA catalyzed by Cobalt (II) 
Tetraphenylporphyrin Complex Under Various Conditionsa 
 
 a Reactions were carried out in chlorobenzene under N2 in the presence of 5Å molecular sieves using 
Co(TPP) as a catalyst with or without additives.  Concentration:  [DPPA] = 0.1M  b  Mole ratio of Styrene 
to DPPA.  c Isolated Yields. 
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reaction could proceed with a nearly complete conversion of DPPA overnight at 100 °C, 
the N-phosphorylated aziridine was isolated in only 50% yield (entry 3) due to formation 
of some unidentified side products during reaction (and possibly during product isolation 
with silica gels).  While a slight increase in yield was obtained at a higher temperature 
(entry 6), prolonged heating resulted in a yield reduction (entries 5 and 8).  A reduced 
yield was also observed at a shorter reaction time (entry 7) or at a lower reaction 
temperature (entry 9). However, a reaction that was carried out at lower temperature for 
longer time gave the desired product in an improved yield (entry 10).  Reduction in 
catalyst loadings dropped the yields for overnight reactions (entries 11 and 12).  A 
negative additive effect was observed for the catalytic process.  Addition of a small 
amount of DMAP completely shut down the reaction (entries 13-15). The negative effect 
was reduced with weaker coordinative additives, such as Ph3P, THF, and CH3CN 
(entries 16-18).  As aforementioned, no desired products were observed when the 
reactions were performed with THF or CH3CN as the solvent. Block of coordination sites 
of cobalt center by the potentially coordinative additives might be responsible for the 
observed negative effects. 
The substrate scope of the Co(TPP)-based aziridination with DPPA was then 
investigated with different alkenes. The results of a series of styrene derivatives are 
summarized in Table 8-2. Under the above-mentioned typical reaction conditions, 
mmethylstyrene was a better substrate than styrene, while aziridination of p-tert-butyl 
styrene gave a slightly lower yield (entries 1-3). The Co-based aziridination system 
appeared equally suitable to styrene derivatives having electron-withdrawing 
substituents, such as halogen and trifluoromethyl groups (entries 4-7). Even the highly 
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electron-deficient pentafluorostyrene could be aziridinated with DPPA, albeit in lower 
yields (entry 8).181  While a low yield was obtained for the aziridination of 2-
vinylnaphthalene (entry 10), the reaction of m-nitrostyrene produced the desired N-
phosphorylated aziridine in the highest yield (entry 9). All the aziridination products were 
isolated in high purity and characterized by 1H, 13C, and 31P NMR, FTIR, and high-
resolution MS spectroscopy.  
 As exemplified with the N-phosphorylated aziridine from styrene (Figure 8-3), 
each of the three aziridine-ring hydrogens exhibits a characteristic doublet of doublet of 
doublets (ddd) peak pattern in the 1H NMR spectrum between 2.2 and 3.8 ppm, which 
results from the coupling among the three hydrogens that was further split by the 
phosphorus atom. 
The catalytic aziridination by Co(TPP) with DPPA can be assumed to proceed via 
a mechanism similar to that proposed for other metalloporphyrin-based systems with 
PhI=NTs.  As proposed in Figure 8-4, this mechanism requires, however, the 
involvement of a cobalt-nitrene intermediate A, which has not been known previously.  
More experimental work is obviously necessary before there is further discussion of the 
reaction mechanism for this new catalytic process. 
In summary, we have demonstrated the first application of the common reagent 
DPPA as a new nitrene source for catalytic aziridination by Co(TPP), forming 
synthetically valuable Nphosphorylated aziridines directly from the 
correspondingalkenes.  Considering its low cost, commercial availability, and high 
stability, DPPA and related phosphoryl azides may find broad applications in metal-
catalyzed aziridination and other nitrene-transfer processes.  In addition to our ongoing
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Table 8-2.  Aziridination of Styrene Derivatives with DPPA Catalyzed by Cobalt 
(II) Tetraphenylporphyrin Complexa 
 
 a Reactions were carried out overnight at 100oC in chlorobenzene under N2 in the presence of 5Å 
molecular sieves using 10 mol % Co(TPP).  Concentration:  [DPPA] = 0.1M; Alkene:DPPA  = 5:1. 











Figure 8-4.  Proposed Aziridination Mechanism with DPPA Catalyzed by  
Cobalt (II) Tetraphenylporphyrin 
 
 164
efforts to understand the mechanism of the Co-catalyzed aziridination, further 
improvement of its catalytic efficiency and the development of its asymmetric variant are 
in progress in our laboratory. 
Experimental Section 
General Considerations. All reactions were carried out under a nitrogen 
atmosphere in an oven dried Schlenk tube.  Diphenylphosphoryl azide (DPPA), the 
metalloporphyrins, and the olefins are commercially available and were used without 
further purification.  Chlorobenzene was dried with calcium hydride in reflux.  Proton, 
carbon, phosphorous, and fluorine nuclear magnetic resonance spectra (1H NMR, 13C 
NMR, 31P NMR, and 19F NMR) were recorded on a 300 MHz spectrometer and 
referenced with respect to residual solvent.  Thin layer chromatography was carried out 
on Silica Gel 60 F-254 TLC plates. 
 General Procedure for Aziridination of Alkenes.  An oven dried Schlenk tube 
equipped with a stirring bar was degassed on a vacuum line and purged with nitrogen.  
The tube was charged with metalloporphyrin (10 mol %) and activated 5Å molecular 
sieves (200 mg).  The tube was capped with a Teflon screw cap, then evacuated on a 
vacuum line for 30-45 min.  The Teflon screw cap was replaced with a rubber septum 
and 2 mL of solvent, diphenylphosphoryl azide (0.2 mmol) and substrate (1.0 mmol) 
were then added successively.  The tube was purged with nitrogen for 1-2 min and the 
contents were stirred and heated at 80-100 oC, overnight.  After completion of the 
reaction, the mixture was cooled down to room temperature.  The molecular sieves 
were removed by filtration and the filtrate was concentrated under vacuum.  The solid 
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residue was purified by flash chromatography (silica gel, ethyl acetate:hexanes (V:V) = 
3:7) to afford the pure product. 
 (2-Phenylaziridin-1-yl)phosphonic acid diphenyl ester. (Table 8-2, Entry 1) was 
synthesized from the reaction of styrene with DPPA and obtained as a yellow oil. 1H 
NMR (300 MHz, CDCl3): δ 7.27-7.00 (m, 15H), 3.63 (ddd, 1H, J ) 16.5, 6.3, 3.6 Hz), 
2.82 (ddd, 1H, J ) 19.5, 6.3, 1.2 Hz), 2.24 (ddd, 1H, J ) 15.6, 3.6, 1.2 Hz). 13C NMR (75 
MHz, CDCl3): δ 129.7, 129.6, 128.5, 128.1, 126.2, 125.2, 120.5, 120.4, 120.3, 39.0, 
38.9, 35.0, 34.9. 31P NMR (121 MHz, CDCl3): δ 6.11 (s). FT-IR (film, cm-1): 1590, 1191, 
941, 669. HRMS-EI ([M]+) for C20H18NO3P, Calculated 351.1024, Found 351.1022. 
 (2-m-Tolylaziridin-1-yl)phosphonic acid diphenyl ester. (Table 8-2, Entry 2) 
was synthesized from the reaction of m methylstyrene with DPPA and obtained as a 
yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.28-6.95 (m, 14H), 3.61 (ddd, 1H, J ) 16.5, 
6.0, 3.3 Hz), 2.80 (dd, 1H, J ) 19.2, 6.0 Hz), 2.22 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 
129.7, 129.6, 128.8, 128.3, 126.8, 125.2, 123.4, 120.5, 120.4, 120.3, 39.0, 38.9, 34.9, 
34.8, 21.3. 31P NMR (121 MHz, CDCl3): ä 6.19 (s). FT-IR (film, cm-1): 1711, 1585, 
1482, 1190, 1010, 932, 762. HRMS-EI ([M]+) for C21H20NO3P, Calculated 365.1181, 
Found 365.1174. 
 [2-(p-tert-Butylphenyl)aziridin-1-yl]phosphonic acid diphenyl ester. (Table 8-
2, Entry 3) was synthesized from the reaction of p-tertbutylstyrene with DPPA and 
obtained as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.28-7.00 (m, 14H), 3.62 (ddd, 
1H, J ) 16.5, 6.0, 3.6 Hz), 2.80 (ddd, 1H, J ) 19.8, 6.6, 1.2 Hz), 2.24 (ddd, 1H, J ) 15.3, 
3.6, 1.2 Hz), 1.24 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 129.7, 129.6, 125.9, 125.4, 
125.2, 120.5, 120.4, 120.3, 38.9, 38.8, 34.9, 34.8, 34.5, 31.3. 31P NMR (121 MHz, 
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CDCl3): δ 6.24 (s). FT-IR (film, cm-1): 1592, 1490, 1193, 943, 773, 689. HRMS-EI 
([M]+) for C24H26NO3P, Calculated 407.1650, Found 407.1658. 
 [2-(p-Bromophenyl)aziridin-1-yl]phosphonic acid diphenyl ester. (Table 8-2, 
Entry 4) was synthesized from the reaction of p-bromostyrene with DPPA and obtained 
as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.35 (d, 2H, J ) 8.4 Hz), 7.28-7.07 (m, 
10H), 7.01 (d, 2H, J ) 8.4 Hz), 3.57 (ddd, 1H, J ) 16.2, 6.0, 3.3 Hz), 2.80 (ddd, 1H, J  = 
18.9, 6.0, 1.2 Hz), 2.19 (ddd, 1H, J ) 15.3, 3.3, 1.2 Hz). 13C NMR (75 MHz, CDCl3): δ 
129.7, 129.6, 127.9, 125.3, 120.4, 120.3, 120.3, 38.3, 38.2, 35.0, 34.9. 31P NMR (121 
MHz, CDCl3): δ 5.76 (s). FT-IR (film, cm-1): 1591, 1489, 1283, 1192, 1163, 1072, 1006, 
945, 827, 774. HRMS-EI ([M]+) for C20H17BrNO3P, Calculated 429.0129, Found 
429.0127. 
 [2-(p-Chlorophenyl)aziridin-1-yl]phosphonic acid diphenyl ester. (Table 8-2, 
Entry 5) was synthesized from the reaction of p-chlorostyrene with DPPA and obtained 
as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.28-7.07 (m, 14H), 3.57 (ddd, 1H, J ) 
16.2, 6.0, 3.3 Hz), 2.80 (ddd, 1H, J ) 19.2, 6.0, 1.2 Hz), 2.19 (ddd, 1H, J ) 15.3, 3.3, 1.2 
Hz). 13C NMR (75 MHz, CDCl3): δ 129.7, 129.6, 128.6, 127.5, 125.3, 120.4, 120.3, 
120.2, 38.3, 38.2, 35.0, 34.9. 31P NMR (121 MHz, CDCl3): δ 5.79 (s). FT-IR (film, cm-1): 
1592, 1490, 1193, 943, 773, 689. HRMS-EI ([M]+) for C20H17ClNO3P, Calculated 
385.0635, Found 385.0629. 
 [2-(p-Fluorophenyl)aziridin-1-yl]phosphonic acid diphenyl ester. (Table 8-2, 
Entry 6) was synthesized from the reaction of p-fluorostyrene with DPPA and obtained 
as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.28-7.04 (m, 12H), 6.92 (t, 2H, J ) 8.7 
Hz), 3.59 (ddd, 1H, J ) 16.5, 6.0, 3.6 Hz), 2.80 (ddd, 1H, J ) 19.5, 6.3, 1.2 Hz), 2.19 
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(ddd, 1H, J ) 15.0, 3.3, 0.6 Hz). 13C NMR (75 MHz, CDCl3): δ 129.7, 129.6, 127.8, 
127.7, 125.3, 120.4, 120.3, 120.2, 115.6, 115.3, 38.3, 38.2, 35.0, 34.9. 31P NMR (121 
MHz, CDCl3): δ 5.96 (s). FT-IR (film, cm-1): 1592, 1490, 1224, 1192, 932, 835, 689. 
HRMS-EI ([M]+) for C20H17FNO3P, Calculated 369.0930, Found 369.0946. 
 [2-(p-Trifluoromethylphenyl)aziridin-1-yl]phosphonic acid diphenyl ester. 
(Table 8-2, Entry 7) was synthesized from the reaction of p-trifluoromethylstyrene with 
DPPA and obtained as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.48 (d, 2H, J ) 7.80 
Hz),7.26 (d, 2H, J ) 7.5 Hz), 7.23-7.04 (m, 10H), 3.65 (ddd, 1H, J ) 16.2, 6.0, 3.6 Hz), 
2.84 (dd, 1H, J ) 19.2, 6.3 Hz), 2.22 (dd, 1H, J ) 15.3, 3.3 Hz). 13C NMR (75 MHz, 
CDCl3): δ 129.8, 129.7, 126.5, 125.5, 125.4, 125.3, 120.3, 120.3, 120.2, 38.3, 38.2, 
35.0, 35.0. 31P NMR (121 MHz, CDCl3): δ 5.63 (s).19F NMR (280 MHz, CDCl3): ä 
62.95. FT-IR (film, cm-1): 1621, 1592, 1490, 1326, 1193, 1165, 1068, 1005, 947, 904, 
774, 689. HRMS-EI ([M]+) for C21H17F3NO3P, Calculated 419.0898, Found 419.0894. 
 (2-Pentafluorophenylaziridin-1-yl)phosphonic acid diphenyl ester. (Table 8-
2, entry 8) was synthesized from the reaction of pentafluorostyrene with DPPA and 
obtained as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.29-7.07 (m, 10H), 3.71 (ddd, 
1H, J ) 16.5, 6.3, 3.6 Hz), 2.86 (dd, 1H, J ) 18.9, 6.3 Hz), 2.76 (dd, 1H, J ) 15.6, 3.6 Hz). 
13C NMR (75 MHz, CDCl3): δ 129.8, 129.7, 125.4, 125.3, 120.2, 120.1, 120.0, 30.9, 
30.0. 31P NMR (121 MHz, CDCl3): δ 5.35 (s). 19F NMR (280 MHz, CDCl3): ä -140, -
152, -160. FT-IR (film, cm-1): 1687, 1520, 1476, 1176, 980. HRMSEI ([M]+) for 
C20H13F5NO3P, Calculated 441.0553, Found 441.0559. 
 [2-(m-Nitrophenyl)aziridin-1-yl]phosphonic acid diphenyl ester. (Table 8-2, 
entry 9) was synthesized from the reaction of m-nitrostyrene with DPPA and obtained 
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as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 8.05 (dd, 1H, J ) 8.1, 0.9 Hz), 7.98 (br s, 
1H), 7.49-7.04 (m, 10H), 3.70 (ddd, 1H, J ) 16.2, 6.0, 3.3 Hz), 2.89 (dd, 1H, J ) 18.6, 6.0 
Hz), 2.25 (dd, 1H, J ) 15.3, 3.3 Hz). 13C NMR (75 MHz, CDCl3): δ 132.3, 129.8, 129.7, 
129.5, 125.4, 123.0, 121.1, 120.3, 120.2, 37.9, 37.8. 31P NMR (121 MHz, CDCl3): δ 
5.27 (s). FT-IR (film, cm-1): 1591, 1531, 1488, 1350, 1190, 950. HRMS-EI ([M - H]+) for 
C20H17N2O5P, Calculated 395.0797,Found 395.0789. 
 [2-(2-Naphthalenyl)aziridin-1-yl]phosphonic acid diphenyl ester. (Table 8-2, 
entry 10) was synthesized from the reaction of 2-vinylnaphthalene with DPPA and 
obtained as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.77-7.64 (m, 4H), 7.42-7.39 (m, 
2H), 7.28-7.05 (m, 10H), 3.80 (ddd, 1H, J ) 16.5, 6.0, 3.6 Hz), 2.89 (ddd, 1H, J ) 19.2, 
6.0, 1.2 Hz), 2.34 (ddd, 1H, J ) 15.3, 3.3, 1.2 Hz). 13C NMR (75 MHz, CDCl3): δ 129.7, 
129.6, 128.3, 127.7, 127.7, 126.3, 126.1, 125.8, 125.2, 123.4, 120.5, 120.4, 120.3, 39.2, 
34.9. 31P NMR (121 MHz, CDCl3): δ 6.13 (s). FT-IR (film, cm-1): 1593, 1489, 1193, 936, 
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(2-Phenyl-aziridin-1-yl)-phosphonic acid diphenyl ester
(2-m-Tolyl-aziridin-1-yl)-phosphonic acid diphenyl ester
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[2-(p-tert-Butylphenyl)-aziridin-1-yl]-phosphonic acid diphenyl ester
[2-(p-Bromophenyl)-aziridin-1-yl]-phosphonic acid diphenyl ester
 
 202
[2-(p-Chlorophenyl)-aziridin-1-yl]-phosphonic acid diphenyl ester
[2-(p-Fluorophenyl)-aziridin-1-yl]-phosphonic acid diphenyl ester
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[2-(p-Trifluoromethyl-phenyl)-aziridin-1-yl]-phosphonic acid diphenyl ester
(2-Pentafluorophenyl-aziridin-1-yl)-phosphonic acid diphenyl ester
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[2-(m-Nitrophenyl)-aziridin-1-yl]-phosphonic acid diphenyl ester
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